Document:

Exhibit
            10.14

            

            [FORM OF SERIES
            A WARRANT]

            

            NEITHER THE ISSUANCE AND SALE
            OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE
            SECURITIES ARE EXERCISEABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
            AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR
            SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION
            STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN
            OPINION OF COUNSEL, IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED
            UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT.
            NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA
            FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE
            SECURITIES.

            

            AMISH
            NATURALS, INC.

            

            WARRANT TO
            PURCHASE COMMON STOCK

            

            Warrant No.: _______

            Number of Shares of Common Stock:

            Date of Issuance: September __, 2007 ("Issuance Date")

            

            
                    Amish
            Naturals, Inc., a Nevada corporation, (the “Company”), hereby
            certifies that, for good and valuable consideration, the receipt and sufficiency of
            which are hereby acknowledged, CASTLERIGG MASTER INVESTMENTS LTD., the registered
            holder hereof or its permitted assigns (the “Holder”), is entitled,
            subject to the terms set forth below, to purchase from the Company, at the Exercise
            Price (as defined below) then in effect, upon surrender of this Warrant to Purchase
            Common Stock (including any Warrants to purchase Common Stock issued in exchange,
            transfer or replacement hereof, the “Warrant”), at any time or times
            on or after the date hereof, but not after 11:59 p.m., New York Time, on the Expiration
            Date (as defined below), ONE MILLION, FIVE HUNDRED NINETY SEVEN THOUSAND, THREE HUNDRED
            THIRTY ONE (1,597,331) fully paid nonassessable shares of Common Stock (as defined
            below) (the “Warrant Shares”). Except as otherwise defined herein,
            capitalized terms in this Warrant shall have the meanings set forth in Section 15. This
            Warrant is one of the Warrants to purchase Common Stock (the “SPA
            Warrants”) issued pursuant to Section 1 of that certain Securities Purchase
            Agreement, dated as of August 31, 2007 (the “Subscription Date”), by
            and among the Company and the investors (the “Buyers”) referred to
            therein (the “Securities Purchase Agreement”).

            
            
            

            
            

            

            
                    1.    
            EXERCISE OF WARRANT.

            

            
                    (a)    
            Mechanics of Exercise. Subject to the terms and conditions hereof (including,
            without limitation, the limitations set forth in Section 1(f)), this Warrant may be
            exercised by the Holder on any day on or after the date hereof in whole or in part, by
            (i) delivery of a written notice, in the form attached hereto as Exhibit A
            (the “Exercise Notice”), of the Holder’s election to exercise
            this Warrant and (ii) (A) payment to the Company of an amount equal to the
            applicable Exercise Price multiplied by the number of Warrant Shares as to which this
            Warrant is being exercised (the “Aggregate Exercise Price”) in cash
            or by wire transfer of immediately available funds or (B) by notifying the Company that
            this Warrant is being exercised pursuant to a Cashless Exercise (as defined in Section
            1(d)). The Holder shall not be required to deliver the original Warrant in order to
            effect an exercise hereunder. Execution and delivery of the Exercise Notice with
            respect to less than all of the Warrant Shares shall have the same effect as
            cancellation of the original Warrant and issuance of a new Warrant evidencing the right
            to purchase the remaining number of Warrant Shares. On or before the first Business Day
            following the date on which the Company has received each of the Exercise Notice and
            the Aggregate Exercise Price (or notice of a Cashless Exercise) (the “Exercise
            Delivery Documents”), the Company shall transmit by facsimile an
            acknowledgment of confirmation of receipt of the Exercise Delivery Documents to the
            Holder and the Company’s transfer agent (the “Transfer
            Agent”). On or before the third Trading Day following the date on which the
            Company has received all of the Exercise Delivery Documents (the “Share
            Delivery Date”), the Company shall (X) provided that the Transfer Agent is
            participating in The Depository Trust Company (“DTC”) Fast Automated
            Securities Transfer Program, upon the request of the Holder, credit such aggregate
            number of shares of Common Stock to which the Holder is entitled pursuant to such
            exercise to the Holder’s or its designee’s balance account with DTC through
            its Deposit Withdrawal Agent Commission system, or (Y) if the Transfer Agent is not
            participating in the DTC Fast Automated Securities Transfer Program, issue and dispatch
            by overnight courier to the address as specified in the Exercise Notice, a certificate,
            registered in the Company’s share register in the name of the Holder or its
            designee, for the number of shares of Common Stock to which the Holder is entitled
            pursuant to such exercise. Upon delivery of the Exercise Delivery Documents, the Holder
            shall be deemed for all corporate purposes to have become the holder of record of the
            Warrant Shares with respect to which this Warrant has been exercised, irrespective of
            the date such Warrant Shares are credited to the Holder’s DTC account or the date
            of delivery of the certificates evidencing such Warrant Shares, as the case may be. If
            this Warrant is submitted in connection with any exercise pursuant to this Section 1(a)
            and the number of Warrant Shares represented by this Warrant submitted for exercise is
            greater than the number of Warrant Shares being acquired upon an exercise, then the
            Company shall as soon as practicable and in no event later than three Business Days
            after any exercise and at its own expense, issue a new Warrant (in accordance with
            Section 7(d)) representing the right to purchase the number of Warrant Shares
            purchasable immediately prior to such exercise under this Warrant, less the number of
            Warrant Shares with respect to which this Warrant is exercised. No fractional shares of
            Common Stock are to be issued upon the exercise of this Warrant, but rather the number
            of shares of Common Stock to be issued shall be rounded up to the nearest whole number.
            The Company shall pay any and all taxes which may be payable with respect to the
            issuance and delivery of Warrant Shares upon exercise of this Warrant.

            
            
            

            
            

            

            
                    (b)    
            Exercise Price. For purposes of this Warrant, “Exercise Price”
            means $1.8781, subject to adjustment as provided herein.

            

            
                    (c)    
            Company’s Failure to Timely Deliver Securities. If the Company shall fail for
            any reason or for no reason to issue to the Holder within three (3) Trading Days of
            receipt of the Exercise Delivery Documents, a certificate for the number of shares of
            Common Stock to which the Holder is entitled and register such shares of Common Stock
            on the Company’s share register or to credit the Holder’s balance account
            with DTC for such number of shares of Common Stock to which the Holder is entitled upon
            the Holder’s exercise of this Warrant, then, in addition to all other remedies
            available to the Holder, the Company shall pay in cash to the Holder on each day after
            such thirdTrading Day that the issuance of such shares of Common Stock is not timely
            effected an amount equal to 1.5% of the product of (A) the sum of the number of shares
            of Common Stock not issued to the Holder on a timely basis and to which the Holder is
            entitled and (B) the Closing Sale Price of the shares of Common Stock on the Trading
            Day immediately preceding the last possible date which the Company could have issued
            such shares of Common Stock to the Holder without violating Section 1(a). In addition
            to the foregoing, if within three (3) Trading Days after the Company’s receipt of
            the facsimile copy of a Exercise Notice the Company shall fail to issue and deliver a
            certificate to the Holder and register such shares of Common Stock on the
            Company’s share register or credit the Holder’s balance account with DTC
            for the number of shares of Common Stock to which the Holder is entitled upon the
            Holder’s exercise hereunder, and if on or after such Trading Day the Holder
            purchases (in an open market transaction or otherwise) shares of Common Stock to
            deliver in satisfaction of a sale by the Holder of shares of Common Stock issuable upon
            such exercise that the Holder anticipated receiving from the Company (a
            “Buy-In”), then the Company shall, within three Business Days after
            the Holder’s request and in the Holder’s discretion, either (i) pay cash to
            the Holder in an amount equal to the Holder’s total purchase price (including
            brokerage commissions, if any) for the shares of Common Stock so purchased (the
            “Buy-In Price”), at which point the Company’s obligation to
            deliver such certificate (and to issue such shares of Common Stock) or credit such
            Holder’s balance account with DTC shall terminate, or (ii) promptly honor its
            obligation to deliver to the Holder a certificate or certificates representing such
            shares of Common Stock or credit such Holder’s balance account with DTC and pay
            cash to the Holder in an amount equal to the excess (if any) of the Buy-In Price over
            the product of (A) such number of shares of Common Stock, times (B) the Closing Bid
            Price on the date of exercise.

            

            
                    (d)    
            Cashless Exercise. Notwithstanding anything contained herein to the contrary, if a
            Registration Statement (as defined in the Registration Rights Agreement) covering the
            resale of the Warrant Shares that are the subject of the Exercise Notice (the
            “Unavailable Warrant Shares”) is not available for the resale of
            such Unavailable Warrant Shares, the Holder may, in its sole discretion, exercise this
            Warrant in whole or in part and, in lieu of making the cash payment otherwise
            contemplated to be made to the Company upon such exercise in payment of the Aggregate
            Exercise Price, elect instead to receive upon such exercise the “Net
            Number” of shares of Common Stock determined according to the following formula
            (a “Cashless Exercise”):

            	
                    	
                    	
                    
	
                    Net Number = 	
                    (A x B) — (A x
                    C)

                    B 	
                      

            

            

            
                    
                      For purposes of the
            foregoing formula:

            

            
                    
                      A= the total number of
            shares with respect to which this Warrant is then being exercised.

            

            
                    
                      B= the Closing Sale Price
            of the shares of Common Stock (as reported by Bloomberg) on the date immediately
            preceding the date of the Exercise Notice.

            

            
                    
                      C= the Exercise Price then
            in effect for the applicable Warrant Shares at the time of such exercise.

            

            
                    (e)  
            Disputes. In the case of a dispute as to the determination of the Exercise Price
            or the arithmetic calculation of the Warrant Shares, the Company shall promptly issue
            to the Holder the number of Warrant Shares that are not disputed and resolve such
            dispute in accordance with Section 12.

            

            
                    (f)  
            Limitations on Exercises.

            

            -4-

            
            
            

            
            

            

            	
                      	
                            (i)  
                    Beneficial Ownership. The Company shall not effect the exercise of this
                    Warrant, and the Holder shall not have the right to exercise this Warrant, to
                    the extent that after giving effect to such exercise, such Person (together
                    with such Person’s affiliates) would beneficially own in excess of 4.99%
                    of the shares of Common Stock outstanding immediately after giving effect to
                    such exercise. For purposes of the foregoing sentence, the aggregate number of
                    shares of Common Stock beneficially owned by such Person and its affiliates
                    shall include the number of shares of Common Stock issuable upon exercise of
                    this Warrant with respect to which the determination of such sentence is being
                    made, but shall exclude shares of Common Stock which would be issuable upon (A)
                    exercise of the remaining, unexercised portion of this Warrant beneficially
                    owned by such Person and its affiliates and (B) exercise or conversion of the
                    unexercised or unconverted portion of any other securities of the Company
                    beneficially owned by such Person and its affiliates (including, without
                    limitation, any convertible notes or convertible preferred stock or warrants)
                    subject to a limitation on conversion or exercise analogous to the limitation
                    contained herein. Except as set forth in the preceding sentence, for purposes
                    of this paragraph, beneficial ownership shall be calculated in accordance with
                    Section 13(d) of the Securities Exchange Act of 1934, as amended (the
                    “Exchange Act”). For purposes of this Warrant, in
                    determining the number of outstanding shares of Common Stock, the Holder may
                    rely on the number of outstanding shares of Common Stock as reflected in (1)
                    the Company’s most recent Form 10-K, Form 10-KSB, Form 10-Q, Form 10-QSB,
                    Current Report on Form 8-K or other public filing with the Securities and
                    Exchange Commission, as the case may be, (2) a more recent public announcement
                    by the Company or (3) any other notice by the Company or the Transfer Agent
                    setting forth the number of shares of Common Stock outstanding. For any reason
                    at any time, upon the written or oral request of the Holder, the Company shall
                    within one (1) Business Day confirm orally and in writing to the Holder the
                    number of shares of Common Stock then outstanding. In any case, the number of
                    outstanding shares of Common Stock shall be determined after giving effect to
                    the conversion or exercise of securities of the Company, including the SPA
                    Securities and the SPA Warrants, by the Holder and its affiliates since the
                    date as of which such number of outstanding shares of Common Stock was
                    reported. By written notice to the Company, the Holder may from time to time
                    increase or decrease the Maximum Percentage to any other percentage not in
                    excess of 9.99% specified in such notice; provided that (i) any such increase
                    will not be effective until the sixty-first (61st) day after such
                    notice is delivered to the Company, and (ii) any such increase or decrease will
                    apply only to the Holder and not to any other holder of SPA Warrants.
                              

            

            

            	
                      	
                            (ii)
                      Principal Market Regulation. The Company shall not be
                    obligated to issue any shares of Common Stock upon exercise of this Warrant or
                    conversion of SPA Securities and no Buyer shall be entitled to receive any
                    shares of Common Stock if the issuance of such shares of Common Stock would
                    exceed that number of shares of Common Stock which the Company may issue upon
                    exercise or conversion, as applicable, of the SPA Warrants and SPA Securities
                    or otherwise without breaching the Company’s obligations under the rules
                    or regulations of any applicable Eligible Market (the “Exchange
                    Cap”), except that such limitation shall not apply in the event that
                    the Company (A) obtains the approval of its shareholders as required by the
                    applicable rules of the Eligible Market for issuances of shares of Common Stock
                    in excess of such amount or (B) obtains a written opinion from outside counsel
                    to the Company that such approval is not required, which opinion shall be
                    reasonably satisfactory to the Required Holders. Until such approval or written
                    opinion is obtained, no Buyer shall be issued in the aggregate, upon exercise
                    or conversion, as applicable, of any SPA Warrants or SPA Securities, shares of
                    Common Stock in an amount greater than the product of the Exchange Cap
                    multiplied by a fraction, the numerator of which is the total number of shares
                    of Common Stock underlying the SPA Warrants issued to such Buyer pursuant to
                    the Securities Purchase Agreement on the Issuance Date and the denominator of
                    which is the aggregate number of shares of Common Stock underlying the SPA
                    Warrants issued to the Buyers pursuant to the Securities Purchase Agreement on
                    the Issuance Date (with respect to each Buyer, the “Exchange Cap
                    Allocation”). In the event that any Buyer shall sell or otherwise
                    transfer any of such Buyer’s SPA Warrants, the transferee shall be
                    allocated a pro rata portion of such Buyer’s Exchange Cap Allocation, and
                    the restrictions of the prior sentence shall apply to such transferee with
                    respect to the portion of the Exchange Cap Allocation allocated to such
                    transferee. In the event that any holder of SPA Warrants shall exercise all of
                    such holder’s SPA Warrants into a number of shares of Common Stock which,
                    in the aggregate, is less than such holder’s Exchange Cap Allocation,
                    then the difference between such holder’s Exchange Cap Allocation and the
                    number of shares of Common Stock actually issued to such holder shall be
                    allocated to the respective Exchange Cap Allocations of the remaining holders
                    of SPA Warrants on a pro rata basis in proportion to the shares of Common Stock
                    underlying the SPA Warrants then held by each such holder. In the event that
                    the Company is prohibited from issuing any Warrant Shares for which an Exercise
                    Notice has been received as a result of the operation of this Section 1(f)(ii),
                    the Company shall pay cash in exchange for cancellation of such Warrant Shares,
                    at a price per Warrant Share equal to the difference between the Closing Sale
                    Price and the Exercise Price as of the date of the attempted exercise.
                    

            

            

            -5-

            
            
            

            
            

            

            	
                      	
                            (g)
                      Insufficient Authorized Shares. If at any time while this
                    Warrant remain outstanding the Company does not have a sufficient number of
                    authorized and unreserved shares of Common Stock to satisfy its obligation to
                    reserve for issuance upon exercise of this Warrant at least a number of shares
                    of Common Stock equal to 130% (the “Required Reserve
                    Amount”) of the number of shares of Common Stock as shall from time
                    to time be necessary to effect the exercise of all of this Warrant then
                    outstanding (an “Authorized Share Failure”), then the
                    Company shall immediately take all action necessary to increase the
                    Company’s authorized shares of Common Stock to an amount sufficient to
                    allow the Company to reserve the Required Reserve Amount for this Warrant then
                    outstanding. Without limiting the generality of the foregoing sentence, as soon
                    as practicable after the date of the occurrence of an Authorized Share Failure,
                    but in no event later than ninety (90) days after the occurrence of such
                    Authorized Share Failure, the Company shall hold a meeting of its stockholders
                    for the approval of an increase in the number of authorized shares of Common
                    Stock. In connection with such meeting, the Company shall provide each
                    stockholder with a proxy statement and shall use its best efforts to solicit
                    its stockholders’ approval of such increase in authorized shares of
                    Common Stock and to cause its board of directors to recommend to the
                    stockholders that they approve such proposal. 

            

            

            
                    2.  
            ADJUSTMENT OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES. The Exercise Price
            and the number of Warrant Shares shall be adjusted from time to time as
            follows:

            

            -6-

            
            
            

            
            

            

            
                    
                      
                      (a) Adjustment upon
            Issuance of shares of Common Stock. If and whenever on or after the Subscription
            Date the Company issues or sells, or in accordance with this Section 2 is deemed to
            have issued or sold, any shares of Common Stock (including the issuance or sale of
            shares of Common Stock owned or held by or for the account of the Company, but
            excluding shares of Common Stock deemed to have been issued by the Company in
            connection with any Excluded Securities) for a consideration per share (the
            “New Issuance Price”) less than the Exercise Price (the
            “Applicable Price”) in effect immediately prior to such issue or
            sale or deemed issuance or sale (the foregoing a “Dilutive
            Issuance”), then immediately after such Dilutive Issuance, the Exercise Price
            then in effect shall be reduced to an amount equal to the New Issuance Price. Upon each
            such adjustment of the Exercise Price hereunder, the number of Warrant Shares shall be
            adjusted to the number of shares of Common Stock determined by multiplying the Exercise
            Price in effect immediately prior to such adjustment by the number of Warrant Shares
            acquirable upon exercise of this Warrant immediately prior to such adjustment and
            dividing the product thereof by the Exercise Price resulting from such adjustment. For
            purposes of determining the adjusted Exercise Price under this Section 2(a), the
            following shall be applicable:

            

            	
                    	
                        
                            (i)
                               Issuance of Options. If
                        the Company in any manner grants any Options and the lowest price per share
                        for which one share of Common Stock is issuable upon the exercise of any
                        such Option or upon conversion, exercise or exchange of any Convertible
                        Securities issuable upon exercise of any such Option is less than the
                        Applicable Price, then such share of Common Stock shall be deemed to be
                        outstanding and to have been issued and sold by the Company at the time of
                        the granting or sale of such Option for such price per share. For purposes
                        of this Section 2(a)(i), the “lowest price per share for which one
                        share of Common Stock is issuable upon exercise of such Options or upon
                        conversion, exercise or exchange of such Convertible Securities issuable
                        upon exercise of any such Option” shall be equal to the sum of the
                        lowest amounts of consideration (if any) received or receivable by the
                        Company with respect to any one share of Common Stock upon the granting or
                        sale of the Option, upon exercise of the Option and upon conversion,
                        exercise or exchange of any Convertible Security issuable upon exercise of
                        such Option. No further adjustment of the Exercise Price or number of
                        Warrant Shares shall be made upon the actual issuance of such shares of
                        Common Stock or of such Convertible Securities upon the exercise of such
                        Options or upon the actual issuance of such shares of Common Stock upon
                        conversion, exercise or exchange of such Convertible Securities.

                    

            

            

            	
                    	
                        
                            (ii)
                               Issuance of Convertible
                        Securities. If the Company in any manner issues or sells any
                        Convertible Securities and the lowest price per share for which one share
                        of Common Stock is issuable upon the conversion, exercise or exchange
                        thereof is less than the Applicable Price, then such share of Common Stock
                        shall be deemed to be outstanding and to have been issued and sold by the
                        Company at the time of the issuance or sale of such Convertible Securities
                        for such price per share. For the purposes of this Section 2(a)(ii), the
                        “lowest price per share for which one share of Common Stock is
                        issuable upon the conversion, exercise or exchange thereof” shall be
                        equal to the sum of the lowest amounts of consideration (if any) received
                        or receivable by the Company with respect to one share of Common Stock upon
                        the issuance or sale of the Convertible Security and upon conversion,
                        exercise or exchange of such Convertible Security. No further adjustment of
                        the Exercise Price or number of Warrant Shares shall be made upon the
                        actual issuance of such shares of Common Stock upon conversion, exercise or
                        exchange of such Convertible Securities, and if any such issue or sale of
                        such Convertible Securities is made upon exercise of any Options for which
                        adjustment of this Warrant has been or is to be made pursuant to other
                        provisions of this Section 2(a), no further adjustment of the Exercise
                        Price or number of Warrant Shares shall be made by reason of such issue or
                        sale.

                    

            

            

            -7-

            
            
            

            
            

            

            	
                    	
                        
                            (iii)
                               Change in Option Price or Rate
                        of Conversion. If the purchase price provided for in any Options, the
                        additional consideration, if any, payable upon the issue, conversion,
                        exercise or exchange of any Convertible Securities, or the rate at which
                        any Convertible Securities are convertible into or exercisable or
                        exchangeable for shares of Common Stock increases or decreases at any time,
                        the Exercise Price and the number of Warrant Shares in effect at the time
                        of such increase or decrease shall be adjusted to the Exercise Price and
                        the number of Warrant Shares which would have been in effect at such time
                        had such Options or Convertible Securities provided for such increased or
                        decreased purchase price, additional consideration or increased or
                        decreased conversion rate, as the case may be, at the time initially
                        granted, issued or sold. For purposes of this Section 2(a)(iii), if the
                        terms of any Option or Convertible Security that was outstanding as of the
                        date of issuance of this Warrant are increased or decreased in the manner
                        described in the immediately preceding sentence, then such Option or
                        Convertible Security and the shares of Common Stock deemed issuable upon
                        exercise, conversion or exchange thereof shall be deemed to have been
                        issued as of the date of such increase or decrease. No adjustment pursuant
                        to this Section 2(a)(iii) shall be made if such adjustment would result in
                        an increase of the Exercise Price then in effect or a decrease in the
                        number of Warrant Shares.

                    

            

            

            	
                    	
                        
                            (iv)
                               Calculation of Consideration
                        Received. In case any Option is issued in connection with the issue or
                        sale of other securities of the Company, together comprising one integrated
                        transaction in which no specific consideration is allocated to such Options
                        by the parties thereto, the Options will be deemed to have been issued for
                        a consideration of $0.01. If any shares of Common Stock, Options or
                        Convertible Securities are issued or sold or deemed to have been issued or
                        sold for cash, the consideration received therefor will be deemed to be the
                        net amount received by the Company therefor. If any shares of Common Stock,
                        Options or Convertible Securities are issued or sold for a consideration
                        other than cash, the amount of such consideration received by the Company
                        will be the fair value of such consideration, except where such
                        consideration consists of publicly traded securities, in which case the
                        amount of consideration received by the Company will be the Closing Sale
                        Price of such security on the date of receipt. If any shares of Common
                        Stock, Options or Convertible Securities are issued to the owners of the
                        non-surviving entity in connection with any merger in which the Company is
                        the surviving entity, the amount of consideration therefor will be deemed
                        to be the fair value of such portion of the net assets and business of the
                        non-surviving entity as is attributable to such shares of Common Stock,
                        Options or Convertible Securities, as the case may be. The fair value of
                        any consideration other than cash or publicly traded securities will be
                        determined jointly by the Company and the Required Holders. If such parties
                        are unable to reach agreement within ten (10) days after the occurrence of
                        an event requiring valuation (the “Valuation Event”),
                        the fair value of such consideration will be determined within five (5)
                        Business Days after the tenth day following the Valuation Event by an
                        independent, reputable appraiser jointly selected by the Company and the
                        Required Holders. The determination of such appraiser shall be final and
                        binding upon all parties absent manifest error and the fees and expenses of
                        such appraiser shall be borne by the Company.

                    

            

            

            -8-

            
            
            

            
            

            

            	
                    	
                        
                            (v)
                               Record Date. If the
                        Company takes a record of the holders of shares of Common Stock for the
                        purpose of entitling them (A) to receive a dividend or other
                        distribution payable in shares of Common Stock, Options or in Convertible
                        Securities or (B) to subscribe for or purchase shares of Common Stock,
                        Options or Convertible Securities, then such record date will be deemed to
                        be the date of the issue or sale of the shares of Common Stock deemed to
                        have been issued or sold upon the declaration of such dividend or the
                        making of such other distribution or the date of the granting of such right
                        of subscription or purchase, as the case may be.

                    

            

            

            	
                    	
                        
                            (vi)
                               Voluntary Adjustment By
                        Company. The Company may at any time during the term of
                        this Warrant reduce the then current  Exercise
                        Price to any amount and for any period of time deemed appropriate by
                        the Board of Directors of the Company. 

                    

            

            

            
                    
            (b)   Adjustment upon Subdivision or Combination of shares of Common
            Stock. If the Company at any time on or after the Subscription Date subdivides (by
            any stock split, stock dividend, recapitalization or otherwise) one or more classes of
            its outstanding shares of Common Stock into a greater number of shares, the Exercise
            Price in effect immediately prior to such subdivision will be proportionately reduced
            and the number of Warrant Shares will be proportionately increased. If the Company at
            any time on or after the Subscription Date combines (by combination, reverse stock
            split or otherwise) one or more classes of its outstanding shares of Common Stock into
            a smaller number of shares, the Exercise Price in effect immediately prior to such
            combination will be proportionately increased and the number of Warrant Shares will be
            proportionately decreased. Any adjustment under this Section 2(b) shall become
            effective at the close of business on the date the subdivision or combination becomes
            effective.

            

            
                    (c)  
            Other Events. If any event occurs of the type contemplated by the provisions of
            this Section 2 but not expressly provided for by such provisions (including, without
            limitation, the granting of stock appreciation rights, phantom stock rights or other
            rights with equity features), then the Company’s Board of Directors will make an
            appropriate adjustment in the Exercise Price and the number of Warrant Shares so as to
            protect the rights of the Holder; provided that no such adjustment pursuant to this
            Section 2(c) will increase the Exercise Price or decrease the number of Warrant Shares
            as otherwise determined pursuant to this Section 2.

            

            -9-

            
            
            

            
            

            

            
                    3.  
            RIGHTS UPON DISTRIBUTION OF ASSETS. If the Company shall declare or make any
            dividend or other distribution of its assets (or rights to acquire its assets) to
            holders of shares of Common Stock, by way of return of capital or otherwise (including,
            without limitation, any distribution of cash, stock or other securities, property or
            options by way of a dividend, spin off, reclassification, corporate rearrangement,
            scheme of arrangement or other similar transaction) (a
            “Distribution”), at any time after the issuance of this Warrant,
            then, in each such case:

            

            
                    
                      (a) any Exercise Price in
            effect immediately prior to the close of business on the record date fixed for the
            determination of holders of shares of Common Stock entitled to receive the Distribution
            shall be reduced, effective as of the close of business on such record date, to a price
            determined by multiplying such Exercise Price by a fraction of which (i) the numerator
            shall be the Closing Bid Price of the shares of Common Stock on the Trading Day
            immediately preceding such record date minus the value of the Distribution (as
            determined in good faith by the Company’s Board of Directors) applicable to one
            share of Common Stock, and (ii) the denominator shall be the Closing Bid Price of the
            shares of Common Stock on the Trading Day immediately preceding such record date;
            and

            

            
                    
                      (b) the number of Warrant
            Shares shall be increased to a number of shares equal to the number of shares of Common
            Stock obtainable immediately prior to the close of business on the record date fixed
            for the determination of holders of shares of Common Stock entitled to receive the
            Distribution multiplied by the reciprocal of the fraction set forth in the immediately
            preceding paragraph (a); provided that in the event that the Distribution is of shares
            of common stock (“Other Shares of Common Stock”) of a company whose
            common shares are traded on a national securities exchange or a national automated
            quotation system, then the Holder may elect to receive a warrant to purchase Other
            Shares of Common Stock in lieu of an increase in the number of Warrant Shares, the
            terms of which shall be identical to those of this Warrant, except that such warrant
            shall be exercisable into the number of shares of Other Shares of Common Stock that
            would have been payable to the Holder pursuant to the Distribution had the Holder
            exercised this Warrant immediately prior to such record date and with an aggregate
            exercise price equal to the product of the amount by which the exercise price of this
            Warrant was decreased with respect to the Distribution pursuant to the terms of the
            immediately preceding paragraph (a) and the number of Warrant Shares calculated in
            accordance with the first part of this paragraph (b).

            

            
                    4.
                   PURCHASE RIGHTS; FUNDAMENTAL
            TRANSACTIONS.

            

            -10-

            
            
            

            
            

            

            
                    
                      (a) Purchase Rights.
            In addition to any adjustments pursuant to Section 2 above, if at any time the Company
            grants, issues or sells any Options, Convertible Securities or rights to purchase
            stock, warrants, securities or other property pro rata to the record holders of any
            class of shares of Common Stock (the “Purchase Rights”), then the
            Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights,
            the aggregate Purchase Rights which the Holder could have acquired if the Holder had
            held the number of shares of Common Stock acquirable upon complete exercise of this
            Warrant (without regard to any limitations on the exercise of this Warrant) immediately
            before the date on which a record is taken for the grant, issuance or sale of such
            Purchase Rights, or, if no such record is taken, the date as of which the record
            holders of shares of Common Stock are to be determined for the grant, issue or sale of
            such Purchase Rights.

            

            
                    
                      (b) Fundamental
            Transactions. The Company shall not enter into or be party to a Fundamental
            Transaction unless (i)  the Successor Entity assumes in writing all of the
            obligations of the Company under this Warrant and the other Transaction Documents in
            accordance with the provisions of this Section (4)(b) pursuant to written agreements in
            form and substance satisfactory to the Required Holders and approved by the Required
            Holders prior to such Fundamental Transaction, including agreements to deliver to each
            holder of Warrants in exchange for such Warrants a security of the Successor Entity
            evidenced by a written instrument substantially similar in form and substance to this
            Warrant, including, without limitation, an adjusted exercise price equal to the value
            for the shares of Common Stock reflected by the terms of such Fundamental Transaction,
            and exercisable for a corresponding number of shares of capital stock equivalent to the
            shares of Common Stock acquirable and receivable upon exercise of this Warrant (without
            regard to any limitations on the exercise of this Warrant) prior to such Fundamental
            Transaction, and satisfactory to the Required Holders and (ii) the Successor
            Entity (including its Parent Entity) is a publicly traded corporation whose common
            stock is quoted on or listed for trading on an Eligible Market. Upon the occurrence of
            any Fundamental Transaction, the Successor Entity shall succeed to, and be substituted
            for (so that from and after the date of such Fundamental Transaction, the provisions of
            this Warrant referring to the “Company” shall refer instead to the
            Successor Entity), and may exercise every right and power of the Company and shall
            assume all of the obligations of the Company under this Warrant with the same effect as
            if such Successor Entity had been named as the Company herein. Upon consummation of the
            Fundamental Transaction, the Successor Entity shall deliver to the Holder confirmation
            that there shall be issued upon exercise of this Warrant at any time after the
            consummation of the Fundamental Transaction, in lieu of the shares of the Common Stock
            (or other securities, cash, assets or other property) purchasable upon the exercise of
            the Warrant prior to such Fundamental Transaction, such shares of the publicly traded
            Common Stock (or its equivalent) of the Successor Entity (including its Parent Entity),
            as adjusted in accordance with the provisions of this Warrant. In addition to and not
            in substitution for any other rights hereunder, prior to the consummation of any
            Fundamental Transaction pursuant to which holders of shares of Common Stock are
            entitled to receive securities or other assets with respect to or in exchange for
            shares of Common Stock (a “Corporate Event”), the Company shall make
            appropriate provision to insure that the Holder will thereafter have the right to
            receive upon an exercise of this Warrant at any time after the consummation of the
            Fundamental Transaction but prior to the Expiration Date, in lieu of the shares of the
            Common Stock (or other securities, cash, assets or other property) purchasable upon the
            exercise of the Warrant prior to such Fundamental Transaction, such shares of stock,
            securities, cash, assets or any other property whatsoever (including warrants or other
            purchase or subscription rights) which the Holder would have been entitled to receive
            upon the happening of such Fundamental Transaction had the Warrant been exercised
            immediately prior to such Fundamental Transaction. Provision made pursuant to the
            preceding sentence shall be in a form and substance reasonably satisfactory to the
            Required Holders. The provisions of this Section shall apply similarly and equally to
            successive Fundamental Transactions and Corporate Events and shall be applied without
            regard to any limitations on the exercise of this Warrant.

            

            -11-

            
            
            

            
            

            

            
                    
                     (c) Notwithstanding the foregoing
            and the provisions of Section 4(b) above, in the event of a Fundamental Transaction, at
            the request of the Holder delivered before the ninetieth (90th) day after the
            consummation of such Fundamental Transaction, the Company (or the Successor Entity)
            shall purchase this Warrant from the Holder by paying to the Holder, within five (5)
            Business Days of such request (or, if later, on the effective date of the Fundamental
            Transaction, cash in an amount equal to the Black-Scholes Value of the remaining
            unexercised portion of this Warrant on the date of such Fundamental
            Transaction.

            

            

            

            

            

            

            

            

            -12-

            
            
            

            
            

            

            
                    5.  
            WARRANT HOLDER NOT DEEMED A STOCKHOLDER. Except as otherwise specifically
            provided herein, the Holder, solely in such Person’s capacity as a holder of this
            Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of
            share capital of the Company for any purpose, nor shall anything contained in this
            Warrant be construed to confer upon the Holder, solely in such Person’s capacity
            as the Holder of this Warrant, any of the rights of a shareholder of the Company or any
            right to vote, give or withhold consent to any corporate action (whether any
            reorganization, issue of stock, reclassification of stock, consolidation, merger,
            conveyance or otherwise), receive notice of meetings, receive dividends or subscription
            rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which
            such Person is then entitled to receive upon the due exercise of this Warrant. In
            addition, nothing contained in this Warrant shall be construed as imposing any
            liabilities on the Holder to purchase any securities (upon exercise of this Warrant or
            otherwise) or as a shareholder of the Company, whether such liabilities are asserted by
            the Company or by creditors of the Company. Notwithstanding this Section 5, the Company
            shall provide the Holder with copies of the same notices and other information given to
            the shareholders of the Company generally, contemporaneously with the giving thereof to
            the shareholders.

            

            
                    6.  
            NONCIRCUMVENTION. The Company hereby covenants and agrees that the Company will
            not, by amendment of its Articles of Incorporation, Bylaws or through any
            reorganization, transfer of assets, consolidation, merger, scheme of arrangement,
            dissolution, issue or sale of securities, or any other voluntary action, avoid or seek
            to avoid the observance or performance of any of the terms of this Warrant, and will at
            all times in good faith carry out all the provisions of this Warrant and take all
            action as may be required to protect the rights of the Holder. Without limiting the
            generality of the foregoing, the Company (i) shall not increase the par value of
            any shares of Common Stock receivable upon the exercise of this Warrant above the
            Exercise Price then in effect, (ii) shall take all such actions as may be
            necessary or appropriate in order that the Company may validly and legally issue fully
            paid and nonassessable shares of Common Stock upon the exercise of this Warrant, and
            (iii) shall, so long as any of the SPA Warrants are outstanding, take all action
            necessary to reserve and keep available out of its authorized and unissued shares of
            Common Stock, solely for the purpose of effecting the exercise of the SPA Warrants,
            130% of the number of shares of Common Stock as shall from time to time be necessary to
            effect the exercise of the SPA Warrants then outstanding (without regard to any
            limitations on exercise).

            

            
                    7.  
            REISSUANCE OF WARRANTS.

            

            
                    
                      (a) Transfer of
            Warrant.   If this Warrant is to be transferred, the Holder shall
            surrender this Warrant to the Company, whereupon the Company will forthwith issue and
            deliver upon the order of the Holder a new Warrant (in accordance with Section 7(d)),
            registered as the Holder may request, representing the right to purchase the number of
            Warrant Shares being transferred by the Holder and, if less than the total number of
            Warrant Shares then underlying this Warrant is being transferred, a new Warrant (in
            accordance with Section 7(d)) to the Holder representing the right to purchase the
            number of Warrant Shares not being transferred.

            

            -13-

            
            
            

            
            

            

            
                    
                      (b)   Lost,
            Stolen or Mutilated Warrant. Upon receipt by the Company of evidence reasonably
            satisfactory to the Company of the loss, theft, destruction or mutilation of this
            Warrant, and, in the case of loss, theft or destruction, of any indemnification
            undertaking by the Holder to the Company in customary form and, in the case of
            mutilation, upon surrender and cancellation of this Warrant, the Company shall execute
            and deliver to the Holder a new Warrant (in accordance with Section 7(d)) representing
            the right to purchase the Warrant Shares then underlying this Warrant.

            

            
                    
                      (c) Exchangeable for
            Multiple Warrants. This Warrant is exchangeable, upon the surrender hereof by the
            Holder at the principal office of the Company, for a new Warrant or Warrants (in
            accordance with Section 7(d)) representing in the aggregate the right to purchase the
            number of Warrant Shares then underlying this Warrant, and each such new Warrant will
            represent the right to purchase such portion of such Warrant Shares as is designated by
            the Holder at the time of such surrender; provided, however, that no Warrants for
            fractional shares of Common Stock shall be given.

            

            
                    
                      (d) Issuance of New
            Warrants. Whenever the Company is required to issue a new Warrant pursuant to the
            terms of this Warrant, such new Warrant (i) shall be of like tenor with this Warrant,
            (ii) shall represent, as indicated on the face of such new Warrant, the right to
            purchase the Warrant Shares then underlying this Warrant (or in the case of a new
            Warrant being issued pursuant to Section 7(a) or Section 7(c), the Warrant Shares
            designated by the Holder which, when added to the number of shares of Common Stock
            underlying the other new Warrants issued in connection with such issuance, does not
            exceed the number of Warrant Shares then underlying this Warrant), (iii) shall have an
            issuance date, as indicated on the face of such new Warrant which is the same as the
            Issuance Date, and (iv) shall have the same rights and conditions as this
            Warrant.

            

            
                    8.  
            NOTICES. Whenever notice is required to be given under this Warrant, unless
            otherwise provided herein, such notice shall be given in accordance with Section 9(f)
            of the Securities Purchase Agreement. The Company shall provide the Holder with prompt
            written notice of all actions taken pursuant to this Warrant, including in reasonable
            detail a description of such action and the reason therefore. Without limiting the
            generality of the foregoing, the Company will give written notice to the Holder (i)
            immediately upon any adjustment of the Exercise Price, setting forth in reasonable
            detail, and certifying, the calculation of such adjustment and (ii) at least fifteen
            days prior to the date on which the Company closes its books or takes a record (A) with
            respect to any dividend or distribution upon the shares of Common Stock, (B) with
            respect to any grants, issuances or sales of any Options, Convertible Securities or
            rights to purchase stock, warrants, securities or other property to holders of shares
            of Common Stock or (C) for determining rights to vote with respect to any Fundamental
            Transaction, dissolution or liquidation, provided in each case that such information
            shall be made known to the public prior to or in conjunction with such notice being
            provided to the Holder.

            

            
                    9.  
            AMENDMENT AND WAIVER. Except as otherwise provided herein, the provisions of
            this Warrant may be amended and the Company may take any action herein prohibited, or
            omit to perform any act herein required to be performed by it, only if the Company has
            obtained the written consent of the Required Holders; provided that no such action may
            increase the exercise price of any SPA Warrant or decrease the number of shares or
            class of stock obtainable upon exercise of any SPA Warrant without the written consent
            of the Holder. No such amendment shall be effective to the extent that it applies to
            less than all of the holders of the SPA Warrants then outstanding.

            

            -14-

            
            
            

            
            

            

            
                    10.  
            GOVERNING LAW. This Warrant shall be governed by and construed and enforced in
            accordance with, and all questions concerning the construction, validity,
            interpretation and performance of this Warrant shall be governed by, the internal laws
            of the State of New York, without giving effect to any choice of law or conflict of law
            provision or rule (whether of the State of New York or any other jurisdictions) that
            would cause the application of the laws of any jurisdictions other than the State of
            New York.

            

            
                    11.  
            CONSTRUCTION; HEADINGS. This Warrant shall be deemed to be jointly drafted by
            the Company and all the Buyers and shall not be construed against any person as the
            drafter hereof. The headings of this Warrant are for convenience of reference and shall
            not form part of, or affect the interpretation of, this Warrant.

            

            
                    12.  
            DISPUTE RESOLUTION. In the case of a dispute as to the determination of the
            Exercise Price or the arithmetic calculation of the Warrant Shares, the Company shall
            submit the disputed determinations or arithmetic calculations via facsimile within two
            Business Days of receipt of the Exercise Notice giving rise to such dispute, as the
            case may be, to the Holder. If the Holder and the Company are unable to agree upon such
            determination or calculation of the Exercise Price or the Warrant Shares within three
            Business Days of such disputed determination or arithmetic calculation being submitted
            to the Holder, then the Company shall, within two Business Days submit via facsimile
            (a) the disputed determination of the Exercise Price to an independent, reputable
            investment bank selected by the Company and approved by the Holder or (b) the disputed
            arithmetic calculation of the Warrant Shares to the Company’s independent,
            outside accountant. The Company shall cause at its expense the investment bank or the
            accountant, as the case may be, to perform the determinations or calculations and
            notify the Company and the Holder of the results no later than ten Business Days from
            the time it receives the disputed determinations or calculations. Such investment
            bank’s or accountant’s determination or calculation, as the case may be,
            shall be binding upon all parties absent demonstrable error.

            

            
                    13.  
            REMEDIES, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF. The remedies
            provided in this Warrant shall be cumulative and in addition to all other remedies
            available under this Warrant and the other Transaction Documents, at law or in equity
            (including a decree of specific performance and/or other injunctive relief), and
            nothing herein shall limit the right of the Holder right to pursue actual damages for
            any failure by the Company to comply with the terms of this Warrant. The Company
            acknowledges that a breach by it of its obligations hereunder will cause irreparable
            harm to the Holder and that the remedy at law for any such breach may be inadequate.
            The Company therefore agrees that, in the event of any such breach or threatened
            breach, the holder of this Warrant shall be entitled, in addition to all other
            available remedies, to an injunction restraining any breach, without the necessity of
            showing economic loss and without any bond or other security being required.

            

            
                    14.  
            TRANSFER. This Warrant may be offered for sale, sold, transferred or assigned
            without the consent of the Company, except as may otherwise be required by Section 2(g)
            of the Securities Purchase Agreement.

            

            -15-

            
            
            

            
            

            

            
                    15.  
            CERTAIN DEFINITIONS. For purposes of this Warrant, the following terms shall
            have the following meanings:

            

            
                    
                      (a) “Approved
            Stock Plan” means any employee benefit plan which has been approved by the
            Board of Directors of the Company, pursuant to which the Company’s securities may
            be issued to any employee, consultant, officer or director for services provided to the
            Company.

            

            
                    
                      (b) “Black Scholes
            Value” means the value of this Warrant based on the Black and Scholes Option
            Pricing Model obtained from the “OV” function on Bloomberg determined as of
            the day of closing of the applicable Fundamental Transaction for pricing purposes and
            reflecting (i) a risk-free interest rate corresponding to the U.S. Treasury rate for a
            period equal to the remaining term of this Warrant as of such date of request, (ii) an
            expected volatility equal to the greater of 100% and the 100 day volatility obtained
            from the HVT function on Bloomberg as of the day immediately following the public
            announcement of the applicable Fundamental Transaction and (iii) the underlying price
            per share used in such calculation shall be the sum of the price per share being
            offered in cash, if any, plus the value of any non cash consideration, if any, being
            offered in the Fundamental Transaction.

            

            
                    
                      (c)
            “Bloomberg” means Bloomberg Financial Markets.

            

            
                    
                      (d) “Business
            Day” means any day other than Saturday, Sunday or other day on which
            commercial banks in The City of New York are authorized or required by law to remain
            closed.

            

            
                    
                      (e) “Closing Bid
            Price” and “Closing Sale Price” means, for any security as
            of any date, the last closing bid price and last closing trade price, respectively, for
            such security on the Principal Market, as reported by Bloomberg, or, if the Principal
            Market begins to operate on an extended hours basis and does not designate the closing
            bid price or the closing trade price, as the case may be, then the last bid price or
            last trade price, respectively, of such security prior to 4:00:00 p.m., New York Time,
            as reported by Bloomberg, or, if the Principal Market is not the principal securities
            exchange or trading market for such security, the last closing bid price or last trade
            price, respectively, of such security on the principal securities exchange or trading
            market where such security is listed or traded as reported by Bloomberg, or if the
            foregoing do not apply, the last closing bid price or last trade price, respectively,
            of such security in the over-the-counter market on the electronic bulletin board for
            such security as reported by Bloomberg, or, if no closing bid price or last trade
            price, respectively, is reported for such security by Bloomberg, the average of the bid
            prices, or the ask prices, respectively, of any market makers for such security as
            reported in the “pink sheets” by Pink Sheets LLC (formerly the National
            Quotation Bureau, Inc.). If the Closing Bid Price or the Closing Sale Price cannot be
            calculated for a security on a particular date on any of the foregoing bases, the
            Closing Bid Price or the Closing Sale Price, as the case may be, of such security on
            such date shall be the fair market value as mutually determined by the Company and the
            Holder. If the Company and the Holder are unable to agree upon the fair market value of
            such security, then such dispute shall be resolved pursuant to Section 12. All such
            determinations to be appropriately adjusted for any stock dividend, stock split, stock
            combination or other similar transaction during the applicable calculation
            period.

            

            -16-

            
            
            

            
            

            

            
                    
                      (f) “Common
            Stock” means (i) the Company’s shares of Common Stock, par value
            $0.001 per share, and (ii) any share capital into which such Common Stock shall
            have been changed or any share capital resulting from a reclassification of such Common
            Stock.

            

            
                    
                      (g) “Convertible
            Securities” means any stock or securities (other than Options) directly or
            indirectly convertible into or exercisable or exchangeable for shares of Common
            Stock.

            

            
                    
                      (h) “Eligible
            Market” means the Principal Market, the American Stock Exchange, The New York
            Stock Exchange, Inc., The NASDAQ Global Market The NASDAQ Capital Market or The NASDAQ
            Global Select Market.

            

            
                    
                      (i) “Excluded
            Securities” means any Common Stock issued or issuable: (i) in connection with
            any Approved Stock Plan; (ii) upon conversion of the SPA Securities or the exercise of
            the SPA Warrants; (iii) in connection with the payment of any Interest Shares on the
            SPA Securities; and (iv) upon exercise of any Options or Convertible Securities which
            are outstanding on the day immediately preceding the Subscription Date, provided that
            the terms of such Options or Convertible Securities are not amended, modified or
            changed on or after the Subscription Date.

            

            
                    
                      (j) “Expiration
            Date” means seven (7) years after the earlier of (A) such time as all of the
            Registrable Securities (as defined in the Registration Rights Agreement) are available
            for resale pursuant to an effective Registration Statement (as defined in the
            Registration Rights Agreement) and (B) two (2) years after the Issuance Date or, if any
            such date falls on a day other than a Business Day or on which trading does not take
            place on the Principal market (a “Holiday”), the next day that is
            not a Holiday.

            

            
                    
                      (k) “Fundamental
            Transaction” means that the Company shall directly or indirectly, in one or
            more related transactions, (i) consolidate or merge with or into (whether or not the
            Company is the surviving corporation) another Person, or (ii) sell, assign, transfer,
            convey or otherwise dispose of all or substantially all of the properties or assets of
            the Company to another Person, or (iii) allow another Person to make a purchase, tender
            or exchange offer that is accepted by the holders of more than the 50% of either the
            outstanding shares of Common Stock (not including any shares of Common Stock held by
            the Person or Persons making or party to, or associated or affiliated with the Persons
            making or party to, such purchase, tender or exchange offer), or (iv) consummate a
            stock purchase agreement or other business combination (including, without limitation,
            a reorganization, recapitalization, spin-off or scheme of arrangement) with another
            Person whereby such other Person acquires more than the 50% of the outstanding shares
            of Common Stock (not including any shares of Common Stock held by the other Person or
            other Persons making or party to, or associated or affiliated with the other Persons
            making or party to, such stock purchase agreement or other business combination), or
            (v) reorganize, recapitalize or reclassify its Common Stock, or (vi) any
            “person” or “group” (as these terms are used for purposes of
            Sections 13(d) and 14(d) of the Exchange Act), become the “beneficial
            owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly,
            of 50% of the aggregate ordinary voting power represented by issued and outstanding
            Common Stock.

            

            -17-

            
            
            

            
            

            

            
                    
                      (l)
            “Options” means any rights, warrants or options to subscribe for or
            purchase shares of Common Stock or Convertible Securities.

            

            
                    
                      (m) “Parent
            Entity” of a Person means an entity that, directly or indirectly, controls
            the applicable Person and whose common stock or equivalent equity security is quoted or
            listed on an Eligible Market, or, if there is more than one such Person or Parent
            Entity, the Person or Parent Entity with the largest public market capitalization as of
            the date of consummation of the Fundamental Transaction.

            

            
                    
                      (n)
            “Person” means an individual, a limited liability company, a
            partnership, a joint venture, a corporation, a trust, an unincorporated organization,
            any other entity and a government or any department or agency thereof.

            

            
                    
                      (o) “Principal
            Market” means the OTC Bulletin Board.

            

            
                    
                      (p) “Registration
            Rights Agreement” means that certain Registration Rights Agreement dated as
            of the Issuance Date by and among the Company and the Buyers.

            

            
                    
                      (q) “Required
            Holders” means the holders of the SPA Warrants representing at least a
            majority of shares of Common Stock underlying the SPA Warrants then
            outstanding.

            

            
                    
                      (r) “SPA
            Securities” means the Notes issued pursuant to the Securities Purchase
            Agreement.

            

            
                    
                      (s) “Successor
            Entity” means the Person (or, if so elected by the Required Holders, the
            Parent Entity) formed by, resulting from or surviving any Fundamental Transaction or
            the Person (or, if so elected by the Required Holders, the Parent Entity) with which
            such Fundamental Transaction shall have been entered into.

            

            
                    
                      (t) “Trading
            Day” means any day on which the Common Stock is traded on the Principal
            Market, or, if the Principal Market is not the principal trading market for the Common
            Stock, then on the principal securities exchange or securities market on which the
            Common Stock is then traded; provided that “Trading Day” shall not include
            any day on which the Common Stock is scheduled to trade on such exchange or market for
            less than 4.5 hours or any day that the Common Stock is suspended from trading during
            the final hour of trading on such exchange or market (or if such exchange or market
            does not designate in advance the closing time of trading on such exchange or market,
            then during the hour ending at 4:00:00 p.m., New York Time).

            

            -18-

            
            
            

            
            

            

            
                    
                      (u) “Weighted
            Average Price” means, for any security as of any date, the dollar
            volume-weighted average price for such security on the Principal Market during the
            period beginning at 9:30:01 a.m., New York Time (or such other time as the Principal
            Market publicly announces is the official open of trading), and ending at 4:00:00 p.m.,
            New York Time (or such other time as the Principal Market publicly announces is the
            official close of trading) as reported by Bloomberg through its “Volume at
            Price” functions, or, if the foregoing does not apply, the dollar volume-weighted
            average price of such security in the over-the-counter market on the electronic
            bulletin board for such security during the period beginning at 9:30:01 a.m., New York
            Time (or such other time as such market publicly announces is the official open of
            trading), and ending at 4:00:00 p.m., New York Time (or such other time as such market
            publicly announces is the official close of trading) as reported by Bloomberg, or, if
            no dollar volume-weighted average price is reported for such security by Bloomberg for
            such hours, the average of the highest closing bid price and the lowest closing ask
            price of any of the market makers for such security as reported in the “pink
            sheets” by Pink Sheets LLC (formerly the National Quotation Bureau, Inc.). If the
            Weighted Average Price cannot be calculated for a security on a particular date on any
            of the foregoing bases, the Weighted Average Price of such security on such date shall
            be the fair market value as mutually determined by the Company and the Holder. If the
            Company and the Holder are unable to agree upon the fair market value of such security,
            then such dispute shall be resolved pursuant to Section 12. All such determinations are
            to be appropriately adjusted for any stock dividend, stock split, stock combination or
            other similar transaction during the applicable calculation period.

            

            [Signature Page
            Follows]

            

            

            

            

            

            

            -19-

            
            

            
            

            

            
                    
            IN WITNESS WHEREOF, the Company has caused this Warrant to Purchase Common Stock to
            be duly executed as of the Issuance Date set out above.

            	
                    	
                    
	
                    	AMISH
                    NATURALS, INC.

                    

                    By:___________________________

                    Name:

                    Title: 

            

            

            

            

            
            

            
            

            

            EXHIBIT
            A

            

            EXERCISE NOTICE
            TO BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS

            WARRANT TO PURCHASE COMMON STOCK

            

            AMISH NATURALS,
            INC.

            

            
                    The
            undersigned holder hereby exercises the right to purchase _________________ of the
            shares of Common Stock (“Warrant Shares”) of Amish Naturals, Inc., a
            Nevada corporation (the “Company”), evidenced by the attached
            Warrant to Purchase Common Stock (the “Warrant”). Capitalized terms
            used herein and not otherwise defined shall have the respective meanings set forth in
            the Warrant.

            

            
                1.       
            Form of Exercise Price. The Holder intends that payment of the Exercise Price shall be
            made as:

            

            	 	
                    ____________ a "Cash
                    Exercise" with respect to _________________ Warrant Shares; and/or 

            

            

            	 	
                    ____________ a "Cashless
                    Exercise" with respect to _______________ Warrant Shares. 

            

            

            
                2.       
            Payment of Exercise Price. In the event that the holder has elected a Cash Exercise
            with respect to some or all of the Warrant Shares to be issued pursuant hereto, the
            holder shall pay the Aggregate Exercise Price in the sum of $___________________ to the
            Company in accordance with the terms of the Warrant.

            

            
                3.       
            Delivery of Warrant Shares. The Company shall deliver to the holder __________ Warrant
            Shares in accordance with the terms of the Warrant.

            

            Date:
            _______________ __, ______

            

            
            ____________________________

                 Name of Registered Holder

            

            By:______________________

                   Name:

                   Title:

            
            
            

            
            

            

            
            ACKNOWLEDGMENT

            

            
                    The
            Company hereby acknowledges this Exercise Notice and hereby directs Signature Stock
            Transfer, Inc. to issue the above indicated number of shares of Common Stock in
            accordance with the Transfer Agent Instructions dated September __, 2007 from the
            Company and acknowledged and agreed to by Signature Stock Transfer,
            Inc.

            	
                    	
                    
	
                    	AMISH
                    NATURALS, INC.

                    

                    By: _______________________________________________

                             Name:

                             Title: 

            

            

            

            

            

            
            
            

            
            

            

            [FORM OF SERIES
            B WARRANT]

            

            NEITHER THE ISSUANCE AND SALE
            OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE
            SECURITIES ARE EXERCISEABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
            AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR
            SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION
            STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN
            OPINION OF COUNSEL, IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED
            UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT.
            NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA
            FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE
            SECURITIES.

            

            AMISH
            NATURALS, INC.

            

            WARRANT TO
            PURCHASE COMMON STOCK

            

            Warrant No.: _______

            Number of Shares of Common Stock:

            Date of Issuance: September __, 2007 ("Issuance Date")

            

            
                    Amish
            Naturals, Inc., a Nevada corporation, (the “Company”), hereby
            certifies that, for good and valuable consideration, the receipt and sufficiency of
            which are hereby acknowledged, CASTLERIGG MASTER INVESTMENTS LTD., the registered
            holder hereof or its permitted assigns (the “Holder”), is entitled,
            subject to the terms set forth below, to purchase from the Company, at the Exercise
            Price (as defined below) then in effect, upon surrender of this Warrant to Purchase
            Common Stock (including any Warrants to purchase Common Stock issued in exchange,
            transfer or replacement hereof, the “Warrant”), at any time or times
            on or after the date hereof, but not after 11:59 p.m., New York Time, on the Expiration
            Date (as defined below), SEVEN HUNDRED NINETY EIGHT THOUSAND, SIX HUNDRED SIXTY FIVE
            (798,665) fully paid nonassessable shares of Common Stock (as defined below) (the
            “Warrant Shares”). Except as otherwise defined herein, capitalized
            terms in this Warrant shall have the meanings set forth in Section 15. This Warrant is
            one of the Warrants to purchase Common Stock (the “SPA Warrants”)
            issued pursuant to Section 1 of that certain Securities Purchase Agreement, dated as of
            August 31, 2007 (the “Subscription Date”), by and among the Company
            and the investors (the “Buyers”) referred to therein (the
            “Securities Purchase Agreement”).

            
            
            

            
            

            

            
                    1.    
            EXERCISE OF WARRANT.

            

            
                    (a)    
            Mechanics of Exercise. Subject to the terms and conditions hereof (including,
            without limitation, the limitations set forth in Section 1(f)), this Warrant may be
            exercised by the Holder on any day on or after the date hereof in whole or in part, by
            (i) delivery of a written notice, in the form attached hereto as Exhibit A
            (the “Exercise Notice”), of the Holder’s election to exercise
            this Warrant and (ii) (A) payment to the Company of an amount equal to the
            applicable Exercise Price multiplied by the number of Warrant Shares as to which this
            Warrant is being exercised (the “Aggregate Exercise Price”) in cash
            or by wire transfer of immediately available funds or (B) by notifying the Company that
            this Warrant is being exercised pursuant to a Cashless Exercise (as defined in Section
            1(d)). The Holder shall not be required to deliver the original Warrant in order to
            effect an exercise hereunder. Execution and delivery of the Exercise Notice with
            respect to less than all of the Warrant Shares shall have the same effect as
            cancellation of the original Warrant and issuance of a new Warrant evidencing the right
            to purchase the remaining number of Warrant Shares. On or before the first Business Day
            following the date on which the Company has received each of the Exercise Notice and
            the Aggregate Exercise Price (or notice of a Cashless Exercise) (the “Exercise
            Delivery Documents”), the Company shall transmit by facsimile an
            acknowledgment of confirmation of receipt of the Exercise Delivery Documents to the
            Holder and the Company’s transfer agent (the “Transfer
            Agent”). On or before the third Trading Day following the date on which the
            Company has received all of the Exercise Delivery Documents (the “Share
            Delivery Date”), the Company shall (X) provided that the Transfer Agent is
            participating in The Depository Trust Company (“DTC”) Fast Automated
            Securities Transfer Program, upon the request of the Holder, credit such aggregate
            number of shares of Common Stock to which the Holder is entitled pursuant to such
            exercise to the Holder’s or its designee’s balance account with DTC through
            its Deposit Withdrawal Agent Commission system, or (Y) if the Transfer Agent is not
            participating in the DTC Fast Automated Securities Transfer Program, issue and dispatch
            by overnight courier to the address as specified in the Exercise Notice, a certificate,
            registered in the Company’s share register in the name of the Holder or its
            designee, for the number of shares of Common Stock to which the Holder is entitled
            pursuant to such exercise. Upon delivery of the Exercise Delivery Documents, the Holder
            shall be deemed for all corporate purposes to have become the holder of record of the
            Warrant Shares with respect to which this Warrant has been exercised, irrespective of
            the date such Warrant Shares are credited to the Holder’s DTC account or the date
            of delivery of the certificates evidencing such Warrant Shares, as the case may be. If
            this Warrant is submitted in connection with any exercise pursuant to this Section 1(a)
            and the number of Warrant Shares represented by this Warrant submitted for exercise is
            greater than the number of Warrant Shares being acquired upon an exercise, then the
            Company shall as soon as practicable and in no event later than three Business Days
            after any exercise and at its own expense, issue a new Warrant (in accordance with
            Section 7(d)) representing the right to purchase the number of Warrant Shares
            purchasable immediately prior to such exercise under this Warrant, less the number of
            Warrant Shares with respect to which this Warrant is exercised. No fractional shares of
            Common Stock are to be issued upon the exercise of this Warrant, but rather the number
            of shares of Common Stock to be issued shall be rounded up to the nearest whole number.
            The Company shall pay any and all taxes which may be payable with respect to the
            issuance and delivery of Warrant Shares upon exercise of this Warrant.

            
            
            

            
            

            

            
                    (b)    
            Exercise Price. For purposes of this Warrant, “Exercise Price”
            means $2.50, subject to adjustment as provided herein.

            

            
                    (c)    
            Company’s Failure to Timely Deliver Securities. If the Company shall fail for
            any reason or for no reason to issue to the Holder within three (3) Trading Days of
            receipt of the Exercise Delivery Documents, a certificate for the number of shares of
            Common Stock to which the Holder is entitled and register such shares of Common Stock
            on the Company’s share register or to credit the Holder’s balance account
            with DTC for such number of shares of Common Stock to which the Holder is entitled upon
            the Holder’s exercise of this Warrant, then, in addition to all other remedies
            available to the Holder, the Company shall pay in cash to the Holder on each day after
            such thirdTrading Day that the issuance of such shares of Common Stock is not timely
            effected an amount equal to 1.5% of the product of (A) the sum of the number of shares
            of Common Stock not issued to the Holder on a timely basis and to which the Holder is
            entitled and (B) the Closing Sale Price of the shares of Common Stock on the Trading
            Day immediately preceding the last possible date which the Company could have issued
            such shares of Common Stock to the Holder without violating Section 1(a). In addition
            to the foregoing, if within three (3) Trading Days after the Company’s receipt of
            the facsimile copy of a Exercise Notice the Company shall fail to issue and deliver a
            certificate to the Holder and register such shares of Common Stock on the
            Company’s share register or credit the Holder’s balance account with DTC
            for the number of shares of Common Stock to which the Holder is entitled upon the
            Holder’s exercise hereunder, and if on or after such Trading Day the Holder
            purchases (in an open market transaction or otherwise) shares of Common Stock to
            deliver in satisfaction of a sale by the Holder of shares of Common Stock issuable upon
            such exercise that the Holder anticipated receiving from the Company (a
            “Buy-In”), then the Company shall, within three Business Days after
            the Holder’s request and in the Holder’s discretion, either (i) pay cash to
            the Holder in an amount equal to the Holder’s total purchase price (including
            brokerage commissions, if any) for the shares of Common Stock so purchased (the
            “Buy-In Price”), at which point the Company’s obligation to
            deliver such certificate (and to issue such shares of Common Stock) or credit such
            Holder’s balance account with DTC shall terminate, or (ii) promptly honor its
            obligation to deliver to the Holder a certificate or certificates representing such
            shares of Common Stock or credit such Holder’s balance account with DTC and pay
            cash to the Holder in an amount equal to the excess (if any) of the Buy-In Price over
            the product of (A) such number of shares of Common Stock, times (B) the Closing Bid
            Price on the date of exercise.

            

            
                    (d)    
            Cashless Exercise. Notwithstanding anything contained herein to the contrary, if a
            Registration Statement (as defined in the Registration Rights Agreement) covering the
            resale of the Warrant Shares that are the subject of the Exercise Notice (the
            “Unavailable Warrant Shares”) is not available for the resale of
            such Unavailable Warrant Shares, the Holder may, in its sole discretion, exercise this
            Warrant in whole or in part and, in lieu of making the cash payment otherwise
            contemplated to be made to the Company upon such exercise in payment of the Aggregate
            Exercise Price, elect instead to receive upon such exercise the “Net
            Number” of shares of Common Stock determined according to the following formula
            (a “Cashless Exercise”):

            	
                    	
                    	
                    
	
                    Net Number = 	
                    (A x B) — (A x
                    C)

                    B 	
                      

            

            

            
                    
                      For purposes of the
            foregoing formula:

            

            
                    
                      A= the total number of
            shares with respect to which this Warrant is then being exercised.

            

            
                    
                      B= the Closing Sale Price
            of the shares of Common Stock (as reported by Bloomberg) on the date immediately
            preceding the date of the Exercise Notice.

            

            
                    
                      C= the Exercise Price then
            in effect for the applicable Warrant Shares at the time of such exercise.

            

            
                    (e)  
            Disputes. In the case of a dispute as to the determination of the Exercise Price
            or the arithmetic calculation of the Warrant Shares, the Company shall promptly issue
            to the Holder the number of Warrant Shares that are not disputed and resolve such
            dispute in accordance with Section 12.

            

            
                    (f)  
            Limitations on Exercises.

            

            -4-

            
            
            

            
            

            

            	
                      	
                            (i)  
                    Beneficial Ownership. The Company shall not effect the exercise of this
                    Warrant, and the Holder shall not have the right to exercise this Warrant, to
                    the extent that after giving effect to such exercise, such Person (together
                    with such Person’s affiliates) would beneficially own in excess of 4.99%
                    of the shares of Common Stock outstanding immediately after giving effect to
                    such exercise. For purposes of the foregoing sentence, the aggregate number of
                    shares of Common Stock beneficially owned by such Person and its affiliates
                    shall include the number of shares of Common Stock issuable upon exercise of
                    this Warrant with respect to which the determination of such sentence is being
                    made, but shall exclude shares of Common Stock which would be issuable upon (A)
                    exercise of the remaining, unexercised portion of this Warrant beneficially
                    owned by such Person and its affiliates and (B) exercise or conversion of the
                    unexercised or unconverted portion of any other securities of the Company
                    beneficially owned by such Person and its affiliates (including, without
                    limitation, any convertible notes or convertible preferred stock or warrants)
                    subject to a limitation on conversion or exercise analogous to the limitation
                    contained herein. Except as set forth in the preceding sentence, for purposes
                    of this paragraph, beneficial ownership shall be calculated in accordance with
                    Section 13(d) of the Securities Exchange Act of 1934, as amended (the
                    “Exchange Act”). For purposes of this Warrant, in
                    determining the number of outstanding shares of Common Stock, the Holder may
                    rely on the number of outstanding shares of Common Stock as reflected in (1)
                    the Company’s most recent Form 10-K, Form 10-KSB, Form 10-Q, Form 10-QSB,
                    Current Report on Form 8-K or other public filing with the Securities and
                    Exchange Commission, as the case may be, (2) a more recent public announcement
                    by the Company or (3) any other notice by the Company or the Transfer Agent
                    setting forth the number of shares of Common Stock outstanding. For any reason
                    at any time, upon the written or oral request of the Holder, the Company shall
                    within one (1) Business Day confirm orally and in writing to the Holder the
                    number of shares of Common Stock then outstanding. In any case, the number of
                    outstanding shares of Common Stock shall be determined after giving effect to
                    the conversion or exercise of securities of the Company, including the SPA
                    Securities and the SPA Warrants, by the Holder and its affiliates since the
                    date as of which such number of outstanding shares of Common Stock was
                    reported. By written notice to the Company, the Holder may from time to time
                    increase or decrease the Maximum Percentage to any other percentage not in
                    excess of 9.99% specified in such notice; provided that (i) any such increase
                    will not be effective until the sixty-first (61st) day after such
                    notice is delivered to the Company, and (ii) any such increase or decrease will
                    apply only to the Holder and not to any other holder of SPA Warrants.
                              

            

            

            	
                      	
                            (ii)
                      Principal Market Regulation. The Company shall not be
                    obligated to issue any shares of Common Stock upon exercise of this Warrant or
                    conversion of SPA Securities and no Buyer shall be entitled to receive any
                    shares of Common Stock if the issuance of such shares of Common Stock would
                    exceed that number of shares of Common Stock which the Company may issue upon
                    exercise or conversion, as applicable, of the SPA Warrants and SPA Securities
                    or otherwise without breaching the Company’s obligations under the rules
                    or regulations of any applicable Eligible Market (the “Exchange
                    Cap”), except that such limitation shall not apply in the event that
                    the Company (A) obtains the approval of its shareholders as required by the
                    applicable rules of the Eligible Market for issuances of shares of Common Stock
                    in excess of such amount or (B) obtains a written opinion from outside counsel
                    to the Company that such approval is not required, which opinion shall be
                    reasonably satisfactory to the Required Holders. Until such approval or written
                    opinion is obtained, no Buyer shall be issued in the aggregate, upon exercise
                    or conversion, as applicable, of any SPA Warrants or SPA Securities, shares of
                    Common Stock in an amount greater than the product of the Exchange Cap
                    multiplied by a fraction, the numerator of which is the total number of shares
                    of Common Stock underlying the SPA Warrants issued to such Buyer pursuant to
                    the Securities Purchase Agreement on the Issuance Date and the denominator of
                    which is the aggregate number of shares of Common Stock underlying the SPA
                    Warrants issued to the Buyers pursuant to the Securities Purchase Agreement on
                    the Issuance Date (with respect to each Buyer, the “Exchange Cap
                    Allocation”). In the event that any Buyer shall sell or otherwise
                    transfer any of such Buyer’s SPA Warrants, the transferee shall be
                    allocated a pro rata portion of such Buyer’s Exchange Cap Allocation, and
                    the restrictions of the prior sentence shall apply to such transferee with
                    respect to the portion of the Exchange Cap Allocation allocated to such
                    transferee. In the event that any holder of SPA Warrants shall exercise all of
                    such holder’s SPA Warrants into a number of shares of Common Stock which,
                    in the aggregate, is less than such holder’s Exchange Cap Allocation,
                    then the difference between such holder’s Exchange Cap Allocation and the
                    number of shares of Common Stock actually issued to such holder shall be
                    allocated to the respective Exchange Cap Allocations of the remaining holders
                    of SPA Warrants on a pro rata basis in proportion to the shares of Common Stock
                    underlying the SPA Warrants then held by each such holder. In the event that
                    the Company is prohibited from issuing any Warrant Shares for which an Exercise
                    Notice has been received as a result of the operation of this Section 1(f)(ii),
                    the Company shall pay cash in exchange for cancellation of such Warrant Shares,
                    at a price per Warrant Share equal to the difference between the Closing Sale
                    Price and the Exercise Price as of the date of the attempted exercise.
                    

            

            

            -5-

            
            
            

            
            

            

            	
                      	
                            (g)
                      Insufficient Authorized Shares. If at any time while this
                    Warrant remain outstanding the Company does not have a sufficient number of
                    authorized and unreserved shares of Common Stock to satisfy its obligation to
                    reserve for issuance upon exercise of this Warrant at least a number of shares
                    of Common Stock equal to 130% (the “Required Reserve
                    Amount”) of the number of shares of Common Stock as shall from time
                    to time be necessary to effect the exercise of all of this Warrant then
                    outstanding (an “Authorized Share Failure”), then the
                    Company shall immediately take all action necessary to increase the
                    Company’s authorized shares of Common Stock to an amount sufficient to
                    allow the Company to reserve the Required Reserve Amount for this Warrant then
                    outstanding. Without limiting the generality of the foregoing sentence, as soon
                    as practicable after the date of the occurrence of an Authorized Share Failure,
                    but in no event later than ninety (90) days after the occurrence of such
                    Authorized Share Failure, the Company shall hold a meeting of its stockholders
                    for the approval of an increase in the number of authorized shares of Common
                    Stock. In connection with such meeting, the Company shall provide each
                    stockholder with a proxy statement and shall use its best efforts to solicit
                    its stockholders’ approval of such increase in authorized shares of
                    Common Stock and to cause its board of directors to recommend to the
                    stockholders that they approve such proposal. 

            

            

            
                    2.  
            ADJUSTMENT OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES. The Exercise Price
            and the number of Warrant Shares shall be adjusted from time to time as
            follows:

            

            -6-

            
            
            

            
            

            

            
                    
                      
                      (a) Adjustment upon
            Issuance of shares of Common Stock. If and whenever on or after the Subscription
            Date the Company issues or sells, or in accordance with this Section 2 is deemed to
            have issued or sold, any shares of Common Stock (including the issuance or sale of
            shares of Common Stock owned or held by or for the account of the Company, but
            excluding shares of Common Stock deemed to have been issued by the Company in
            connection with any Excluded Securities) for a consideration per share (the
            “New Issuance Price”) less than the Exercise Price (the
            “Applicable Price”) in effect immediately prior to such issue or
            sale or deemed issuance or sale (the foregoing a “Dilutive
            Issuance”), then immediately after such Dilutive Issuance, the Exercise Price
            then in effect shall be reduced to an amount equal to the New Issuance Price. Upon each
            such adjustment of the Exercise Price hereunder, the number of Warrant Shares shall be
            adjusted to the number of shares of Common Stock determined by multiplying the Exercise
            Price in effect immediately prior to such adjustment by the number of Warrant Shares
            acquirable upon exercise of this Warrant immediately prior to such adjustment and
            dividing the product thereof by the Exercise Price resulting from such adjustment. For
            purposes of determining the adjusted Exercise Price under this Section 2(a), the
            following shall be applicable:

            

            	
                    	
                        
                            (i)
                               Issuance of Options. If
                        the Company in any manner grants any Options and the lowest price per share
                        for which one share of Common Stock is issuable upon the exercise of any
                        such Option or upon conversion, exercise or exchange of any Convertible
                        Securities issuable upon exercise of any such Option is less than the
                        Applicable Price, then such share of Common Stock shall be deemed to be
                        outstanding and to have been issued and sold by the Company at the time of
                        the granting or sale of such Option for such price per share. For purposes
                        of this Section 2(a)(i), the “lowest price per share for which one
                        share of Common Stock is issuable upon exercise of such Options or upon
                        conversion, exercise or exchange of such Convertible Securities issuable
                        upon exercise of any such Option” shall be equal to the sum of the
                        lowest amounts of consideration (if any) received or receivable by the
                        Company with respect to any one share of Common Stock upon the granting or
                        sale of the Option, upon exercise of the Option and upon conversion,
                        exercise or exchange of any Convertible Security issuable upon exercise of
                        such Option. No further adjustment of the Exercise Price or number of
                        Warrant Shares shall be made upon the actual issuance of such shares of
                        Common Stock or of such Convertible Securities upon the exercise of such
                        Options or upon the actual issuance of such shares of Common Stock upon
                        conversion, exercise or exchange of such Convertible Securities.

                    

            

            

            	
                    	
                        
                            (ii)
                               Issuance of Convertible
                        Securities. If the Company in any manner issues or sells any
                        Convertible Securities and the lowest price per share for which one share
                        of Common Stock is issuable upon the conversion, exercise or exchange
                        thereof is less than the Applicable Price, then such share of Common Stock
                        shall be deemed to be outstanding and to have been issued and sold by the
                        Company at the time of the issuance or sale of such Convertible Securities
                        for such price per share. For the purposes of this Section 2(a)(ii), the
                        “lowest price per share for which one share of Common Stock is
                        issuable upon the conversion, exercise or exchange thereof” shall be
                        equal to the sum of the lowest amounts of consideration (if any) received
                        or receivable by the Company with respect to one share of Common Stock upon
                        the issuance or sale of the Convertible Security and upon conversion,
                        exercise or exchange of such Convertible Security. No further adjustment of
                        the Exercise Price or number of Warrant Shares shall be made upon the
                        actual issuance of such shares of Common Stock upon conversion, exercise or
                        exchange of such Convertible Securities, and if any such issue or sale of
                        such Convertible Securities is made upon exercise of any Options for which
                        adjustment of this Warrant has been or is to be made pursuant to other
                        provisions of this Section 2(a), no further adjustment of the Exercise
                        Price or number of Warrant Shares shall be made by reason of such issue or
                        sale.

                    

            

            

            -7-

            
            
            

            
            

            

            	
                    	
                        
                            (iii)
                               Change in Option Price or Rate
                        of Conversion. If the purchase price provided for in any Options, the
                        additional consideration, if any, payable upon the issue, conversion,
                        exercise or exchange of any Convertible Securities, or the rate at which
                        any Convertible Securities are convertible into or exercisable or
                        exchangeable for shares of Common Stock increases or decreases at any time,
                        the Exercise Price and the number of Warrant Shares in effect at the time
                        of such increase or decrease shall be adjusted to the Exercise Price and
                        the number of Warrant Shares which would have been in effect at such time
                        had such Options or Convertible Securities provided for such increased or
                        decreased purchase price, additional consideration or increased or
                        decreased conversion rate, as the case may be, at the time initially
                        granted, issued or sold. For purposes of this Section 2(a)(iii), if the
                        terms of any Option or Convertible Security that was outstanding as of the
                        date of issuance of this Warrant are increased or decreased in the manner
                        described in the immediately preceding sentence, then such Option or
                        Convertible Security and the shares of Common Stock deemed issuable upon
                        exercise, conversion or exchange thereof shall be deemed to have been
                        issued as of the date of such increase or decrease. No adjustment pursuant
                        to this Section 2(a)(iii) shall be made if such adjustment would result in
                        an increase of the Exercise Price then in effect or a decrease in the
                        number of Warrant Shares.

                    

            

            

            	
                    	
                        
                            (iv)
                               Calculation of Consideration
                        Received. In case any Option is issued in connection with the issue or
                        sale of other securities of the Company, together comprising one integrated
                        transaction in which no specific consideration is allocated to such Options
                        by the parties thereto, the Options will be deemed to have been issued for
                        a consideration of $0.01. If any shares of Common Stock, Options or
                        Convertible Securities are issued or sold or deemed to have been issued or
                        sold for cash, the consideration received therefor will be deemed to be the
                        net amount received by the Company therefor. If any shares of Common Stock,
                        Options or Convertible Securities are issued or sold for a consideration
                        other than cash, the amount of such consideration received by the Company
                        will be the fair value of such consideration, except where such
                        consideration consists of publicly traded securities, in which case the
                        amount of consideration received by the Company will be the Closing Sale
                        Price of such security on the date of receipt. If any shares of Common
                        Stock, Options or Convertible Securities are issued to the owners of the
                        non-surviving entity in connection with any merger in which the Company is
                        the surviving entity, the amount of consideration therefor will be deemed
                        to be the fair value of such portion of the net assets and business of the
                        non-surviving entity as is attributable to such shares of Common Stock,
                        Options or Convertible Securities, as the case may be. The fair value of
                        any consideration other than cash or publicly traded securities will be
                        determined jointly by the Company and the Required Holders. If such parties
                        are unable to reach agreement within ten (10) days after the occurrence of
                        an event requiring valuation (the “Valuation Event”),
                        the fair value of such consideration will be determined within five (5)
                        Business Days after the tenth day following the Valuation Event by an
                        independent, reputable appraiser jointly selected by the Company and the
                        Required Holders. The determination of such appraiser shall be final and
                        binding upon all parties absent manifest error and the fees and expenses of
                        such appraiser shall be borne by the Company.

                    

            

            

            -8-

            
            
            

            
            

            

            	
                    	
                        
                            (v)
                               Record Date. If the
                        Company takes a record of the holders of shares of Common Stock for the
                        purpose of entitling them (A) to receive a dividend or other
                        distribution payable in shares of Common Stock, Options or in Convertible
                        Securities or (B) to subscribe for or purchase shares of Common Stock,
                        Options or Convertible Securities, then such record date will be deemed to
                        be the date of the issue or sale of the shares of Common Stock deemed to
                        have been issued or sold upon the declaration of such dividend or the
                        making of such other distribution or the date of the granting of such right
                        of subscription or purchase, as the case may be.

                    

            

            

            	
                    	
                        
                            (vi)
                               Voluntary Adjustment By
                        Company. The Company may at any time during the term of
                        this Warrant reduce the then current  Exercise
                        Price to any amount and for any period of time deemed appropriate by
                        the Board of Directors of the Company. 

                    

            

            

            
                    
            (b)   Adjustment upon Subdivision or Combination of shares of Common
            Stock. If the Company at any time on or after the Subscription Date subdivides (by
            any stock split, stock dividend, recapitalization or otherwise) one or more classes of
            its outstanding shares of Common Stock into a greater number of shares, the Exercise
            Price in effect immediately prior to such subdivision will be proportionately reduced
            and the number of Warrant Shares will be proportionately increased. If the Company at
            any time on or after the Subscription Date combines (by combination, reverse stock
            split or otherwise) one or more classes of its outstanding shares of Common Stock into
            a smaller number of shares, the Exercise Price in effect immediately prior to such
            combination will be proportionately increased and the number of Warrant Shares will be
            proportionately decreased. Any adjustment under this Section 2(b) shall become
            effective at the close of business on the date the subdivision or combination becomes
            effective.

            

            
                    (c)  
            Other Events. If any event occurs of the type contemplated by the provisions of
            this Section 2 but not expressly provided for by such provisions (including, without
            limitation, the granting of stock appreciation rights, phantom stock rights or other
            rights with equity features), then the Company’s Board of Directors will make an
            appropriate adjustment in the Exercise Price and the number of Warrant Shares so as to
            protect the rights of the Holder; provided that no such adjustment pursuant to this
            Section 2(c) will increase the Exercise Price or decrease the number of Warrant Shares
            as otherwise determined pursuant to this Section 2.

            

            -9-

            
            
            

            
            

            

            
                    3.  
            RIGHTS UPON DISTRIBUTION OF ASSETS. If the Company shall declare or make any
            dividend or other distribution of its assets (or rights to acquire its assets) to
            holders of shares of Common Stock, by way of return of capital or otherwise (including,
            without limitation, any distribution of cash, stock or other securities, property or
            options by way of a dividend, spin off, reclassification, corporate rearrangement,
            scheme of arrangement or other similar transaction) (a
            “Distribution”), at any time after the issuance of this Warrant,
            then, in each such case:

            

            
                    
                      (a) any Exercise Price in
            effect immediately prior to the close of business on the record date fixed for the
            determination of holders of shares of Common Stock entitled to receive the Distribution
            shall be reduced, effective as of the close of business on such record date, to a price
            determined by multiplying such Exercise Price by a fraction of which (i) the numerator
            shall be the Closing Bid Price of the shares of Common Stock on the Trading Day
            immediately preceding such record date minus the value of the Distribution (as
            determined in good faith by the Company’s Board of Directors) applicable to one
            share of Common Stock, and (ii) the denominator shall be the Closing Bid Price of the
            shares of Common Stock on the Trading Day immediately preceding such record date;
            and

            

            
                    
                      (b) the number of Warrant
            Shares shall be increased to a number of shares equal to the number of shares of Common
            Stock obtainable immediately prior to the close of business on the record date fixed
            for the determination of holders of shares of Common Stock entitled to receive the
            Distribution multiplied by the reciprocal of the fraction set forth in the immediately
            preceding paragraph (a); provided that in the event that the Distribution is of shares
            of common stock (“Other Shares of Common Stock”) of a company whose
            common shares are traded on a national securities exchange or a national automated
            quotation system, then the Holder may elect to receive a warrant to purchase Other
            Shares of Common Stock in lieu of an increase in the number of Warrant Shares, the
            terms of which shall be identical to those of this Warrant, except that such warrant
            shall be exercisable into the number of shares of Other Shares of Common Stock that
            would have been payable to the Holder pursuant to the Distribution had the Holder
            exercised this Warrant immediately prior to such record date and with an aggregate
            exercise price equal to the product of the amount by which the exercise price of this
            Warrant was decreased with respect to the Distribution pursuant to the terms of the
            immediately preceding paragraph (a) and the number of Warrant Shares calculated in
            accordance with the first part of this paragraph (b).

            

            
                    4.
                   PURCHASE RIGHTS; FUNDAMENTAL
            TRANSACTIONS.

            

            -10-

            
            
            

            
            

            

            
                    
                      (a) Purchase Rights.
            In addition to any adjustments pursuant to Section 2 above, if at any time the Company
            grants, issues or sells any Options, Convertible Securities or rights to purchase
            stock, warrants, securities or other property pro rata to the record holders of any
            class of shares of Common Stock (the “Purchase Rights”), then the
            Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights,
            the aggregate Purchase Rights which the Holder could have acquired if the Holder had
            held the number of shares of Common Stock acquirable upon complete exercise of this
            Warrant (without regard to any limitations on the exercise of this Warrant) immediately
            before the date on which a record is taken for the grant, issuance or sale of such
            Purchase Rights, or, if no such record is taken, the date as of which the record
            holders of shares of Common Stock are to be determined for the grant, issue or sale of
            such Purchase Rights.

            

            
                    
                      (b) Fundamental
            Transactions. The Company shall not enter into or be party to a Fundamental
            Transaction unless (i)  the Successor Entity assumes in writing all of the
            obligations of the Company under this Warrant and the other Transaction Documents in
            accordance with the provisions of this Section (4)(b) pursuant to written agreements in
            form and substance satisfactory to the Required Holders and approved by the Required
            Holders prior to such Fundamental Transaction, including agreements to deliver to each
            holder of Warrants in exchange for such Warrants a security of the Successor Entity
            evidenced by a written instrument substantially similar in form and substance to this
            Warrant, including, without limitation, an adjusted exercise price equal to the value
            for the shares of Common Stock reflected by the terms of such Fundamental Transaction,
            and exercisable for a corresponding number of shares of capital stock equivalent to the
            shares of Common Stock acquirable and receivable upon exercise of this Warrant (without
            regard to any limitations on the exercise of this Warrant) prior to such Fundamental
            Transaction, and satisfactory to the Required Holders and (ii) the Successor
            Entity (including its Parent Entity) is a publicly traded corporation whose common
            stock is quoted on or listed for trading on an Eligible Market. Upon the occurrence of
            any Fundamental Transaction, the Successor Entity shall succeed to, and be substituted
            for (so that from and after the date of such Fundamental Transaction, the provisions of
            this Warrant referring to the “Company” shall refer instead to the
            Successor Entity), and may exercise every right and power of the Company and shall
            assume all of the obligations of the Company under this Warrant with the same effect as
            if such Successor Entity had been named as the Company herein. Upon consummation of the
            Fundamental Transaction, the Successor Entity shall deliver to the Holder confirmation
            that there shall be issued upon exercise of this Warrant at any time after the
            consummation of the Fundamental Transaction, in lieu of the shares of the Common Stock
            (or other securities, cash, assets or other property) purchasable upon the exercise of
            the Warrant prior to such Fundamental Transaction, such shares of the publicly traded
            Common Stock (or its equivalent) of the Successor Entity (including its Parent Entity),
            as adjusted in accordance with the provisions of this Warrant. In addition to and not
            in substitution for any other rights hereunder, prior to the consummation of any
            Fundamental Transaction pursuant to which holders of shares of Common Stock are
            entitled to receive securities or other assets with respect to or in exchange for
            shares of Common Stock (a “Corporate Event”), the Company shall make
            appropriate provision to insure that the Holder will thereafter have the right to
            receive upon an exercise of this Warrant at any time after the consummation of the
            Fundamental Transaction but prior to the Expiration Date, in lieu of the shares of the
            Common Stock (or other securities, cash, assets or other property) purchasable upon the
            exercise of the Warrant prior to such Fundamental Transaction, such shares of stock,
            securities, cash, assets or any other property whatsoever (including warrants or other
            purchase or subscription rights) which the Holder would have been entitled to receive
            upon the happening of such Fundamental Transaction had the Warrant been exercised
            immediately prior to such Fundamental Transaction. Provision made pursuant to the
            preceding sentence shall be in a form and substance reasonably satisfactory to the
            Required Holders. The provisions of this Section shall apply similarly and equally to
            successive Fundamental Transactions and Corporate Events and shall be applied without
            regard to any limitations on the exercise of this Warrant.

            

            -11-

            
            
            

            
            

            

            
                    
                     (c) Notwithstanding the foregoing
            and the provisions of Section 4(b) above, in the event of a Fundamental Transaction, at
            the request of the Holder delivered before the ninetieth (90th) day after the
            consummation of such Fundamental Transaction, the Company (or the Successor Entity)
            shall purchase this Warrant from the Holder by paying to the Holder, within five (5)
            Business Days of such request (or, if later, on the effective date of the Fundamental
            Transaction, cash in an amount equal to the Black-Scholes Value of the remaining
            unexercised portion of this Warrant on the date of such Fundamental
            Transaction.

            

            

            

            

            

            

            

            

            -12-

            
            
            

            
            

            

            
                    5.  
            WARRANT HOLDER NOT DEEMED A STOCKHOLDER. Except as otherwise specifically
            provided herein, the Holder, solely in such Person’s capacity as a holder of this
            Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of
            share capital of the Company for any purpose, nor shall anything contained in this
            Warrant be construed to confer upon the Holder, solely in such Person’s capacity
            as the Holder of this Warrant, any of the rights of a shareholder of the Company or any
            right to vote, give or withhold consent to any corporate action (whether any
            reorganization, issue of stock, reclassification of stock, consolidation, merger,
            conveyance or otherwise), receive notice of meetings, receive dividends or subscription
            rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which
            such Person is then entitled to receive upon the due exercise of this Warrant. In
            addition, nothing contained in this Warrant shall be construed as imposing any
            liabilities on the Holder to purchase any securities (upon exercise of this Warrant or
            otherwise) or as a shareholder of the Company, whether such liabilities are asserted by
            the Company or by creditors of the Company. Notwithstanding this Section 5, the Company
            shall provide the Holder with copies of the same notices and other information given to
            the shareholders of the Company generally, contemporaneously with the giving thereof to
            the shareholders.

            

            
                    6.  
            NONCIRCUMVENTION. The Company hereby covenants and agrees that the Company will
            not, by amendment of its Articles of Incorporation, Bylaws or through any
            reorganization, transfer of assets, consolidation, merger, scheme of arrangement,
            dissolution, issue or sale of securities, or any other voluntary action, avoid or seek
            to avoid the observance or performance of any of the terms of this Warrant, and will at
            all times in good faith carry out all the provisions of this Warrant and take all
            action as may be required to protect the rights of the Holder. Without limiting the
            generality of the foregoing, the Company (i) shall not increase the par value of
            any shares of Common Stock receivable upon the exercise of this Warrant above the
            Exercise Price then in effect, (ii) shall take all such actions as may be
            necessary or appropriate in order that the Company may validly and legally issue fully
            paid and nonassessable shares of Common Stock upon the exercise of this Warrant, and
            (iii) shall, so long as any of the SPA Warrants are outstanding, take all action
            necessary to reserve and keep available out of its authorized and unissued shares of
            Common Stock, solely for the purpose of effecting the exercise of the SPA Warrants,
            130% of the number of shares of Common Stock as shall from time to time be necessary to
            effect the exercise of the SPA Warrants then outstanding (without regard to any
            limitations on exercise).

            

            
                    7.  
            REISSUANCE OF WARRANTS.

            

            
                    
                      (a) Transfer of
            Warrant.   If this Warrant is to be transferred, the Holder shall
            surrender this Warrant to the Company, whereupon the Company will forthwith issue and
            deliver upon the order of the Holder a new Warrant (in accordance with Section 7(d)),
            registered as the Holder may request, representing the right to purchase the number of
            Warrant Shares being transferred by the Holder and, if less than the total number of
            Warrant Shares then underlying this Warrant is being transferred, a new Warrant (in
            accordance with Section 7(d)) to the Holder representing the right to purchase the
            number of Warrant Shares not being transferred.

            

            -13-

            
            
            

            
            

            

            
                    
                      (b)   Lost,
            Stolen or Mutilated Warrant. Upon receipt by the Company of evidence reasonably
            satisfactory to the Company of the loss, theft, destruction or mutilation of this
            Warrant, and, in the case of loss, theft or destruction, of any indemnification
            undertaking by the Holder to the Company in customary form and, in the case of
            mutilation, upon surrender and cancellation of this Warrant, the Company shall execute
            and deliver to the Holder a new Warrant (in accordance with Section 7(d)) representing
            the right to purchase the Warrant Shares then underlying this Warrant.

            

            
                    
                      (c) Exchangeable for
            Multiple Warrants. This Warrant is exchangeable, upon the surrender hereof by the
            Holder at the principal office of the Company, for a new Warrant or Warrants (in
            accordance with Section 7(d)) representing in the aggregate the right to purchase the
            number of Warrant Shares then underlying this Warrant, and each such new Warrant will
            represent the right to purchase such portion of such Warrant Shares as is designated by
            the Holder at the time of such surrender; provided, however, that no Warrants for
            fractional shares of Common Stock shall be given.

            

            
                    
                      (d) Issuance of New
            Warrants. Whenever the Company is required to issue a new Warrant pursuant to the
            terms of this Warrant, such new Warrant (i) shall be of like tenor with this Warrant,
            (ii) shall represent, as indicated on the face of such new Warrant, the right to
            purchase the Warrant Shares then underlying this Warrant (or in the case of a new
            Warrant being issued pursuant to Section 7(a) or Section 7(c), the Warrant Shares
            designated by the Holder which, when added to the number of shares of Common Stock
            underlying the other new Warrants issued in connection with such issuance, does not
            exceed the number of Warrant Shares then underlying this Warrant), (iii) shall have an
            issuance date, as indicated on the face of such new Warrant which is the same as the
            Issuance Date, and (iv) shall have the same rights and conditions as this
            Warrant.

            

            
                    8.  
            NOTICES. Whenever notice is required to be given under this Warrant, unless
            otherwise provided herein, such notice shall be given in accordance with Section 9(f)
            of the Securities Purchase Agreement. The Company shall provide the Holder with prompt
            written notice of all actions taken pursuant to this Warrant, including in reasonable
            detail a description of such action and the reason therefore. Without limiting the
            generality of the foregoing, the Company will give written notice to the Holder (i)
            immediately upon any adjustment of the Exercise Price, setting forth in reasonable
            detail, and certifying, the calculation of such adjustment and (ii) at least fifteen
            days prior to the date on which the Company closes its books or takes a record (A) with
            respect to any dividend or distribution upon the shares of Common Stock, (B) with
            respect to any grants, issuances or sales of any Options, Convertible Securities or
            rights to purchase stock, warrants, securities or other property to holders of shares
            of Common Stock or (C) for determining rights to vote with respect to any Fundamental
            Transaction, dissolution or liquidation, provided in each case that such information
            shall be made known to the public prior to or in conjunction with such notice being
            provided to the Holder.

            

            
                    9.  
            AMENDMENT AND WAIVER. Except as otherwise provided herein, the provisions of
            this Warrant may be amended and the Company may take any action herein prohibited, or
            omit to perform any act herein required to be performed by it, only if the Company has
            obtained the written consent of the Required Holders; provided that no such action may
            increase the exercise price of any SPA Warrant or decrease the number of shares or
            class of stock obtainable upon exercise of any SPA Warrant without the written consent
            of the Holder. No such amendment shall be effective to the extent that it applies to
            less than all of the holders of the SPA Warrants then outstanding.

            

            -14-

            
            
            

            
            

            

            
                    10.  
            GOVERNING LAW. This Warrant shall be governed by and construed and enforced in
            accordance with, and all questions concerning the construction, validity,
            interpretation and performance of this Warrant shall be governed by, the internal laws
            of the State of New York, without giving effect to any choice of law or conflict of law
            provision or rule (whether of the State of New York or any other jurisdictions) that
            would cause the application of the laws of any jurisdictions other than the State of
            New York.

            

            
                    11.  
            CONSTRUCTION; HEADINGS. This Warrant shall be deemed to be jointly drafted by
            the Company and all the Buyers and shall not be construed against any person as the
            drafter hereof. The headings of this Warrant are for convenience of reference and shall
            not form part of, or affect the interpretation of, this Warrant.

            

            
                    12.  
            DISPUTE RESOLUTION. In the case of a dispute as to the determination of the
            Exercise Price or the arithmetic calculation of the Warrant Shares, the Company shall
            submit the disputed determinations or arithmetic calculations via facsimile within two
            Business Days of receipt of the Exercise Notice giving rise to such dispute, as the
            case may be, to the Holder. If the Holder and the Company are unable to agree upon such
            determination or calculation of the Exercise Price or the Warrant Shares within three
            Business Days of such disputed determination or arithmetic calculation being submitted
            to the Holder, then the Company shall, within two Business Days submit via facsimile
            (a) the disputed determination of the Exercise Price to an independent, reputable
            investment bank selected by the Company and approved by the Holder or (b) the disputed
            arithmetic calculation of the Warrant Shares to the Company’s independent,
            outside accountant. The Company shall cause at its expense the investment bank or the
            accountant, as the case may be, to perform the determinations or calculations and
            notify the Company and the Holder of the results no later than ten Business Days from
            the time it receives the disputed determinations or calculations. Such investment
            bank’s or accountant’s determination or calculation, as the case may be,
            shall be binding upon all parties absent demonstrable error.

            

            
                    13.  
            REMEDIES, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF. The remedies
            provided in this Warrant shall be cumulative and in addition to all other remedies
            available under this Warrant and the other Transaction Documents, at law or in equity
            (including a decree of specific performance and/or other injunctive relief), and
            nothing herein shall limit the right of the Holder right to pursue actual damages for
            any failure by the Company to comply with the terms of this Warrant. The Company
            acknowledges that a breach by it of its obligations hereunder will cause irreparable
            harm to the Holder and that the remedy at law for any such breach may be inadequate.
            The Company therefore agrees that, in the event of any such breach or threatened
            breach, the holder of this Warrant shall be entitled, in addition to all other
            available remedies, to an injunction restraining any breach, without the necessity of
            showing economic loss and without any bond or other security being required.

            

            
                    14.  
            TRANSFER. This Warrant may be offered for sale, sold, transferred or assigned
            without the consent of the Company, except as may otherwise be required by Section 2(g)
            of the Securities Purchase Agreement.

            

            -15-

            
            
            

            
            

            

            
                    15.  
            CERTAIN DEFINITIONS. For purposes of this Warrant, the following terms shall
            have the following meanings:

            

            
                    
                      (a) “Approved
            Stock Plan” means any employee benefit plan which has been approved by the
            Board of Directors of the Company, pursuant to which the Company’s securities may
            be issued to any employee, consultant, officer or director for services provided to the
            Company.

            

            
                    
                      (b) “Black Scholes
            Value” means the value of this Warrant based on the Black and Scholes Option
            Pricing Model obtained from the “OV” function on Bloomberg determined as of
            the day of closing of the applicable Fundamental Transaction for pricing purposes and
            reflecting (i) a risk-free interest rate corresponding to the U.S. Treasury rate for a
            period equal to the remaining term of this Warrant as of such date of request, (ii) an
            expected volatility equal to the greater of 100% and the 100 day volatility obtained
            from the HVT function on Bloomberg as of the day immediately following the public
            announcement of the applicable Fundamental Transaction and (iii) the underlying price
            per share used in such calculation shall be the sum of the price per share being
            offered in cash, if any, plus the value of any non cash consideration, if any, being
            offered in the Fundamental Transaction.

            

            
                    
                      (c)
            “Bloomberg” means Bloomberg Financial Markets.

            

            
                    
                      (d) “Business
            Day” means any day other than Saturday, Sunday or other day on which
            commercial banks in The City of New York are authorized or required by law to remain
            closed.

            

            
                    
                      (e) “Closing Bid
            Price” and “Closing Sale Price” means, for any security as
            of any date, the last closing bid price and last closing trade price, respectively, for
            such security on the Principal Market, as reported by Bloomberg, or, if the Principal
            Market begins to operate on an extended hours basis and does not designate the closing
            bid price or the closing trade price, as the case may be, then the last bid price or
            last trade price, respectively, of such security prior to 4:00:00 p.m., New York Time,
            as reported by Bloomberg, or, if the Principal Market is not the principal securities
            exchange or trading market for such security, the last closing bid price or last trade
            price, respectively, of such security on the principal securities exchange or trading
            market where such security is listed or traded as reported by Bloomberg, or if the
            foregoing do not apply, the last closing bid price or last trade price, respectively,
            of such security in the over-the-counter market on the electronic bulletin board for
            such security as reported by Bloomberg, or, if no closing bid price or last trade
            price, respectively, is reported for such security by Bloomberg, the average of the bid
            prices, or the ask prices, respectively, of any market makers for such security as
            reported in the “pink sheets” by Pink Sheets LLC (formerly the National
            Quotation Bureau, Inc.). If the Closing Bid Price or the Closing Sale Price cannot be
            calculated for a security on a particular date on any of the foregoing bases, the
            Closing Bid Price or the Closing Sale Price, as the case may be, of such security on
            such date shall be the fair market value as mutually determined by the Company and the
            Holder. If the Company and the Holder are unable to agree upon the fair market value of
            such security, then such dispute shall be resolved pursuant to Section 12. All such
            determinations to be appropriately adjusted for any stock dividend, stock split, stock
            combination or other similar transaction during the applicable calculation
            period.

            

            -16-

            
            
            

            
            

            

            
                    
                      (f) “Common
            Stock” means (i) the Company’s shares of Common Stock, par value
            $0.001 per share, and (ii) any share capital into which such Common Stock shall
            have been changed or any share capital resulting from a reclassification of such Common
            Stock.

            

            
                    
                      (g) “Convertible
            Securities” means any stock or securities (other than Options) directly or
            indirectly convertible into or exercisable or exchangeable for shares of Common
            Stock.

            

            
                    
                      (h) “Eligible
            Market” means the Principal Market, the American Stock Exchange, The New York
            Stock Exchange, Inc., The NASDAQ Global Market The NASDAQ Capital Market or The NASDAQ
            Global Select Market.

            

            
                    
                      (i) “Excluded
            Securities” means any Common Stock issued or issuable: (i) in connection with
            any Approved Stock Plan; (ii) upon conversion of the SPA Securities or the exercise of
            the SPA Warrants; (iii) in connection with the payment of any Interest Shares on the
            SPA Securities; and (iv) upon exercise of any Options or Convertible Securities which
            are outstanding on the day immediately preceding the Subscription Date, provided that
            the terms of such Options or Convertible Securities are not amended, modified or
            changed on or after the Subscription Date.

            

            
                    
                      (j) “Expiration
            Date” means seven (7) years after the earlier of (A) such time as all of the
            Registrable Securities (as defined in the Registration Rights Agreement) are available
            for resale pursuant to an effective Registration Statement (as defined in the
            Registration Rights Agreement) and (B) two (2) years after the Issuance Date or, if any
            such date falls on a day other than a Business Day or on which trading does not take
            place on the Principal market (a “Holiday”), the next day that is
            not a Holiday.

            

            
                    
                      (k) “Fundamental
            Transaction” means that the Company shall directly or indirectly, in one or
            more related transactions, (i) consolidate or merge with or into (whether or not the
            Company is the surviving corporation) another Person, or (ii) sell, assign, transfer,
            convey or otherwise dispose of all or substantially all of the properties or assets of
            the Company to another Person, or (iii) allow another Person to make a purchase, tender
            or exchange offer that is accepted by the holders of more than the 50% of either the
            outstanding shares of Common Stock (not including any shares of Common Stock held by
            the Person or Persons making or party to, or associated or affiliated with the Persons
            making or party to, such purchase, tender or exchange offer), or (iv) consummate a
            stock purchase agreement or other business combination (including, without limitation,
            a reorganization, recapitalization, spin-off or scheme of arrangement) with another
            Person whereby such other Person acquires more than the 50% of the outstanding shares
            of Common Stock (not including any shares of Common Stock held by the other Person or
            other Persons making or party to, or associated or affiliated with the other Persons
            making or party to, such stock purchase agreement or other business combination), or
            (v) reorganize, recapitalize or reclassify its Common Stock, or (vi) any
            “person” or “group” (as these terms are used for purposes of
            Sections 13(d) and 14(d) of the Exchange Act), become the “beneficial
            owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly,
            of 50% of the aggregate ordinary voting power represented by issued and outstanding
            Common Stock.

            

            -17-

            
            
            

            
            

            

            
                    
                      (l)
            “Options” means any rights, warrants or options to subscribe for or
            purchase shares of Common Stock or Convertible Securities.

            

            
                    
                      (m) “Parent
            Entity” of a Person means an entity that, directly or indirectly, controls
            the applicable Person and whose common stock or equivalent equity security is quoted or
            listed on an Eligible Market, or, if there is more than one such Person or Parent
            Entity, the Person or Parent Entity with the largest public market capitalization as of
            the date of consummation of the Fundamental Transaction.

            

            
                    
                      (n)
            “Person” means an individual, a limited liability company, a
            partnership, a joint venture, a corporation, a trust, an unincorporated organization,
            any other entity and a government or any department or agency thereof.

            

            
                    
                      (o) “Principal
            Market” means the OTC Bulletin Board.

            

            
                    
                      (p) “Registration
            Rights Agreement” means that certain Registration Rights Agreement dated as
            of the Issuance Date by and among the Company and the Buyers.

            

            
                    
                      (q) “Required
            Holders” means the holders of the SPA Warrants representing at least a
            majority of shares of Common Stock underlying the SPA Warrants then
            outstanding.

            

            
                    
                      (r) “SPA
            Securities” means the Notes issued pursuant to the Securities Purchase
            Agreement.

            

            
                    
                      (s) “Successor
            Entity” means the Person (or, if so elected by the Required Holders, the
            Parent Entity) formed by, resulting from or surviving any Fundamental Transaction or
            the Person (or, if so elected by the Required Holders, the Parent Entity) with which
            such Fundamental Transaction shall have been entered into.

            

            
                    
                      (t) “Trading
            Day” means any day on which the Common Stock is traded on the Principal
            Market, or, if the Principal Market is not the principal trading market for the Common
            Stock, then on the principal securities exchange or securities market on which the
            Common Stock is then traded; provided that “Trading Day” shall not include
            any day on which the Common Stock is scheduled to trade on such exchange or market for
            less than 4.5 hours or any day that the Common Stock is suspended from trading during
            the final hour of trading on such exchange or market (or if such exchange or market
            does not designate in advance the closing time of trading on such exchange or market,
            then during the hour ending at 4:00:00 p.m., New York Time).

            

            -18-

            
            
            

            
            

            

            
                    
                      (u) “Weighted
            Average Price” means, for any security as of any date, the dollar
            volume-weighted average price for such security on the Principal Market during the
            period beginning at 9:30:01 a.m., New York Time (or such other time as the Principal
            Market publicly announces is the official open of trading), and ending at 4:00:00 p.m.,
            New York Time (or such other time as the Principal Market publicly announces is the
            official close of trading) as reported by Bloomberg through its “Volume at
            Price” functions, or, if the foregoing does not apply, the dollar volume-weighted
            average price of such security in the over-the-counter market on the electronic
            bulletin board for such security during the period beginning at 9:30:01 a.m., New York
            Time (or such other time as such market publicly announces is the official open of
            trading), and ending at 4:00:00 p.m., New York Time (or such other time as such market
            publicly announces is the official close of trading) as reported by Bloomberg, or, if
            no dollar volume-weighted average price is reported for such security by Bloomberg for
            such hours, the average of the highest closing bid price and the lowest closing ask
            price of any of the market makers for such security as reported in the “pink
            sheets” by Pink Sheets LLC (formerly the National Quotation Bureau, Inc.). If the
            Weighted Average Price cannot be calculated for a security on a particular date on any
            of the foregoing bases, the Weighted Average Price of such security on such date shall
            be the fair market value as mutually determined by the Company and the Holder. If the
            Company and the Holder are unable to agree upon the fair market value of such security,
            then such dispute shall be resolved pursuant to Section 12. All such determinations are
            to be appropriately adjusted for any stock dividend, stock split, stock combination or
            other similar transaction during the applicable calculation period.

            

            [Signature Page
            Follows]

            

            

            

            

            

            

            -19-

            
            

            
            

            

            
                    
            IN WITNESS WHEREOF, the Company has caused this Warrant to Purchase Common Stock to
            be duly executed as of the Issuance Date set out above.

            	
                    	
                    
	
                    	AMISH
                    NATURALS, INC.

                    

                    By:___________________________

                    Name:

                    Title: 

            

            

            

            

            
            

            
            

            

            EXHIBIT
            A

            

            EXERCISE NOTICE
            TO BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS

            WARRANT TO PURCHASE COMMON STOCK

            

            AMISH NATURALS,
            INC.

            

            
                    The
            undersigned holder hereby exercises the right to purchase _________________ of the
            shares of Common Stock (“Warrant Shares”) of Amish Naturals, Inc., a
            Nevada corporation (the “Company”), evidenced by the attached
            Warrant to Purchase Common Stock (the “Warrant”). Capitalized terms
            used herein and not otherwise defined shall have the respective meanings set forth in
            the Warrant.

            

            
                1.       
            Form of Exercise Price. The Holder intends that payment of the Exercise Price shall be
            made as:

            

            	 	
                    ____________ a "Cash
                    Exercise" with respect to _________________ Warrant Shares; and/or 

            

            

            	 	
                    ____________ a "Cashless
                    Exercise" with respect to _______________ Warrant Shares. 

            

            

            
                2.       
            Payment of Exercise Price. In the event that the holder has elected a Cash Exercise
            with respect to some or all of the Warrant Shares to be issued pursuant hereto, the
            holder shall pay the Aggregate Exercise Price in the sum of $___________________ to the
            Company in accordance with the terms of the Warrant.

            

            
                3.       
            Delivery of Warrant Shares. The Company shall deliver to the holder __________ Warrant
            Shares in accordance with the terms of the Warrant.

            

            Date:
            _______________ __, ______

            

            
            ____________________________

                 Name of Registered Holder

            

            By:______________________

                   Name:

                   Title:

            
            
            

            
            

            

            
            ACKNOWLEDGMENT

            

            
                    The
            Company hereby acknowledges this Exercise Notice and hereby directs Signature Stock
            Transfer, Inc. to issue the above indicated number of shares of Common Stock in
            accordance with the Transfer Agent Instructions dated September __, 2007 from the
            Company and acknowledged and agreed to by Signature Stock Transfer,
            Inc.

            	
                    	
                    
	
                    	AMISH
                    NATURALS, INC.

                    

                    By: _______________________________________________

                             Name:

                             Title: 

            

            

            

            

            

            
            
            

            
            

            

            [FORM OF SERIES
            C WARRANT]

            

            NEITHER THE ISSUANCE AND SALE
            OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE
            SECURITIES ARE EXERCISEABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
            AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR
            SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION
            STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN
            OPINION OF COUNSEL, IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED
            UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT.
            NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA
            FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE
            SECURITIES.

            

            AMISH
            NATURALS, INC.

            

            WARRANT TO
            PURCHASE COMMON STOCK

            

            Warrant No.: _______

            Number of Shares of Common Stock:

            Date of Issuance: September __, 2007 ("Issuance Date")

            

            
                    Amish
            Naturals, Inc., a Nevada corporation, (the “Company”), hereby
            certifies that, for good and valuable consideration, the receipt and sufficiency of
            which are hereby acknowledged, CASTLERIGG MASTER INVESTMENTS LTD., the registered
            holder hereof or its permitted assigns (the “Holder”), is entitled,
            subject to the terms set forth below, to purchase from the Company, at the Exercise
            Price (as defined below) then in effect, upon surrender of this Warrant to Purchase
            Common Stock (including any Warrants to purchase Common Stock issued in exchange,
            transfer or replacement hereof, the “Warrant”), at any time or times
            on or after the date hereof, but not after 11:59 p.m., New York Time, on the Expiration
            Date (as defined below), SEVEN HUNDRED NINETY EIGHT THOUSAND, SIX HUNDRED SIXTY FIVE
            (798,665) fully paid nonassessable shares of Common Stock (as defined below) (the
            “Warrant Shares”). Except as otherwise defined herein, capitalized
            terms in this Warrant shall have the meanings set forth in Section 15. This Warrant is
            one of the Warrants to purchase Common Stock (the “SPA Warrants”)
            issued pursuant to Section 1 of that certain Securities Purchase Agreement, dated as of
            August 31, 2007 (the “Subscription Date”), by and among the Company
            and the investors (the “Buyers”) referred to therein (the
            “Securities Purchase Agreement”).

            
            
            

            
            

            

            
                    1.    
            EXERCISE OF WARRANT.

            

            
                    (a)    
            Mechanics of Exercise. Subject to the terms and conditions hereof (including,
            without limitation, the limitations set forth in Section 1(f)), this Warrant may be
            exercised by the Holder on any day on or after the date hereof in whole or in part, by
            (i) delivery of a written notice, in the form attached hereto as Exhibit A
            (the “Exercise Notice”), of the Holder’s election to exercise
            this Warrant and (ii) (A) payment to the Company of an amount equal to the
            applicable Exercise Price multiplied by the number of Warrant Shares as to which this
            Warrant is being exercised (the “Aggregate Exercise Price”) in cash
            or by wire transfer of immediately available funds or (B) by notifying the Company that
            this Warrant is being exercised pursuant to a Cashless Exercise (as defined in Section
            1(d)). The Holder shall not be required to deliver the original Warrant in order to
            effect an exercise hereunder. Execution and delivery of the Exercise Notice with
            respect to less than all of the Warrant Shares shall have the same effect as
            cancellation of the original Warrant and issuance of a new Warrant evidencing the right
            to purchase the remaining number of Warrant Shares. On or before the first Business Day
            following the date on which the Company has received each of the Exercise Notice and
            the Aggregate Exercise Price (or notice of a Cashless Exercise) (the “Exercise
            Delivery Documents”), the Company shall transmit by facsimile an
            acknowledgment of confirmation of receipt of the Exercise Delivery Documents to the
            Holder and the Company’s transfer agent (the “Transfer
            Agent”). On or before the third Trading Day following the date on which the
            Company has received all of the Exercise Delivery Documents (the “Share
            Delivery Date”), the Company shall (X) provided that the Transfer Agent is
            participating in The Depository Trust Company (“DTC”) Fast Automated
            Securities Transfer Program, upon the request of the Holder, credit such aggregate
            number of shares of Common Stock to which the Holder is entitled pursuant to such
            exercise to the Holder’s or its designee’s balance account with DTC through
            its Deposit Withdrawal Agent Commission system, or (Y) if the Transfer Agent is not
            participating in the DTC Fast Automated Securities Transfer Program, issue and dispatch
            by overnight courier to the address as specified in the Exercise Notice, a certificate,
            registered in the Company’s share register in the name of the Holder or its
            designee, for the number of shares of Common Stock to which the Holder is entitled
            pursuant to such exercise. Upon delivery of the Exercise Delivery Documents, the Holder
            shall be deemed for all corporate purposes to have become the holder of record of the
            Warrant Shares with respect to which this Warrant has been exercised, irrespective of
            the date such Warrant Shares are credited to the Holder’s DTC account or the date
            of delivery of the certificates evidencing such Warrant Shares, as the case may be. If
            this Warrant is submitted in connection with any exercise pursuant to this Section 1(a)
            and the number of Warrant Shares represented by this Warrant submitted for exercise is
            greater than the number of Warrant Shares being acquired upon an exercise, then the
            Company shall as soon as practicable and in no event later than three Business Days
            after any exercise and at its own expense, issue a new Warrant (in accordance with
            Section 7(d)) representing the right to purchase the number of Warrant Shares
            purchasable immediately prior to such exercise under this Warrant, less the number of
            Warrant Shares with respect to which this Warrant is exercised. No fractional shares of
            Common Stock are to be issued upon the exercise of this Warrant, but rather the number
            of shares of Common Stock to be issued shall be rounded up to the nearest whole number.
            The Company shall pay any and all taxes which may be payable with respect to the
            issuance and delivery of Warrant Shares upon exercise of this Warrant.

            
            
            

            
            

            

            
                    (b)    
            Exercise Price. For purposes of this Warrant, “Exercise Price”
            means $3.00, subject to adjustment as provided herein.

            

            
                    (c)    
            Company’s Failure to Timely Deliver Securities. If the Company shall fail for
            any reason or for no reason to issue to the Holder within three (3) Trading Days of
            receipt of the Exercise Delivery Documents, a certificate for the number of shares of
            Common Stock to which the Holder is entitled and register such shares of Common Stock
            on the Company’s share register or to credit the Holder’s balance account
            with DTC for such number of shares of Common Stock to which the Holder is entitled upon
            the Holder’s exercise of this Warrant, then, in addition to all other remedies
            available to the Holder, the Company shall pay in cash to the Holder on each day after
            such thirdTrading Day that the issuance of such shares of Common Stock is not timely
            effected an amount equal to 1.5% of the product of (A) the sum of the number of shares
            of Common Stock not issued to the Holder on a timely basis and to which the Holder is
            entitled and (B) the Closing Sale Price of the shares of Common Stock on the Trading
            Day immediately preceding the last possible date which the Company could have issued
            such shares of Common Stock to the Holder without violating Section 1(a). In addition
            to the foregoing, if within three (3) Trading Days after the Company’s receipt of
            the facsimile copy of a Exercise Notice the Company shall fail to issue and deliver a
            certificate to the Holder and register such shares of Common Stock on the
            Company’s share register or credit the Holder’s balance account with DTC
            for the number of shares of Common Stock to which the Holder is entitled upon the
            Holder’s exercise hereunder, and if on or after such Trading Day the Holder
            purchases (in an open market transaction or otherwise) shares of Common Stock to
            deliver in satisfaction of a sale by the Holder of shares of Common Stock issuable upon
            such exercise that the Holder anticipated receiving from the Company (a
            “Buy-In”), then the Company shall, within three Business Days after
            the Holder’s request and in the Holder’s discretion, either (i) pay cash to
            the Holder in an amount equal to the Holder’s total purchase price (including
            brokerage commissions, if any) for the shares of Common Stock so purchased (the
            “Buy-In Price”), at which point the Company’s obligation to
            deliver such certificate (and to issue such shares of Common Stock) or credit such
            Holder’s balance account with DTC shall terminate, or (ii) promptly honor its
            obligation to deliver to the Holder a certificate or certificates representing such
            shares of Common Stock or credit such Holder’s balance account with DTC and pay
            cash to the Holder in an amount equal to the excess (if any) of the Buy-In Price over
            the product of (A) such number of shares of Common Stock, times (B) the Closing Bid
            Price on the date of exercise.

            

            
                    (d)    
            Cashless Exercise. Notwithstanding anything contained herein to the contrary, if a
            Registration Statement (as defined in the Registration Rights Agreement) covering the
            resale of the Warrant Shares that are the subject of the Exercise Notice (the
            “Unavailable Warrant Shares”) is not available for the resale of
            such Unavailable Warrant Shares, the Holder may, in its sole discretion, exercise this
            Warrant in whole or in part and, in lieu of making the cash payment otherwise
            contemplated to be made to the Company upon such exercise in payment of the Aggregate
            Exercise Price, elect instead to receive upon such exercise the “Net
            Number” of shares of Common Stock determined according to the following formula
            (a “Cashless Exercise”):

            	
                    	
                    	
                    
	
                    Net Number = 	
                    (A x B) — (A x
                    C)

                    B 	
                      

            

            

            
                    
                      For purposes of the
            foregoing formula:

            

            
                    
                      A= the total number of
            shares with respect to which this Warrant is then being exercised.

            

            
                    
                      B= the Closing Sale Price
            of the shares of Common Stock (as reported by Bloomberg) on the date immediately
            preceding the date of the Exercise Notice.

            

            
                    
                      C= the Exercise Price then
            in effect for the applicable Warrant Shares at the time of such exercise.

            

            
                    (e)  
            Disputes. In the case of a dispute as to the determination of the Exercise Price
            or the arithmetic calculation of the Warrant Shares, the Company shall promptly issue
            to the Holder the number of Warrant Shares that are not disputed and resolve such
            dispute in accordance with Section 12.

            

            
                    (f)  
            Limitations on Exercises.

            

            -4-

            
            
            

            
            

            

            	
                      	
                            (i)  
                    Beneficial Ownership. The Company shall not effect the exercise of this
                    Warrant, and the Holder shall not have the right to exercise this Warrant, to
                    the extent that after giving effect to such exercise, such Person (together
                    with such Person’s affiliates) would beneficially own in excess of 4.99%
                    of the shares of Common Stock outstanding immediately after giving effect to
                    such exercise. For purposes of the foregoing sentence, the aggregate number of
                    shares of Common Stock beneficially owned by such Person and its affiliates
                    shall include the number of shares of Common Stock issuable upon exercise of
                    this Warrant with respect to which the determination of such sentence is being
                    made, but shall exclude shares of Common Stock which would be issuable upon (A)
                    exercise of the remaining, unexercised portion of this Warrant beneficially
                    owned by such Person and its affiliates and (B) exercise or conversion of the
                    unexercised or unconverted portion of any other securities of the Company
                    beneficially owned by such Person and its affiliates (including, without
                    limitation, any convertible notes or convertible preferred stock or warrants)
                    subject to a limitation on conversion or exercise analogous to the limitation
                    contained herein. Except as set forth in the preceding sentence, for purposes
                    of this paragraph, beneficial ownership shall be calculated in accordance with
                    Section 13(d) of the Securities Exchange Act of 1934, as amended (the
                    “Exchange Act”). For purposes of this Warrant, in
                    determining the number of outstanding shares of Common Stock, the Holder may
                    rely on the number of outstanding shares of Common Stock as reflected in (1)
                    the Company’s most recent Form 10-K, Form 10-KSB, Form 10-Q, Form 10-QSB,
                    Current Report on Form 8-K or other public filing with the Securities and
                    Exchange Commission, as the case may be, (2) a more recent public announcement
                    by the Company or (3) any other notice by the Company or the Transfer Agent
                    setting forth the number of shares of Common Stock outstanding. For any reason
                    at any time, upon the written or oral request of the Holder, the Company shall
                    within one (1) Business Day confirm orally and in writing to the Holder the
                    number of shares of Common Stock then outstanding. In any case, the number of
                    outstanding shares of Common Stock shall be determined after giving effect to
                    the conversion or exercise of securities of the Company, including the SPA
                    Securities and the SPA Warrants, by the Holder and its affiliates since the
                    date as of which such number of outstanding shares of Common Stock was
                    reported. By written notice to the Company, the Holder may from time to time
                    increase or decrease the Maximum Percentage to any other percentage not in
                    excess of 9.99% specified in such notice; provided that (i) any such increase
                    will not be effective until the sixty-first (61st) day after such
                    notice is delivered to the Company, and (ii) any such increase or decrease will
                    apply only to the Holder and not to any other holder of SPA Warrants.
                              

            

            

            	
                      	
                            (ii)
                      Principal Market Regulation. The Company shall not be
                    obligated to issue any shares of Common Stock upon exercise of this Warrant or
                    conversion of SPA Securities and no Buyer shall be entitled to receive any
                    shares of Common Stock if the issuance of such shares of Common Stock would
                    exceed that number of shares of Common Stock which the Company may issue upon
                    exercise or conversion, as applicable, of the SPA Warrants and SPA Securities
                    or otherwise without breaching the Company’s obligations under the rules
                    or regulations of any applicable Eligible Market (the “Exchange
                    Cap”), except that such limitation shall not apply in the event that
                    the Company (A) obtains the approval of its shareholders as required by the
                    applicable rules of the Eligible Market for issuances of shares of Common Stock
                    in excess of such amount or (B) obtains a written opinion from outside counsel
                    to the Company that such approval is not required, which opinion shall be
                    reasonably satisfactory to the Required Holders. Until such approval or written
                    opinion is obtained, no Buyer shall be issued in the aggregate, upon exercise
                    or conversion, as applicable, of any SPA Warrants or SPA Securities, shares of
                    Common Stock in an amount greater than the product of the Exchange Cap
                    multiplied by a fraction, the numerator of which is the total number of shares
                    of Common Stock underlying the SPA Warrants issued to such Buyer pursuant to
                    the Securities Purchase Agreement on the Issuance Date and the denominator of
                    which is the aggregate number of shares of Common Stock underlying the SPA
                    Warrants issued to the Buyers pursuant to the Securities Purchase Agreement on
                    the Issuance Date (with respect to each Buyer, the “Exchange Cap
                    Allocation”). In the event that any Buyer shall sell or otherwise
                    transfer any of such Buyer’s SPA Warrants, the transferee shall be
                    allocated a pro rata portion of such Buyer’s Exchange Cap Allocation, and
                    the restrictions of the prior sentence shall apply to such transferee with
                    respect to the portion of the Exchange Cap Allocation allocated to such
                    transferee. In the event that any holder of SPA Warrants shall exercise all of
                    such holder’s SPA Warrants into a number of shares of Common Stock which,
                    in the aggregate, is less than such holder’s Exchange Cap Allocation,
                    then the difference between such holder’s Exchange Cap Allocation and the
                    number of shares of Common Stock actually issued to such holder shall be
                    allocated to the respective Exchange Cap Allocations of the remaining holders
                    of SPA Warrants on a pro rata basis in proportion to the shares of Common Stock
                    underlying the SPA Warrants then held by each such holder. In the event that
                    the Company is prohibited from issuing any Warrant Shares for which an Exercise
                    Notice has been received as a result of the operation of this Section 1(f)(ii),
                    the Company shall pay cash in exchange for cancellation of such Warrant Shares,
                    at a price per Warrant Share equal to the difference between the Closing Sale
                    Price and the Exercise Price as of the date of the attempted exercise.
                    

            

            

            -5-

            
            
            

            
            

            

            	
                      	
                            (g)
                      Insufficient Authorized Shares. If at any time while this
                    Warrant remain outstanding the Company does not have a sufficient number of
                    authorized and unreserved shares of Common Stock to satisfy its obligation to
                    reserve for issuance upon exercise of this Warrant at least a number of shares
                    of Common Stock equal to 130% (the “Required Reserve
                    Amount”) of the number of shares of Common Stock as shall from time
                    to time be necessary to effect the exercise of all of this Warrant then
                    outstanding (an “Authorized Share Failure”), then the
                    Company shall immediately take all action necessary to increase the
                    Company’s authorized shares of Common Stock to an amount sufficient to
                    allow the Company to reserve the Required Reserve Amount for this Warrant then
                    outstanding. Without limiting the generality of the foregoing sentence, as soon
                    as practicable after the date of the occurrence of an Authorized Share Failure,
                    but in no event later than ninety (90) days after the occurrence of such
                    Authorized Share Failure, the Company shall hold a meeting of its stockholders
                    for the approval of an increase in the number of authorized shares of Common
                    Stock. In connection with such meeting, the Company shall provide each
                    stockholder with a proxy statement and shall use its best efforts to solicit
                    its stockholders’ approval of such increase in authorized shares of
                    Common Stock and to cause its board of directors to recommend to the
                    stockholders that they approve such proposal. 

            

            

            
                    2.  
            ADJUSTMENT OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES. The Exercise Price
            and the number of Warrant Shares shall be adjusted from time to time as
            follows:

            

            -6-

            
            
            

            
            

            

            
                    
                      
                      (a) Adjustment upon
            Issuance of shares of Common Stock. If and whenever on or after the Subscription
            Date the Company issues or sells, or in accordance with this Section 2 is deemed to
            have issued or sold, any shares of Common Stock (including the issuance or sale of
            shares of Common Stock owned or held by or for the account of the Company, but
            excluding shares of Common Stock deemed to have been issued by the Company in
            connection with any Excluded Securities) for a consideration per share (the
            “New Issuance Price”) less than the Exercise Price (the
            “Applicable Price”) in effect immediately prior to such issue or
            sale or deemed issuance or sale (the foregoing a “Dilutive
            Issuance”), then immediately after such Dilutive Issuance, the Exercise Price
            then in effect shall be reduced to an amount equal to the New Issuance Price. Upon each
            such adjustment of the Exercise Price hereunder, the number of Warrant Shares shall be
            adjusted to the number of shares of Common Stock determined by multiplying the Exercise
            Price in effect immediately prior to such adjustment by the number of Warrant Shares
            acquirable upon exercise of this Warrant immediately prior to such adjustment and
            dividing the product thereof by the Exercise Price resulting from such adjustment. For
            purposes of determining the adjusted Exercise Price under this Section 2(a), the
            following shall be applicable:

            

            	
                    	
                        
                            (i)
                               Issuance of Options. If
                        the Company in any manner grants any Options and the lowest price per share
                        for which one share of Common Stock is issuable upon the exercise of any
                        such Option or upon conversion, exercise or exchange of any Convertible
                        Securities issuable upon exercise of any such Option is less than the
                        Applicable Price, then such share of Common Stock shall be deemed to be
                        outstanding and to have been issued and sold by the Company at the time of
                        the granting or sale of such Option for such price per share. For purposes
                        of this Section 2(a)(i), the “lowest price per share for which one
                        share of Common Stock is issuable upon exercise of such Options or upon
                        conversion, exercise or exchange of such Convertible Securities issuable
                        upon exercise of any such Option” shall be equal to the sum of the
                        lowest amounts of consideration (if any) received or receivable by the
                        Company with respect to any one share of Common Stock upon the granting or
                        sale of the Option, upon exercise of the Option and upon conversion,
                        exercise or exchange of any Convertible Security issuable upon exercise of
                        such Option. No further adjustment of the Exercise Price or number of
                        Warrant Shares shall be made upon the actual issuance of such shares of
                        Common Stock or of such Convertible Securities upon the exercise of such
                        Options or upon the actual issuance of such shares of Common Stock upon
                        conversion, exercise or exchange of such Convertible Securities.

                    

            

            

            	
                    	
                        
                            (ii)
                               Issuance of Convertible
                        Securities. If the Company in any manner issues or sells any
                        Convertible Securities and the lowest price per share for which one share
                        of Common Stock is issuable upon the conversion, exercise or exchange
                        thereof is less than the Applicable Price, then such share of Common Stock
                        shall be deemed to be outstanding and to have been issued and sold by the
                        Company at the time of the issuance or sale of such Convertible Securities
                        for such price per share. For the purposes of this Section 2(a)(ii), the
                        “lowest price per share for which one share of Common Stock is
                        issuable upon the conversion, exercise or exchange thereof” shall be
                        equal to the sum of the lowest amounts of consideration (if any) received
                        or receivable by the Company with respect to one share of Common Stock upon
                        the issuance or sale of the Convertible Security and upon conversion,
                        exercise or exchange of such Convertible Security. No further adjustment of
                        the Exercise Price or number of Warrant Shares shall be made upon the
                        actual issuance of such shares of Common Stock upon conversion, exercise or
                        exchange of such Convertible Securities, and if any such issue or sale of
                        such Convertible Securities is made upon exercise of any Options for which
                        adjustment of this Warrant has been or is to be made pursuant to other
                        provisions of this Section 2(a), no further adjustment of the Exercise
                        Price or number of Warrant Shares shall be made by reason of such issue or
                        sale.

                    

            

            

            -7-

            
            
            

            
            

            

            	
                    	
                        
                            (iii)
                               Change in Option Price or Rate
                        of Conversion. If the purchase price provided for in any Options, the
                        additional consideration, if any, payable upon the issue, conversion,
                        exercise or exchange of any Convertible Securities, or the rate at which
                        any Convertible Securities are convertible into or exercisable or
                        exchangeable for shares of Common Stock increases or decreases at any time,
                        the Exercise Price and the number of Warrant Shares in effect at the time
                        of such increase or decrease shall be adjusted to the Exercise Price and
                        the number of Warrant Shares which would have been in effect at such time
                        had such Options or Convertible Securities provided for such increased or
                        decreased purchase price, additional consideration or increased or
                        decreased conversion rate, as the case may be, at the time initially
                        granted, issued or sold. For purposes of this Section 2(a)(iii), if the
                        terms of any Option or Convertible Security that was outstanding as of the
                        date of issuance of this Warrant are increased or decreased in the manner
                        described in the immediately preceding sentence, then such Option or
                        Convertible Security and the shares of Common Stock deemed issuable upon
                        exercise, conversion or exchange thereof shall be deemed to have been
                        issued as of the date of such increase or decrease. No adjustment pursuant
                        to this Section 2(a)(iii) shall be made if such adjustment would result in
                        an increase of the Exercise Price then in effect or a decrease in the
                        number of Warrant Shares.

                    

            

            

            	
                    	
                        
                            (iv)
                               Calculation of Consideration
                        Received. In case any Option is issued in connection with the issue or
                        sale of other securities of the Company, together comprising one integrated
                        transaction in which no specific consideration is allocated to such Options
                        by the parties thereto, the Options will be deemed to have been issued for
                        a consideration of $0.01. If any shares of Common Stock, Options or
                        Convertible Securities are issued or sold or deemed to have been issued or
                        sold for cash, the consideration received therefor will be deemed to be the
                        net amount received by the Company therefor. If any shares of Common Stock,
                        Options or Convertible Securities are issued or sold for a consideration
                        other than cash, the amount of such consideration received by the Company
                        will be the fair value of such consideration, except where such
                        consideration consists of publicly traded securities, in which case the
                        amount of consideration received by the Company will be the Closing Sale
                        Price of such security on the date of receipt. If any shares of Common
                        Stock, Options or Convertible Securities are issued to the owners of the
                        non-surviving entity in connection with any merger in which the Company is
                        the surviving entity, the amount of consideration therefor will be deemed
                        to be the fair value of such portion of the net assets and business of the
                        non-surviving entity as is attributable to such shares of Common Stock,
                        Options or Convertible Securities, as the case may be. The fair value of
                        any consideration other than cash or publicly traded securities will be
                        determined jointly by the Company and the Required Holders. If such parties
                        are unable to reach agreement within ten (10) days after the occurrence of
                        an event requiring valuation (the “Valuation Event”),
                        the fair value of such consideration will be determined within five (5)
                        Business Days after the tenth day following the Valuation Event by an
                        independent, reputable appraiser jointly selected by the Company and the
                        Required Holders. The determination of such appraiser shall be final and
                        binding upon all parties absent manifest error and the fees and expenses of
                        such appraiser shall be borne by the Company.

                    

            

            

            -8-

            
            
            

            
            

            

            	
                    	
                        
                            (v)
                               Record Date. If the
                        Company takes a record of the holders of shares of Common Stock for the
                        purpose of entitling them (A) to receive a dividend or other
                        distribution payable in shares of Common Stock, Options or in Convertible
                        Securities or (B) to subscribe for or purchase shares of Common Stock,
                        Options or Convertible Securities, then such record date will be deemed to
                        be the date of the issue or sale of the shares of Common Stock deemed to
                        have been issued or sold upon the declaration of such dividend or the
                        making of such other distribution or the date of the granting of such right
                        of subscription or purchase, as the case may be.

                    

            

            

            	
                    	
                        
                            (vi)
                               Voluntary Adjustment By
                        Company. The Company may at any time during the term of
                        this Warrant reduce the then current  Exercise
                        Price to any amount and for any period of time deemed appropriate by
                        the Board of Directors of the Company. 

                    

            

            

            
                    
            (b)   Adjustment upon Subdivision or Combination of shares of Common
            Stock. If the Company at any time on or after the Subscription Date subdivides (by
            any stock split, stock dividend, recapitalization or otherwise) one or more classes of
            its outstanding shares of Common Stock into a greater number of shares, the Exercise
            Price in effect immediately prior to such subdivision will be proportionately reduced
            and the number of Warrant Shares will be proportionately increased. If the Company at
            any time on or after the Subscription Date combines (by combination, reverse stock
            split or otherwise) one or more classes of its outstanding shares of Common Stock into
            a smaller number of shares, the Exercise Price in effect immediately prior to such
            combination will be proportionately increased and the number of Warrant Shares will be
            proportionately decreased. Any adjustment under this Section 2(b) shall become
            effective at the close of business on the date the subdivision or combination becomes
            effective.

            

            
                    (c)  
            Other Events. If any event occurs of the type contemplated by the provisions of
            this Section 2 but not expressly provided for by such provisions (including, without
            limitation, the granting of stock appreciation rights, phantom stock rights or other
            rights with equity features), then the Company’s Board of Directors will make an
            appropriate adjustment in the Exercise Price and the number of Warrant Shares so as to
            protect the rights of the Holder; provided that no such adjustment pursuant to this
            Section 2(c) will increase the Exercise Price or decrease the number of Warrant Shares
            as otherwise determined pursuant to this Section 2.

            

            -9-

            
            
            

            
            

            

            
                    3.  
            RIGHTS UPON DISTRIBUTION OF ASSETS. If the Company shall declare or make any
            dividend or other distribution of its assets (or rights to acquire its assets) to
            holders of shares of Common Stock, by way of return of capital or otherwise (including,
            without limitation, any distribution of cash, stock or other securities, property or
            options by way of a dividend, spin off, reclassification, corporate rearrangement,
            scheme of arrangement or other similar transaction) (a
            “Distribution”), at any time after the issuance of this Warrant,
            then, in each such case:

            

            
                    
                      (a) any Exercise Price in
            effect immediately prior to the close of business on the record date fixed for the
            determination of holders of shares of Common Stock entitled to receive the Distribution
            shall be reduced, effective as of the close of business on such record date, to a price
            determined by multiplying such Exercise Price by a fraction of which (i) the numerator
            shall be the Closing Bid Price of the shares of Common Stock on the Trading Day
            immediately preceding such record date minus the value of the Distribution (as
            determined in good faith by the Company’s Board of Directors) applicable to one
            share of Common Stock, and (ii) the denominator shall be the Closing Bid Price of the
            shares of Common Stock on the Trading Day immediately preceding such record date;
            and

            

            
                    
                      (b) the number of Warrant
            Shares shall be increased to a number of shares equal to the number of shares of Common
            Stock obtainable immediately prior to the close of business on the record date fixed
            for the determination of holders of shares of Common Stock entitled to receive the
            Distribution multiplied by the reciprocal of the fraction set forth in the immediately
            preceding paragraph (a); provided that in the event that the Distribution is of shares
            of common stock (“Other Shares of Common Stock”) of a company whose
            common shares are traded on a national securities exchange or a national automated
            quotation system, then the Holder may elect to receive a warrant to purchase Other
            Shares of Common Stock in lieu of an increase in the number of Warrant Shares, the
            terms of which shall be identical to those of this Warrant, except that such warrant
            shall be exercisable into the number of shares of Other Shares of Common Stock that
            would have been payable to the Holder pursuant to the Distribution had the Holder
            exercised this Warrant immediately prior to such record date and with an aggregate
            exercise price equal to the product of the amount by which the exercise price of this
            Warrant was decreased with respect to the Distribution pursuant to the terms of the
            immediately preceding paragraph (a) and the number of Warrant Shares calculated in
            accordance with the first part of this paragraph (b).

            

            
                    4.
                   PURCHASE RIGHTS; FUNDAMENTAL
            TRANSACTIONS.

            

            -10-

            
            
            

            
            

            

            
                    
                      (a) Purchase Rights.
            In addition to any adjustments pursuant to Section 2 above, if at any time the Company
            grants, issues or sells any Options, Convertible Securities or rights to purchase
            stock, warrants, securities or other property pro rata to the record holders of any
            class of shares of Common Stock (the “Purchase Rights”), then the
            Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights,
            the aggregate Purchase Rights which the Holder could have acquired if the Holder had
            held the number of shares of Common Stock acquirable upon complete exercise of this
            Warrant (without regard to any limitations on the exercise of this Warrant) immediately
            before the date on which a record is taken for the grant, issuance or sale of such
            Purchase Rights, or, if no such record is taken, the date as of which the record
            holders of shares of Common Stock are to be determined for the grant, issue or sale of
            such Purchase Rights.

            

            
                    
                      (b) Fundamental
            Transactions. The Company shall not enter into or be party to a Fundamental
            Transaction unless (i)  the Successor Entity assumes in writing all of the
            obligations of the Company under this Warrant and the other Transaction Documents in
            accordance with the provisions of this Section (4)(b) pursuant to written agreements in
            form and substance satisfactory to the Required Holders and approved by the Required
            Holders prior to such Fundamental Transaction, including agreements to deliver to each
            holder of Warrants in exchange for such Warrants a security of the Successor Entity
            evidenced by a written instrument substantially similar in form and substance to this
            Warrant, including, without limitation, an adjusted exercise price equal to the value
            for the shares of Common Stock reflected by the terms of such Fundamental Transaction,
            and exercisable for a corresponding number of shares of capital stock equivalent to the
            shares of Common Stock acquirable and receivable upon exercise of this Warrant (without
            regard to any limitations on the exercise of this Warrant) prior to such Fundamental
            Transaction, and satisfactory to the Required Holders and (ii) the Successor
            Entity (including its Parent Entity) is a publicly traded corporation whose common
            stock is quoted on or listed for trading on an Eligible Market. Upon the occurrence of
            any Fundamental Transaction, the Successor Entity shall succeed to, and be substituted
            for (so that from and after the date of such Fundamental Transaction, the provisions of
            this Warrant referring to the “Company” shall refer instead to the
            Successor Entity), and may exercise every right and power of the Company and shall
            assume all of the obligations of the Company under this Warrant with the same effect as
            if such Successor Entity had been named as the Company herein. Upon consummation of the
            Fundamental Transaction, the Successor Entity shall deliver to the Holder confirmation
            that there shall be issued upon exercise of this Warrant at any time after the
            consummation of the Fundamental Transaction, in lieu of the shares of the Common Stock
            (or other securities, cash, assets or other property) purchasable upon the exercise of
            the Warrant prior to such Fundamental Transaction, such shares of the publicly traded
            Common Stock (or its equivalent) of the Successor Entity (including its Parent Entity),
            as adjusted in accordance with the provisions of this Warrant. In addition to and not
            in substitution for any other rights hereunder, prior to the consummation of any
            Fundamental Transaction pursuant to which holders of shares of Common Stock are
            entitled to receive securities or other assets with respect to or in exchange for
            shares of Common Stock (a “Corporate Event”), the Company shall make
            appropriate provision to insure that the Holder will thereafter have the right to
            receive upon an exercise of this Warrant at any time after the consummation of the
            Fundamental Transaction but prior to the Expiration Date, in lieu of the shares of the
            Common Stock (or other securities, cash, assets or other property) purchasable upon the
            exercise of the Warrant prior to such Fundamental Transaction, such shares of stock,
            securities, cash, assets or any other property whatsoever (including warrants or other
            purchase or subscription rights) which the Holder would have been entitled to receive
            upon the happening of such Fundamental Transaction had the Warrant been exercised
            immediately prior to such Fundamental Transaction. Provision made pursuant to the
            preceding sentence shall be in a form and substance reasonably satisfactory to the
            Required Holders. The provisions of this Section shall apply similarly and equally to
            successive Fundamental Transactions and Corporate Events and shall be applied without
            regard to any limitations on the exercise of this Warrant.

            

            -11-

            
            
            

            
            

            

            
                    
                     (c) Notwithstanding the foregoing
            and the provisions of Section 4(b) above, in the event of a Fundamental Transaction, at
            the request of the Holder delivered before the ninetieth (90th) day after the
            consummation of such Fundamental Transaction, the Company (or the Successor Entity)
            shall purchase this Warrant from the Holder by paying to the Holder, within five (5)
            Business Days of such request (or, if later, on the effective date of the Fundamental
            Transaction, cash in an amount equal to the Black-Scholes Value of the remaining
            unexercised portion of this Warrant on the date of such Fundamental
            Transaction.

            

            

            

            

            

            

            

            

            -12-

            
            
            

            
            

            

            
                    5.  
            WARRANT HOLDER NOT DEEMED A STOCKHOLDER. Except as otherwise specifically
            provided herein, the Holder, solely in such Person’s capacity as a holder of this
            Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of
            share capital of the Company for any purpose, nor shall anything contained in this
            Warrant be construed to confer upon the Holder, solely in such Person’s capacity
            as the Holder of this Warrant, any of the rights of a shareholder of the Company or any
            right to vote, give or withhold consent to any corporate action (whether any
            reorganization, issue of stock, reclassification of stock, consolidation, merger,
            conveyance or otherwise), receive notice of meetings, receive dividends or subscription
            rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which
            such Person is then entitled to receive upon the due exercise of this Warrant. In
            addition, nothing contained in this Warrant shall be construed as imposing any
            liabilities on the Holder to purchase any securities (upon exercise of this Warrant or
            otherwise) or as a shareholder of the Company, whether such liabilities are asserted by
            the Company or by creditors of the Company. Notwithstanding this Section 5, the Company
            shall provide the Holder with copies of the same notices and other information given to
            the shareholders of the Company generally, contemporaneously with the giving thereof to
            the shareholders.

            

            
                    6.  
            NONCIRCUMVENTION. The Company hereby covenants and agrees that the Company will
            not, by amendment of its Articles of Incorporation, Bylaws or through any
            reorganization, transfer of assets, consolidation, merger, scheme of arrangement,
            dissolution, issue or sale of securities, or any other voluntary action, avoid or seek
            to avoid the observance or performance of any of the terms of this Warrant, and will at
            all times in good faith carry out all the provisions of this Warrant and take all
            action as may be required to protect the rights of the Holder. Without limiting the
            generality of the foregoing, the Company (i) shall not increase the par value of
            any shares of Common Stock receivable upon the exercise of this Warrant above the
            Exercise Price then in effect, (ii) shall take all such actions as may be
            necessary or appropriate in order that the Company may validly and legally issue fully
            paid and nonassessable shares of Common Stock upon the exercise of this Warrant, and
            (iii) shall, so long as any of the SPA Warrants are outstanding, take all action
            necessary to reserve and keep available out of its authorized and unissued shares of
            Common Stock, solely for the purpose of effecting the exercise of the SPA Warrants,
            130% of the number of shares of Common Stock as shall from time to time be necessary to
            effect the exercise of the SPA Warrants then outstanding (without regard to any
            limitations on exercise).

            

            
                    7.  
            REISSUANCE OF WARRANTS.

            

            
                    
                      (a) Transfer of
            Warrant.   If this Warrant is to be transferred, the Holder shall
            surrender this Warrant to the Company, whereupon the Company will forthwith issue and
            deliver upon the order of the Holder a new Warrant (in accordance with Section 7(d)),
            registered as the Holder may request, representing the right to purchase the number of
            Warrant Shares being transferred by the Holder and, if less than the total number of
            Warrant Shares then underlying this Warrant is being transferred, a new Warrant (in
            accordance with Section 7(d)) to the Holder representing the right to purchase the
            number of Warrant Shares not being transferred.

            

            -13-

            
            
            

            
            

            

            
                    
                      (b)   Lost,
            Stolen or Mutilated Warrant. Upon receipt by the Company of evidence reasonably
            satisfactory to the Company of the loss, theft, destruction or mutilation of this
            Warrant, and, in the case of loss, theft or destruction, of any indemnification
            undertaking by the Holder to the Company in customary form and, in the case of
            mutilation, upon surrender and cancellation of this Warrant, the Company shall execute
            and deliver to the Holder a new Warrant (in accordance with Section 7(d)) representing
            the right to purchase the Warrant Shares then underlying this Warrant.

            

            
                    
                      (c) Exchangeable for
            Multiple Warrants. This Warrant is exchangeable, upon the surrender hereof by the
            Holder at the principal office of the Company, for a new Warrant or Warrants (in
            accordance with Section 7(d)) representing in the aggregate the right to purchase the
            number of Warrant Shares then underlying this Warrant, and each such new Warrant will
            represent the right to purchase such portion of such Warrant Shares as is designated by
            the Holder at the time of such surrender; provided, however, that no Warrants for
            fractional shares of Common Stock shall be given.

            

            
                    
                      (d) Issuance of New
            Warrants. Whenever the Company is required to issue a new Warrant pursuant to the
            terms of this Warrant, such new Warrant (i) shall be of like tenor with this Warrant,
            (ii) shall represent, as indicated on the face of such new Warrant, the right to
            purchase the Warrant Shares then underlying this Warrant (or in the case of a new
            Warrant being issued pursuant to Section 7(a) or Section 7(c), the Warrant Shares
            designated by the Holder which, when added to the number of shares of Common Stock
            underlying the other new Warrants issued in connection with such issuance, does not
            exceed the number of Warrant Shares then underlying this Warrant), (iii) shall have an
            issuance date, as indicated on the face of such new Warrant which is the same as the
            Issuance Date, and (iv) shall have the same rights and conditions as this
            Warrant.

            

            
                    8.  
            NOTICES. Whenever notice is required to be given under this Warrant, unless
            otherwise provided herein, such notice shall be given in accordance with Section 9(f)
            of the Securities Purchase Agreement. The Company shall provide the Holder with prompt
            written notice of all actions taken pursuant to this Warrant, including in reasonable
            detail a description of such action and the reason therefore. Without limiting the
            generality of the foregoing, the Company will give written notice to the Holder (i)
            immediately upon any adjustment of the Exercise Price, setting forth in reasonable
            detail, and certifying, the calculation of such adjustment and (ii) at least fifteen
            days prior to the date on which the Company closes its books or takes a record (A) with
            respect to any dividend or distribution upon the shares of Common Stock, (B) with
            respect to any grants, issuances or sales of any Options, Convertible Securities or
            rights to purchase stock, warrants, securities or other property to holders of shares
            of Common Stock or (C) for determining rights to vote with respect to any Fundamental
            Transaction, dissolution or liquidation, provided in each case that such information
            shall be made known to the public prior to or in conjunction with such notice being
            provided to the Holder.

            

            
                    9.  
            AMENDMENT AND WAIVER. Except as otherwise provided herein, the provisions of
            this Warrant may be amended and the Company may take any action herein prohibited, or
            omit to perform any act herein required to be performed by it, only if the Company has
            obtained the written consent of the Required Holders; provided that no such action may
            increase the exercise price of any SPA Warrant or decrease the number of shares or
            class of stock obtainable upon exercise of any SPA Warrant without the written consent
            of the Holder. No such amendment shall be effective to the extent that it applies to
            less than all of the holders of the SPA Warrants then outstanding.

            

            -14-

            
            
            

            
            

            

            
                    10.  
            GOVERNING LAW. This Warrant shall be governed by and construed and enforced in
            accordance with, and all questions concerning the construction, validity,
            interpretation and performance of this Warrant shall be governed by, the internal laws
            of the State of New York, without giving effect to any choice of law or conflict of law
            provision or rule (whether of the State of New York or any other jurisdictions) that
            would cause the application of the laws of any jurisdictions other than the State of
            New York.

            

            
                    11.  
            CONSTRUCTION; HEADINGS. This Warrant shall be deemed to be jointly drafted by
            the Company and all the Buyers and shall not be construed against any person as the
            drafter hereof. The headings of this Warrant are for convenience of reference and shall
            not form part of, or affect the interpretation of, this Warrant.

            

            
                    12.  
            DISPUTE RESOLUTION. In the case of a dispute as to the determination of the
            Exercise Price or the arithmetic calculation of the Warrant Shares, the Company shall
            submit the disputed determinations or arithmetic calculations via facsimile within two
            Business Days of receipt of the Exercise Notice giving rise to such dispute, as the
            case may be, to the Holder. If the Holder and the Company are unable to agree upon such
            determination or calculation of the Exercise Price or the Warrant Shares within three
            Business Days of such disputed determination or arithmetic calculation being submitted
            to the Holder, then the Company shall, within two Business Days submit via facsimile
            (a) the disputed determination of the Exercise Price to an independent, reputable
            investment bank selected by the Company and approved by the Holder or (b) the disputed
            arithmetic calculation of the Warrant Shares to the Company’s independent,
            outside accountant. The Company shall cause at its expense the investment bank or the
            accountant, as the case may be, to perform the determinations or calculations and
            notify the Company and the Holder of the results no later than ten Business Days from
            the time it receives the disputed determinations or calculations. Such investment
            bank’s or accountant’s determination or calculation, as the case may be,
            shall be binding upon all parties absent demonstrable error.

            

            
                    13.  
            REMEDIES, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF. The remedies
            provided in this Warrant shall be cumulative and in addition to all other remedies
            available under this Warrant and the other Transaction Documents, at law or in equity
            (including a decree of specific performance and/or other injunctive relief), and
            nothing herein shall limit the right of the Holder right to pursue actual damages for
            any failure by the Company to comply with the terms of this Warrant. The Company
            acknowledges that a breach by it of its obligations hereunder will cause irreparable
            harm to the Holder and that the remedy at law for any such breach may be inadequate.
            The Company therefore agrees that, in the event of any such breach or threatened
            breach, the holder of this Warrant shall be entitled, in addition to all other
            available remedies, to an injunction restraining any breach, without the necessity of
            showing economic loss and without any bond or other security being required.

            

            
                    14.  
            TRANSFER. This Warrant may be offered for sale, sold, transferred or assigned
            without the consent of the Company, except as may otherwise be required by Section 2(g)
            of the Securities Purchase Agreement.

            

            -15-

            
            
            

            
            

            

            
                    15.  
            CERTAIN DEFINITIONS. For purposes of this Warrant, the following terms shall
            have the following meanings:

            

            
                    
                      (a) “Approved
            Stock Plan” means any employee benefit plan which has been approved by the
            Board of Directors of the Company, pursuant to which the Company’s securities may
            be issued to any employee, consultant, officer or director for services provided to the
            Company.

            

            
                    
                      (b) “Black Scholes
            Value” means the value of this Warrant based on the Black and Scholes Option
            Pricing Model obtained from the “OV” function on Bloomberg determined as of
            the day of closing of the applicable Fundamental Transaction for pricing purposes and
            reflecting (i) a risk-free interest rate corresponding to the U.S. Treasury rate for a
            period equal to the remaining term of this Warrant as of such date of request, (ii) an
            expected volatility equal to the greater of 100% and the 100 day volatility obtained
            from the HVT function on Bloomberg as of the day immediately following the public
            announcement of the applicable Fundamental Transaction and (iii) the underlying price
            per share used in such calculation shall be the sum of the price per share being
            offered in cash, if any, plus the value of any non cash consideration, if any, being
            offered in the Fundamental Transaction.

            

            
                    
                      (c)
            “Bloomberg” means Bloomberg Financial Markets.

            

            
                    
                      (d) “Business
            Day” means any day other than Saturday, Sunday or other day on which
            commercial banks in The City of New York are authorized or required by law to remain
            closed.

            

            
                    
                      (e) “Closing Bid
            Price” and “Closing Sale Price” means, for any security as
            of any date, the last closing bid price and last closing trade price, respectively, for
            such security on the Principal Market, as reported by Bloomberg, or, if the Principal
            Market begins to operate on an extended hours basis and does not designate the closing
            bid price or the closing trade price, as the case may be, then the last bid price or
            last trade price, respectively, of such security prior to 4:00:00 p.m., New York Time,
            as reported by Bloomberg, or, if the Principal Market is not the principal securities
            exchange or trading market for such security, the last closing bid price or last trade
            price, respectively, of such security on the principal securities exchange or trading
            market where such security is listed or traded as reported by Bloomberg, or if the
            foregoing do not apply, the last closing bid price or last trade price, respectively,
            of such security in the over-the-counter market on the electronic bulletin board for
            such security as reported by Bloomberg, or, if no closing bid price or last trade
            price, respectively, is reported for such security by Bloomberg, the average of the bid
            prices, or the ask prices, respectively, of any market makers for such security as
            reported in the “pink sheets” by Pink Sheets LLC (formerly the National
            Quotation Bureau, Inc.). If the Closing Bid Price or the Closing Sale Price cannot be
            calculated for a security on a particular date on any of the foregoing bases, the
            Closing Bid Price or the Closing Sale Price, as the case may be, of such security on
            such date shall be the fair market value as mutually determined by the Company and the
            Holder. If the Company and the Holder are unable to agree upon the fair market value of
            such security, then such dispute shall be resolved pursuant to Section 12. All such
            determinations to be appropriately adjusted for any stock dividend, stock split, stock
            combination or other similar transaction during the applicable calculation
            period.

            

            -16-

            
            
            

            
            

            

            
                    
                      (f) “Common
            Stock” means (i) the Company’s shares of Common Stock, par value
            $0.001 per share, and (ii) any share capital into which such Common Stock shall
            have been changed or any share capital resulting from a reclassification of such Common
            Stock.

            

            
                    
                      (g) “Convertible
            Securities” means any stock or securities (other than Options) directly or
            indirectly convertible into or exercisable or exchangeable for shares of Common
            Stock.

            

            
                    
                      (h) “Eligible
            Market” means the Principal Market, the American Stock Exchange, The New York
            Stock Exchange, Inc., The NASDAQ Global Market The NASDAQ Capital Market or The NASDAQ
            Global Select Market.

            

            
                    
                      (i) “Excluded
            Securities” means any Common Stock issued or issuable: (i) in connection with
            any Approved Stock Plan; (ii) upon conversion of the SPA Securities or the exercise of
            the SPA Warrants; (iii) in connection with the payment of any Interest Shares on the
            SPA Securities; and (iv) upon exercise of any Options or Convertible Securities which
            are outstanding on the day immediately preceding the Subscription Date, provided that
            the terms of such Options or Convertible Securities are not amended, modified or
            changed on or after the Subscription Date.

            

            
                    
                      (j) “Expiration
            Date” means seven (7) years after the earlier of (A) such time as all of the
            Registrable Securities (as defined in the Registration Rights Agreement) are available
            for resale pursuant to an effective Registration Statement (as defined in the
            Registration Rights Agreement) and (B) two (2) years after the Issuance Date or, if any
            such date falls on a day other than a Business Day or on which trading does not take
            place on the Principal market (a “Holiday”), the next day that is
            not a Holiday.

            

            
                    
                      (k) “Fundamental
            Transaction” means that the Company shall directly or indirectly, in one or
            more related transactions, (i) consolidate or merge with or into (whether or not the
            Company is the surviving corporation) another Person, or (ii) sell, assign, transfer,
            convey or otherwise dispose of all or substantially all of the properties or assets of
            the Company to another Person, or (iii) allow another Person to make a purchase, tender
            or exchange offer that is accepted by the holders of more than the 50% of either the
            outstanding shares of Common Stock (not including any shares of Common Stock held by
            the Person or Persons making or party to, or associated or affiliated with the Persons
            making or party to, such purchase, tender or exchange offer), or (iv) consummate a
            stock purchase agreement or other business combination (including, without limitation,
            a reorganization, recapitalization, spin-off or scheme of arrangement) with another
            Person whereby such other Person acquires more than the 50% of the outstanding shares
            of Common Stock (not including any shares of Common Stock held by the other Person or
            other Persons making or party to, or associated or affiliated with the other Persons
            making or party to, such stock purchase agreement or other business combination), or
            (v) reorganize, recapitalize or reclassify its Common Stock, or (vi) any
            “person” or “group” (as these terms are used for purposes of
            Sections 13(d) and 14(d) of the Exchange Act), become the “beneficial
            owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly,
            of 50% of the aggregate ordinary voting power represented by issued and outstanding
            Common Stock.

            

            -17-

            
            
            

            
            

            

            
                    
                      (l)
            “Options” means any rights, warrants or options to subscribe for or
            purchase shares of Common Stock or Convertible Securities.

            

            
                    
                      (m) “Parent
            Entity” of a Person means an entity that, directly or indirectly, controls
            the applicable Person and whose common stock or equivalent equity security is quoted or
            listed on an Eligible Market, or, if there is more than one such Person or Parent
            Entity, the Person or Parent Entity with the largest public market capitalization as of
            the date of consummation of the Fundamental Transaction.

            

            
                    
                      (n)
            “Person” means an individual, a limited liability company, a
            partnership, a joint venture, a corporation, a trust, an unincorporated organization,
            any other entity and a government or any department or agency thereof.

            

            
                    
                      (o) “Principal
            Market” means the OTC Bulletin Board.

            

            
                    
                      (p) “Registration
            Rights Agreement” means that certain Registration Rights Agreement dated as
            of the Issuance Date by and among the Company and the Buyers.

            

            
                    
                      (q) “Required
            Holders” means the holders of the SPA Warrants representing at least a
            majority of shares of Common Stock underlying the SPA Warrants then
            outstanding.

            

            
                    
                      (r) “SPA
            Securities” means the Notes issued pursuant to the Securities Purchase
            Agreement.

            

            
                    
                      (s) “Successor
            Entity” means the Person (or, if so elected by the Required Holders, the
            Parent Entity) formed by, resulting from or surviving any Fundamental Transaction or
            the Person (or, if so elected by the Required Holders, the Parent Entity) with which
            such Fundamental Transaction shall have been entered into.

            

            
                    
                      (t) “Trading
            Day” means any day on which the Common Stock is traded on the Principal
            Market, or, if the Principal Market is not the principal trading market for the Common
            Stock, then on the principal securities exchange or securities market on which the
            Common Stock is then traded; provided that “Trading Day” shall not include
            any day on which the Common Stock is scheduled to trade on such exchange or market for
            less than 4.5 hours or any day that the Common Stock is suspended from trading during
            the final hour of trading on such exchange or market (or if such exchange or market
            does not designate in advance the closing time of trading on such exchange or market,
            then during the hour ending at 4:00:00 p.m., New York Time).

            

            -18-

            
            
            

            
            

            

            
                    
                      (u) “Weighted
            Average Price” means, for any security as of any date, the dollar
            volume-weighted average price for such security on the Principal Market during the
            period beginning at 9:30:01 a.m., New York Time (or such other time as the Principal
            Market publicly announces is the official open of trading), and ending at 4:00:00 p.m.,
            New York Time (or such other time as the Principal Market publicly announces is the
            official close of trading) as reported by Bloomberg through its “Volume at
            Price” functions, or, if the foregoing does not apply, the dollar volume-weighted
            average price of such security in the over-the-counter market on the electronic
            bulletin board for such security during the period beginning at 9:30:01 a.m., New York
            Time (or such other time as such market publicly announces is the official open of
            trading), and ending at 4:00:00 p.m., New York Time (or such other time as such market
            publicly announces is the official close of trading) as reported by Bloomberg, or, if
            no dollar volume-weighted average price is reported for such security by Bloomberg for
            such hours, the average of the highest closing bid price and the lowest closing ask
            price of any of the market makers for such security as reported in the “pink
            sheets” by Pink Sheets LLC (formerly the National Quotation Bureau, Inc.). If the
            Weighted Average Price cannot be calculated for a security on a particular date on any
            of the foregoing bases, the Weighted Average Price of such security on such date shall
            be the fair market value as mutually determined by the Company and the Holder. If the
            Company and the Holder are unable to agree upon the fair market value of such security,
            then such dispute shall be resolved pursuant to Section 12. All such determinations are
            to be appropriately adjusted for any stock dividend, stock split, stock combination or
            other similar transaction during the applicable calculation period.

            

            [Signature Page
            Follows]

            

            

            

            

            

            

            -19-

            
            

            
            

            

            
                    
            IN WITNESS WHEREOF, the Company has caused this Warrant to Purchase Common Stock to
            be duly executed as of the Issuance Date set out above.

            	
                    	
                    
	
                    	AMISH
                    NATURALS, INC.

                    

                    By:___________________________

                    Name:

                    Title: 

            

            

            

            

            
            

            
            

            

            EXHIBIT
            A

            

            EXERCISE NOTICE
            TO BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS

            WARRANT TO PURCHASE COMMON STOCK

            

            AMISH NATURALS,
            INC.

            

            
                    The
            undersigned holder hereby exercises the right to purchase _________________ of the
            shares of Common Stock (“Warrant Shares”) of Amish Naturals, Inc., a
            Nevada corporation (the “Company”), evidenced by the attached
            Warrant to Purchase Common Stock (the “Warrant”). Capitalized terms
            used herein and not otherwise defined shall have the respective meanings set forth in
            the Warrant.

            

            
                1.       
            Form of Exercise Price. The Holder intends that payment of the Exercise Price shall be
            made as:

            

            	 	
                    ____________ a "Cash
                    Exercise" with respect to _________________ Warrant Shares; and/or 

            

            

            	 	
                    ____________ a "Cashless
                    Exercise" with respect to _______________ Warrant Shares. 

            

            

            
                2.       
            Payment of Exercise Price. In the event that the holder has elected a Cash Exercise
            with respect to some or all of the Warrant Shares to be issued pursuant hereto, the
            holder shall pay the Aggregate Exercise Price in the sum of $___________________ to the
            Company in accordance with the terms of the Warrant.

            

            
                3.       
            Delivery of Warrant Shares. The Company shall deliver to the holder __________ Warrant
            Shares in accordance with the terms of the Warrant.

            

            Date:
            _______________ __, ______

            

            
            ____________________________

                 Name of Registered Holder

            

            By:______________________

                   Name:

                   Title:

            
            
            

            
            

            

            
            ACKNOWLEDGMENT

            

            
                    The
            Company hereby acknowledges this Exercise Notice and hereby directs Signature Stock
            Transfer, Inc. to issue the above indicated number of shares of Common Stock in
            accordance with the Transfer Agent Instructions dated September __, 2007 from the
            Company and acknowledged and agreed to by Signature Stock Transfer,
            Inc.

            	
                    	
                    
	
                    	AMISH
                    NATURALS, INC.

                    

                    By: _______________________________________________

                             Name:

                             Title:Exhibit
            10.15

            

            [FORM OF SERIES
            D WARRANT]

            

            NEITHER THE ISSUANCE AND SALE
            OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE
            SECURITIES ARE EXERCISEABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
            AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR
            SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION
            STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN
            OPINION OF COUNSEL, IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED
            UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT.
            NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA
            FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE
            SECURITIES.

            

            AMISH
            NATURALS, INC.

            

            WARRANT TO
            PURCHASE COMMON STOCK

            

            Warrant No.: _______

            Number of Shares of Common Stock:

            Date of Issuance: September __, 2007 ("Issuance Date")

            

            
                    Amish
            Naturals, Inc., a Nevada corporation, (the “Company”), hereby
            certifies that, for good and valuable consideration, the receipt and sufficiency of
            which are hereby acknowledged, CASTLERIGG MASTER INVESTMENTS LTD., the registered
            holder hereof or its permitted assigns (the “Holder”), is entitled,
            subject to the terms set forth below, to purchase from the Company, at the Exercise
            Price (as defined below) then in effect, upon surrender of this Warrant to Purchase
            Common Stock (including any Warrants to purchase Common Stock issued in exchange,
            transfer or replacement hereof, the “Warrant”), at any time or times
            on or after the date hereof, but not after 11:59 p.m., New York Time, on the Expiration
            Date (as defined below), THREE MILLION, ONE HUNDRED NINETY FOUR THOUSAND, SIX HUNDRED
            SIXTY ONE ( 3,194,661) fully paid nonassessable shares of Common Stock (as defined
            below) (the “Warrant Shares”). Except as otherwise defined herein,
            capitalized terms in this Warrant shall have the meanings set forth in Section 15. This
            Warrant is one of the Warrants to purchase Common Stock (the “SPA
            Warrants”) issued pursuant to Section 1 of that certain Securities Purchase
            Agreement, dated as of August 31, 2007 (the “Subscription Date”), by
            and among the Company and the investors (the “Buyers”) referred to
            therein (the “Securities Purchase Agreement”).

            
            
            

            
            

            

            
                    1.    
            EXERCISE OF WARRANT.

            

            
                    (a)    
            Mechanics of Exercise. Subject to the terms and conditions hereof (including,
            without limitation, the limitations set forth in Section 1(f)), this Warrant may be
            exercised by the Holder on any day on or after the date hereof in whole or in part, by
            (i) delivery of a written notice, in the form attached hereto as Exhibit A
            (the “Exercise Notice”), of the Holder’s election to exercise
            this Warrant and (ii) (A) payment to the Company of an amount equal to the
            applicable Exercise Price multiplied by the number of Warrant Shares as to which this
            Warrant is being exercised (the “Aggregate Exercise Price”) in cash
            or by wire transfer of immediately available funds or (B) by notifying the Company that
            this Warrant is being exercised pursuant to a Cashless Exercise (as defined in Section
            1(d)). The Holder shall not be required to deliver the original Warrant in order to
            effect an exercise hereunder. Execution and delivery of the Exercise Notice with
            respect to less than all of the Warrant Shares shall have the same effect as
            cancellation of the original Warrant and issuance of a new Warrant evidencing the right
            to purchase the remaining number of Warrant Shares. On or before the first Business Day
            following the date on which the Company has received each of the Exercise Notice and
            the Aggregate Exercise Price (or notice of a Cashless Exercise) (the “Exercise
            Delivery Documents”), the Company shall transmit by facsimile an
            acknowledgment of confirmation of receipt of the Exercise Delivery Documents to the
            Holder and the Company’s transfer agent (the “Transfer
            Agent”). On or before the third Trading Day following the date on which the
            Company has received all of the Exercise Delivery Documents (the “Share
            Delivery Date”), the Company shall (X) provided that the Transfer Agent is
            participating in The Depository Trust Company (“DTC”) Fast Automated
            Securities Transfer Program, upon the request of the Holder, credit such aggregate
            number of shares of Common Stock to which the Holder is entitled pursuant to such
            exercise to the Holder’s or its designee’s balance account with DTC through
            its Deposit Withdrawal Agent Commission system, or (Y) if the Transfer Agent is not
            participating in the DTC Fast Automated Securities Transfer Program, issue and dispatch
            by overnight courier to the address as specified in the Exercise Notice, a certificate,
            registered in the Company’s share register in the name of the Holder or its
            designee, for the number of shares of Common Stock to which the Holder is entitled
            pursuant to such exercise. Upon delivery of the Exercise Delivery Documents, the Holder
            shall be deemed for all corporate purposes to have become the holder of record of the
            Warrant Shares with respect to which this Warrant has been exercised, irrespective of
            the date such Warrant Shares are credited to the Holder’s DTC account or the date
            of delivery of the certificates evidencing such Warrant Shares, as the case may be. If
            this Warrant is submitted in connection with any exercise pursuant to this Section 1(a)
            and the number of Warrant Shares represented by this Warrant submitted for exercise is
            greater than the number of Warrant Shares being acquired upon an exercise, then the
            Company shall as soon as practicable and in no event later than three Business Days
            after any exercise and at its own expense, issue a new Warrant (in accordance with
            Section 7(d)) representing the right to purchase the number of Warrant Shares
            purchasable immediately prior to such exercise under this Warrant, less the number of
            Warrant Shares with respect to which this Warrant is exercised. No fractional shares of
            Common Stock are to be issued upon the exercise of this Warrant, but rather the number
            of shares of Common Stock to be issued shall be rounded up to the nearest whole number.
            The Company shall pay any and all taxes which may be payable with respect to the
            issuance and delivery of Warrant Shares upon exercise of this Warrant.

            
            
            

            
            

            

            
                    (b)    
            Exercise Price. For purposes of this Warrant, “Exercise Price”
            means $1.8781, subject to adjustment as provided herein.

            

            
                    (c)    
            Company’s Failure to Timely Deliver Securities. If the Company shall fail for
            any reason or for no reason to issue to the Holder within three (3) Trading Days of
            receipt of the Exercise Delivery Documents, a certificate for the number of shares of
            Common Stock to which the Holder is entitled and register such shares of Common Stock
            on the Company’s share register or to credit the Holder’s balance account
            with DTC for such number of shares of Common Stock to which the Holder is entitled upon
            the Holder’s exercise of this Warrant, then, in addition to all other remedies
            available to the Holder, the Company shall pay in cash to the Holder on each day after
            such thirdTrading Day that the issuance of such shares of Common Stock is not timely
            effected an amount equal to 1.5% of the product of (A) the sum of the number of shares
            of Common Stock not issued to the Holder on a timely basis and to which the Holder is
            entitled and (B) the Closing Sale Price of the shares of Common Stock on the Trading
            Day immediately preceding the last possible date which the Company could have issued
            such shares of Common Stock to the Holder without violating Section 1(a). In addition
            to the foregoing, if within three (3) Trading Days after the Company’s receipt of
            the facsimile copy of a Exercise Notice the Company shall fail to issue and deliver a
            certificate to the Holder and register such shares of Common Stock on the
            Company’s share register or credit the Holder’s balance account with DTC
            for the number of shares of Common Stock to which the Holder is entitled upon the
            Holder’s exercise hereunder, and if on or after such Trading Day the Holder
            purchases (in an open market transaction or otherwise) shares of Common Stock to
            deliver in satisfaction of a sale by the Holder of shares of Common Stock issuable upon
            such exercise that the Holder anticipated receiving from the Company (a
            “Buy-In”), then the Company shall, within three Business Days after
            the Holder’s request and in the Holder’s discretion, either (i) pay cash to
            the Holder in an amount equal to the Holder’s total purchase price (including
            brokerage commissions, if any) for the shares of Common Stock so purchased (the
            “Buy-In Price”), at which point the Company’s obligation to
            deliver such certificate (and to issue such shares of Common Stock) or credit such
            Holder’s balance account with DTC shall terminate, or (ii) promptly honor its
            obligation to deliver to the Holder a certificate or certificates representing such
            shares of Common Stock or credit such Holder’s balance account with DTC and pay
            cash to the Holder in an amount equal to the excess (if any) of the Buy-In Price over
            the product of (A) such number of shares of Common Stock, times (B) the Closing Bid
            Price on the date of exercise.

            

            
                    (d)    
            Cashless Exercise. Notwithstanding anything contained herein to the contrary, if a
            Registration Statement (as defined in the Registration Rights Agreement) covering the
            resale of the Warrant Shares that are the subject of the Exercise Notice (the
            “Unavailable Warrant Shares”) is not available for the resale of
            such Unavailable Warrant Shares, the Holder may, in its sole discretion, exercise this
            Warrant in whole or in part and, in lieu of making the cash payment otherwise
            contemplated to be made to the Company upon such exercise in payment of the Aggregate
            Exercise Price, elect instead to receive upon such exercise the “Net
            Number” of shares of Common Stock determined according to the following formula
            (a “Cashless Exercise”):

            	
                    	
                    	
                    
	
                    Net Number = 	
                    (A x B) — (A x
                    C)

                    B 	
                      

            

            

            
                    
                      For purposes of the
            foregoing formula:

            

            
                    
                      A= the total number of
            shares with respect to which this Warrant is then being exercised.

            

            
                    
                      B= the Closing Sale Price
            of the shares of Common Stock (as reported by Bloomberg) on the date immediately
            preceding the date of the Exercise Notice.

            

            
                    
                      C= the Exercise Price then
            in effect for the applicable Warrant Shares at the time of such exercise.

            

            
                    (e)  
            Disputes. In the case of a dispute as to the determination of the Exercise Price
            or the arithmetic calculation of the Warrant Shares, the Company shall promptly issue
            to the Holder the number of Warrant Shares that are not disputed and resolve such
            dispute in accordance with Section 12.

            

            
                    (f)  
            Limitations on Exercises.

            

            -4-

            
            
            

            
            

            

            	
                      	
                            (i)  
                    Beneficial Ownership. The Company shall not effect the exercise of this
                    Warrant, and the Holder shall not have the right to exercise this Warrant, to
                    the extent that after giving effect to such exercise, such Person (together
                    with such Person’s affiliates) would beneficially own in excess of 4.99%
                    of the shares of Common Stock outstanding immediately after giving effect to
                    such exercise. For purposes of the foregoing sentence, the aggregate number of
                    shares of Common Stock beneficially owned by such Person and its affiliates
                    shall include the number of shares of Common Stock issuable upon exercise of
                    this Warrant with respect to which the determination of such sentence is being
                    made, but shall exclude shares of Common Stock which would be issuable upon (A)
                    exercise of the remaining, unexercised portion of this Warrant beneficially
                    owned by such Person and its affiliates and (B) exercise or conversion of the
                    unexercised or unconverted portion of any other securities of the Company
                    beneficially owned by such Person and its affiliates (including, without
                    limitation, any convertible notes or convertible preferred stock or warrants)
                    subject to a limitation on conversion or exercise analogous to the limitation
                    contained herein. Except as set forth in the preceding sentence, for purposes
                    of this paragraph, beneficial ownership shall be calculated in accordance with
                    Section 13(d) of the Securities Exchange Act of 1934, as amended (the
                    “Exchange Act”). For purposes of this Warrant, in
                    determining the number of outstanding shares of Common Stock, the Holder may
                    rely on the number of outstanding shares of Common Stock as reflected in (1)
                    the Company’s most recent Form 10-K, Form 10-KSB, Form 10-Q, Form 10-QSB,
                    Current Report on Form 8-K or other public filing with the Securities and
                    Exchange Commission, as the case may be, (2) a more recent public announcement
                    by the Company or (3) any other notice by the Company or the Transfer Agent
                    setting forth the number of shares of Common Stock outstanding. For any reason
                    at any time, upon the written or oral request of the Holder, the Company shall
                    within one (1) Business Day confirm orally and in writing to the Holder the
                    number of shares of Common Stock then outstanding. In any case, the number of
                    outstanding shares of Common Stock shall be determined after giving effect to
                    the conversion or exercise of securities of the Company, including the SPA
                    Securities and the SPA Warrants, by the Holder and its affiliates since the
                    date as of which such number of outstanding shares of Common Stock was
                    reported. By written notice to the Company, the Holder may from time to time
                    increase or decrease the Maximum Percentage to any other percentage not in
                    excess of 9.99% specified in such notice; provided that (i) any such increase
                    will not be effective until the sixty-first (61st) day after such
                    notice is delivered to the Company, and (ii) any such increase or decrease will
                    apply only to the Holder and not to any other holder of SPA Warrants.
                              

            

            

            	
                      	
                            (ii)
                      Principal Market Regulation. The Company shall not be
                    obligated to issue any shares of Common Stock upon exercise of this Warrant or
                    conversion of SPA Securities and no Buyer shall be entitled to receive any
                    shares of Common Stock if the issuance of such shares of Common Stock would
                    exceed that number of shares of Common Stock which the Company may issue upon
                    exercise or conversion, as applicable, of the SPA Warrants and SPA Securities
                    or otherwise without breaching the Company’s obligations under the rules
                    or regulations of any applicable Eligible Market (the “Exchange
                    Cap”), except that such limitation shall not apply in the event that
                    the Company (A) obtains the approval of its shareholders as required by the
                    applicable rules of the Eligible Market for issuances of shares of Common Stock
                    in excess of such amount or (B) obtains a written opinion from outside counsel
                    to the Company that such approval is not required, which opinion shall be
                    reasonably satisfactory to the Required Holders. Until such approval or written
                    opinion is obtained, no Buyer shall be issued in the aggregate, upon exercise
                    or conversion, as applicable, of any SPA Warrants or SPA Securities, shares of
                    Common Stock in an amount greater than the product of the Exchange Cap
                    multiplied by a fraction, the numerator of which is the total number of shares
                    of Common Stock underlying the SPA Warrants issued to such Buyer pursuant to
                    the Securities Purchase Agreement on the Issuance Date and the denominator of
                    which is the aggregate number of shares of Common Stock underlying the SPA
                    Warrants issued to the Buyers pursuant to the Securities Purchase Agreement on
                    the Issuance Date (with respect to each Buyer, the “Exchange Cap
                    Allocation”). In the event that any Buyer shall sell or otherwise
                    transfer any of such Buyer’s SPA Warrants, the transferee shall be
                    allocated a pro rata portion of such Buyer’s Exchange Cap Allocation, and
                    the restrictions of the prior sentence shall apply to such transferee with
                    respect to the portion of the Exchange Cap Allocation allocated to such
                    transferee. In the event that any holder of SPA Warrants shall exercise all of
                    such holder’s SPA Warrants into a number of shares of Common Stock which,
                    in the aggregate, is less than such holder’s Exchange Cap Allocation,
                    then the difference between such holder’s Exchange Cap Allocation and the
                    number of shares of Common Stock actually issued to such holder shall be
                    allocated to the respective Exchange Cap Allocations of the remaining holders
                    of SPA Warrants on a pro rata basis in proportion to the shares of Common Stock
                    underlying the SPA Warrants then held by each such holder. In the event that
                    the Company is prohibited from issuing any Warrant Shares for which an Exercise
                    Notice has been received as a result of the operation of this Section 1(f)(ii),
                    the Company shall pay cash in exchange for cancellation of such Warrant Shares,
                    at a price per Warrant Share equal to the difference between the Closing Sale
                    Price and the Exercise Price as of the date of the attempted exercise.
                    

            

            

            -5-

            
            
            

            
            

            

            	
                      	
                            (g)
                      Insufficient Authorized Shares. If at any time while this
                    Warrant remain outstanding the Company does not have a sufficient number of
                    authorized and unreserved shares of Common Stock to satisfy its obligation to
                    reserve for issuance upon exercise of this Warrant at least a number of shares
                    of Common Stock equal to 130% (the “Required Reserve
                    Amount”) of the number of shares of Common Stock as shall from time
                    to time be necessary to effect the exercise of all of this Warrant then
                    outstanding (an “Authorized Share Failure”), then the
                    Company shall immediately take all action necessary to increase the
                    Company’s authorized shares of Common Stock to an amount sufficient to
                    allow the Company to reserve the Required Reserve Amount for this Warrant then
                    outstanding. Without limiting the generality of the foregoing sentence, as soon
                    as practicable after the date of the occurrence of an Authorized Share Failure,
                    but in no event later than ninety (90) days after the occurrence of such
                    Authorized Share Failure, the Company shall hold a meeting of its stockholders
                    for the approval of an increase in the number of authorized shares of Common
                    Stock. In connection with such meeting, the Company shall provide each
                    stockholder with a proxy statement and shall use its best efforts to solicit
                    its stockholders’ approval of such increase in authorized shares of
                    Common Stock and to cause its board of directors to recommend to the
                    stockholders that they approve such proposal. 

            

            

            
                    2.  
            ADJUSTMENT OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES. The Exercise Price
            and the number of Warrant Shares shall be adjusted from time to time as
            follows:

            

            -6-

            
            
            

            
            

            

            
                    
                      
                      (a) Adjustment upon
            Issuance of shares of Common Stock. If and whenever on or after the Subscription
            Date the Company issues or sells, or in accordance with this Section 2 is deemed to
            have issued or sold, any shares of Common Stock (including the issuance or sale of
            shares of Common Stock owned or held by or for the account of the Company, but
            excluding shares of Common Stock deemed to have been issued by the Company in
            connection with any Excluded Securities) for a consideration per share (the
            “New Issuance Price”) less than the Exercise Price (the
            “Applicable Price”) in effect immediately prior to such issue or
            sale or deemed issuance or sale (the foregoing a “Dilutive
            Issuance”), then immediately after such Dilutive Issuance, the Exercise Price
            then in effect shall be reduced to an amount equal to the New Issuance Price. Upon each
            such adjustment of the Exercise Price hereunder, the number of Warrant Shares shall be
            adjusted to the number of shares of Common Stock determined by multiplying the Exercise
            Price in effect immediately prior to such adjustment by the number of Warrant Shares
            acquirable upon exercise of this Warrant immediately prior to such adjustment and
            dividing the product thereof by the Exercise Price resulting from such adjustment. For
            purposes of determining the adjusted Exercise Price under this Section 2(a), the
            following shall be applicable:

            

            	
                    	
                        
                            (i)
                               Issuance of Options. If
                        the Company in any manner grants any Options and the lowest price per share
                        for which one share of Common Stock is issuable upon the exercise of any
                        such Option or upon conversion, exercise or exchange of any Convertible
                        Securities issuable upon exercise of any such Option is less than the
                        Applicable Price, then such share of Common Stock shall be deemed to be
                        outstanding and to have been issued and sold by the Company at the time of
                        the granting or sale of such Option for such price per share. For purposes
                        of this Section 2(a)(i), the “lowest price per share for which one
                        share of Common Stock is issuable upon exercise of such Options or upon
                        conversion, exercise or exchange of such Convertible Securities issuable
                        upon exercise of any such Option” shall be equal to the sum of the
                        lowest amounts of consideration (if any) received or receivable by the
                        Company with respect to any one share of Common Stock upon the granting or
                        sale of the Option, upon exercise of the Option and upon conversion,
                        exercise or exchange of any Convertible Security issuable upon exercise of
                        such Option. No further adjustment of the Exercise Price or number of
                        Warrant Shares shall be made upon the actual issuance of such shares of
                        Common Stock or of such Convertible Securities upon the exercise of such
                        Options or upon the actual issuance of such shares of Common Stock upon
                        conversion, exercise or exchange of such Convertible Securities.

                    

            

            

            	
                    	
                        
                            (ii)
                               Issuance of Convertible
                        Securities. If the Company in any manner issues or sells any
                        Convertible Securities and the lowest price per share for which one share
                        of Common Stock is issuable upon the conversion, exercise or exchange
                        thereof is less than the Applicable Price, then such share of Common Stock
                        shall be deemed to be outstanding and to have been issued and sold by the
                        Company at the time of the issuance or sale of such Convertible Securities
                        for such price per share. For the purposes of this Section 2(a)(ii), the
                        “lowest price per share for which one share of Common Stock is
                        issuable upon the conversion, exercise or exchange thereof” shall be
                        equal to the sum of the lowest amounts of consideration (if any) received
                        or receivable by the Company with respect to one share of Common Stock upon
                        the issuance or sale of the Convertible Security and upon conversion,
                        exercise or exchange of such Convertible Security. No further adjustment of
                        the Exercise Price or number of Warrant Shares shall be made upon the
                        actual issuance of such shares of Common Stock upon conversion, exercise or
                        exchange of such Convertible Securities, and if any such issue or sale of
                        such Convertible Securities is made upon exercise of any Options for which
                        adjustment of this Warrant has been or is to be made pursuant to other
                        provisions of this Section 2(a), no further adjustment of the Exercise
                        Price or number of Warrant Shares shall be made by reason of such issue or
                        sale.

                    

            

            

            -7-

            
            
            

            
            

            

            	
                    	
                        
                            (iii)
                               Change in Option Price or Rate
                        of Conversion. If the purchase price provided for in any Options, the
                        additional consideration, if any, payable upon the issue, conversion,
                        exercise or exchange of any Convertible Securities, or the rate at which
                        any Convertible Securities are convertible into or exercisable or
                        exchangeable for shares of Common Stock increases or decreases at any time,
                        the Exercise Price and the number of Warrant Shares in effect at the time
                        of such increase or decrease shall be adjusted to the Exercise Price and
                        the number of Warrant Shares which would have been in effect at such time
                        had such Options or Convertible Securities provided for such increased or
                        decreased purchase price, additional consideration or increased or
                        decreased conversion rate, as the case may be, at the time initially
                        granted, issued or sold. For purposes of this Section 2(a)(iii), if the
                        terms of any Option or Convertible Security that was outstanding as of the
                        date of issuance of this Warrant are increased or decreased in the manner
                        described in the immediately preceding sentence, then such Option or
                        Convertible Security and the shares of Common Stock deemed issuable upon
                        exercise, conversion or exchange thereof shall be deemed to have been
                        issued as of the date of such increase or decrease. No adjustment pursuant
                        to this Section 2(a)(iii) shall be made if such adjustment would result in
                        an increase of the Exercise Price then in effect or a decrease in the
                        number of Warrant Shares.

                    

            

            

            	
                    	
                        
                            (iv)
                               Calculation of Consideration
                        Received. In case any Option is issued in connection with the issue or
                        sale of other securities of the Company, together comprising one integrated
                        transaction in which no specific consideration is allocated to such Options
                        by the parties thereto, the Options will be deemed to have been issued for
                        a consideration of $0.01. If any shares of Common Stock, Options or
                        Convertible Securities are issued or sold or deemed to have been issued or
                        sold for cash, the consideration received therefor will be deemed to be the
                        net amount received by the Company therefor. If any shares of Common Stock,
                        Options or Convertible Securities are issued or sold for a consideration
                        other than cash, the amount of such consideration received by the Company
                        will be the fair value of such consideration, except where such
                        consideration consists of publicly traded securities, in which case the
                        amount of consideration received by the Company will be the Closing Sale
                        Price of such security on the date of receipt. If any shares of Common
                        Stock, Options or Convertible Securities are issued to the owners of the
                        non-surviving entity in connection with any merger in which the Company is
                        the surviving entity, the amount of consideration therefor will be deemed
                        to be the fair value of such portion of the net assets and business of the
                        non-surviving entity as is attributable to such shares of Common Stock,
                        Options or Convertible Securities, as the case may be. The fair value of
                        any consideration other than cash or publicly traded securities will be
                        determined jointly by the Company and the Required Holders. If such parties
                        are unable to reach agreement within ten (10) days after the occurrence of
                        an event requiring valuation (the “Valuation Event”),
                        the fair value of such consideration will be determined within five (5)
                        Business Days after the tenth day following the Valuation Event by an
                        independent, reputable appraiser jointly selected by the Company and the
                        Required Holders. The determination of such appraiser shall be final and
                        binding upon all parties absent manifest error and the fees and expenses of
                        such appraiser shall be borne by the Company.

                    

            

            

            -8-

            
            
            

            
            

            

            	
                    	
                        
                            (v)
                               Record Date. If the
                        Company takes a record of the holders of shares of Common Stock for the
                        purpose of entitling them (A) to receive a dividend or other
                        distribution payable in shares of Common Stock, Options or in Convertible
                        Securities or (B) to subscribe for or purchase shares of Common Stock,
                        Options or Convertible Securities, then such record date will be deemed to
                        be the date of the issue or sale of the shares of Common Stock deemed to
                        have been issued or sold upon the declaration of such dividend or the
                        making of such other distribution or the date of the granting of such right
                        of subscription or purchase, as the case may be.

                    

            

            

            	
                    	
                        
                            (vi)
                               Voluntary Adjustment By
                        Company. The Company may at any time during the term of
                        this Warrant reduce the then current  Exercise
                        Price to any amount and for any period of time deemed appropriate by
                        the Board of Directors of the Company. 

                    

            

            

            
                    
            (b)   Adjustment upon Subdivision or Combination of shares of Common
            Stock. If the Company at any time on or after the Subscription Date subdivides (by
            any stock split, stock dividend, recapitalization or otherwise) one or more classes of
            its outstanding shares of Common Stock into a greater number of shares, the Exercise
            Price in effect immediately prior to such subdivision will be proportionately reduced
            and the number of Warrant Shares will be proportionately increased. If the Company at
            any time on or after the Subscription Date combines (by combination, reverse stock
            split or otherwise) one or more classes of its outstanding shares of Common Stock into
            a smaller number of shares, the Exercise Price in effect immediately prior to such
            combination will be proportionately increased and the number of Warrant Shares will be
            proportionately decreased. Any adjustment under this Section 2(b) shall become
            effective at the close of business on the date the subdivision or combination becomes
            effective.

            

            
                    (c)  
            Other Events. If any event occurs of the type contemplated by the provisions of
            this Section 2 but not expressly provided for by such provisions (including, without
            limitation, the granting of stock appreciation rights, phantom stock rights or other
            rights with equity features), then the Company’s Board of Directors will make an
            appropriate adjustment in the Exercise Price and the number of Warrant Shares so as to
            protect the rights of the Holder; provided that no such adjustment pursuant to this
            Section 2(c) will increase the Exercise Price or decrease the number of Warrant Shares
            as otherwise determined pursuant to this Section 2.

            

            -9-

            
            
            

            
            

            

            
                    3.  
            RIGHTS UPON DISTRIBUTION OF ASSETS. If the Company shall declare or make any
            dividend or other distribution of its assets (or rights to acquire its assets) to
            holders of shares of Common Stock, by way of return of capital or otherwise (including,
            without limitation, any distribution of cash, stock or other securities, property or
            options by way of a dividend, spin off, reclassification, corporate rearrangement,
            scheme of arrangement or other similar transaction) (a
            “Distribution”), at any time after the issuance of this Warrant,
            then, in each such case:

            

            
                    
                      (a) any Exercise Price in
            effect immediately prior to the close of business on the record date fixed for the
            determination of holders of shares of Common Stock entitled to receive the Distribution
            shall be reduced, effective as of the close of business on such record date, to a price
            determined by multiplying such Exercise Price by a fraction of which (i) the numerator
            shall be the Closing Bid Price of the shares of Common Stock on the Trading Day
            immediately preceding such record date minus the value of the Distribution (as
            determined in good faith by the Company’s Board of Directors) applicable to one
            share of Common Stock, and (ii) the denominator shall be the Closing Bid Price of the
            shares of Common Stock on the Trading Day immediately preceding such record date;
            and

            

            
                    
                      (b) the number of Warrant
            Shares shall be increased to a number of shares equal to the number of shares of Common
            Stock obtainable immediately prior to the close of business on the record date fixed
            for the determination of holders of shares of Common Stock entitled to receive the
            Distribution multiplied by the reciprocal of the fraction set forth in the immediately
            preceding paragraph (a); provided that in the event that the Distribution is of shares
            of common stock (“Other Shares of Common Stock”) of a company whose
            common shares are traded on a national securities exchange or a national automated
            quotation system, then the Holder may elect to receive a warrant to purchase Other
            Shares of Common Stock in lieu of an increase in the number of Warrant Shares, the
            terms of which shall be identical to those of this Warrant, except that such warrant
            shall be exercisable into the number of shares of Other Shares of Common Stock that
            would have been payable to the Holder pursuant to the Distribution had the Holder
            exercised this Warrant immediately prior to such record date and with an aggregate
            exercise price equal to the product of the amount by which the exercise price of this
            Warrant was decreased with respect to the Distribution pursuant to the terms of the
            immediately preceding paragraph (a) and the number of Warrant Shares calculated in
            accordance with the first part of this paragraph (b).

            

            
                    4.
                   PURCHASE RIGHTS; FUNDAMENTAL
            TRANSACTIONS.

            

            -10-

            
            
            

            
            

            

            
                    
                      (a) Purchase Rights.
            In addition to any adjustments pursuant to Section 2 above, if at any time the Company
            grants, issues or sells any Options, Convertible Securities or rights to purchase
            stock, warrants, securities or other property pro rata to the record holders of any
            class of shares of Common Stock (the “Purchase Rights”), then the
            Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights,
            the aggregate Purchase Rights which the Holder could have acquired if the Holder had
            held the number of shares of Common Stock acquirable upon complete exercise of this
            Warrant (without regard to any limitations on the exercise of this Warrant) immediately
            before the date on which a record is taken for the grant, issuance or sale of such
            Purchase Rights, or, if no such record is taken, the date as of which the record
            holders of shares of Common Stock are to be determined for the grant, issue or sale of
            such Purchase Rights.

            

            
                    
                      (b) Fundamental
            Transactions. The Company shall not enter into or be party to a Fundamental
            Transaction unless (i)  the Successor Entity assumes in writing all of the
            obligations of the Company under this Warrant and the other Transaction Documents in
            accordance with the provisions of this Section (4)(b) pursuant to written agreements in
            form and substance satisfactory to the Required Holders and approved by the Required
            Holders prior to such Fundamental Transaction, including agreements to deliver to each
            holder of Warrants in exchange for such Warrants a security of the Successor Entity
            evidenced by a written instrument substantially similar in form and substance to this
            Warrant, including, without limitation, an adjusted exercise price equal to the value
            for the shares of Common Stock reflected by the terms of such Fundamental Transaction,
            and exercisable for a corresponding number of shares of capital stock equivalent to the
            shares of Common Stock acquirable and receivable upon exercise of this Warrant (without
            regard to any limitations on the exercise of this Warrant) prior to such Fundamental
            Transaction, and satisfactory to the Required Holders and (ii) the Successor
            Entity (including its Parent Entity) is a publicly traded corporation whose common
            stock is quoted on or listed for trading on an Eligible Market. Upon the occurrence of
            any Fundamental Transaction, the Successor Entity shall succeed to, and be substituted
            for (so that from and after the date of such Fundamental Transaction, the provisions of
            this Warrant referring to the “Company” shall refer instead to the
            Successor Entity), and may exercise every right and power of the Company and shall
            assume all of the obligations of the Company under this Warrant with the same effect as
            if such Successor Entity had been named as the Company herein. Upon consummation of the
            Fundamental Transaction, the Successor Entity shall deliver to the Holder confirmation
            that there shall be issued upon exercise of this Warrant at any time after the
            consummation of the Fundamental Transaction, in lieu of the shares of the Common Stock
            (or other securities, cash, assets or other property) purchasable upon the exercise of
            the Warrant prior to such Fundamental Transaction, such shares of the publicly traded
            Common Stock (or its equivalent) of the Successor Entity (including its Parent Entity),
            as adjusted in accordance with the provisions of this Warrant. In addition to and not
            in substitution for any other rights hereunder, prior to the consummation of any
            Fundamental Transaction pursuant to which holders of shares of Common Stock are
            entitled to receive securities or other assets with respect to or in exchange for
            shares of Common Stock (a “Corporate Event”), the Company shall make
            appropriate provision to insure that the Holder will thereafter have the right to
            receive upon an exercise of this Warrant at any time after the consummation of the
            Fundamental Transaction but prior to the Expiration Date, in lieu of the shares of the
            Common Stock (or other securities, cash, assets or other property) purchasable upon the
            exercise of the Warrant prior to such Fundamental Transaction, such shares of stock,
            securities, cash, assets or any other property whatsoever (including warrants or other
            purchase or subscription rights) which the Holder would have been entitled to receive
            upon the happening of such Fundamental Transaction had the Warrant been exercised
            immediately prior to such Fundamental Transaction. Provision made pursuant to the
            preceding sentence shall be in a form and substance reasonably satisfactory to the
            Required Holders. The provisions of this Section shall apply similarly and equally to
            successive Fundamental Transactions and Corporate Events and shall be applied without
            regard to any limitations on the exercise of this Warrant.

            

            -11-

            
            
            

            
            

            

            
                    
                     (c) Notwithstanding the foregoing
            and the provisions of Section 4(b) above, in the event of a Fundamental Transaction, at
            the request of the Holder delivered before the ninetieth (90th) day after the
            consummation of such Fundamental Transaction, the Company (or the Successor Entity)
            shall purchase this Warrant from the Holder by paying to the Holder, within five (5)
            Business Days of such request (or, if later, on the effective date of the Fundamental
            Transaction, cash in an amount equal to the Black-Scholes Value of the remaining
            unexercised portion of this Warrant on the date of such Fundamental
            Transaction.

            

            

            

            

            

            

            

            

            -12-

            
            
            

            
            

            

            
                    5.  
            WARRANT HOLDER NOT DEEMED A STOCKHOLDER. Except as otherwise specifically
            provided herein, the Holder, solely in such Person’s capacity as a holder of this
            Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of
            share capital of the Company for any purpose, nor shall anything contained in this
            Warrant be construed to confer upon the Holder, solely in such Person’s capacity
            as the Holder of this Warrant, any of the rights of a shareholder of the Company or any
            right to vote, give or withhold consent to any corporate action (whether any
            reorganization, issue of stock, reclassification of stock, consolidation, merger,
            conveyance or otherwise), receive notice of meetings, receive dividends or subscription
            rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which
            such Person is then entitled to receive upon the due exercise of this Warrant. In
            addition, nothing contained in this Warrant shall be construed as imposing any
            liabilities on the Holder to purchase any securities (upon exercise of this Warrant or
            otherwise) or as a shareholder of the Company, whether such liabilities are asserted by
            the Company or by creditors of the Company. Notwithstanding this Section 5, the Company
            shall provide the Holder with copies of the same notices and other information given to
            the shareholders of the Company generally, contemporaneously with the giving thereof to
            the shareholders.

            

            
                    6.  
            NONCIRCUMVENTION. The Company hereby covenants and agrees that the Company will
            not, by amendment of its Articles of Incorporation, Bylaws or through any
            reorganization, transfer of assets, consolidation, merger, scheme of arrangement,
            dissolution, issue or sale of securities, or any other voluntary action, avoid or seek
            to avoid the observance or performance of any of the terms of this Warrant, and will at
            all times in good faith carry out all the provisions of this Warrant and take all
            action as may be required to protect the rights of the Holder. Without limiting the
            generality of the foregoing, the Company (i) shall not increase the par value of
            any shares of Common Stock receivable upon the exercise of this Warrant above the
            Exercise Price then in effect, (ii) shall take all such actions as may be
            necessary or appropriate in order that the Company may validly and legally issue fully
            paid and nonassessable shares of Common Stock upon the exercise of this Warrant, and
            (iii) shall, so long as any of the SPA Warrants are outstanding, take all action
            necessary to reserve and keep available out of its authorized and unissued shares of
            Common Stock, solely for the purpose of effecting the exercise of the SPA Warrants,
            130% of the number of shares of Common Stock as shall from time to time be necessary to
            effect the exercise of the SPA Warrants then outstanding (without regard to any
            limitations on exercise).

            

            
                    7.  
            REISSUANCE OF WARRANTS.

            

            
                    
                      (a) Transfer of
            Warrant.   If this Warrant is to be transferred, the Holder shall
            surrender this Warrant to the Company, whereupon the Company will forthwith issue and
            deliver upon the order of the Holder a new Warrant (in accordance with Section 7(d)),
            registered as the Holder may request, representing the right to purchase the number of
            Warrant Shares being transferred by the Holder and, if less than the total number of
            Warrant Shares then underlying this Warrant is being transferred, a new Warrant (in
            accordance with Section 7(d)) to the Holder representing the right to purchase the
            number of Warrant Shares not being transferred.

            

            -13-

            
            
            

            
            

            

            
                    
                      (b)   Lost,
            Stolen or Mutilated Warrant. Upon receipt by the Company of evidence reasonably
            satisfactory to the Company of the loss, theft, destruction or mutilation of this
            Warrant, and, in the case of loss, theft or destruction, of any indemnification
            undertaking by the Holder to the Company in customary form and, in the case of
            mutilation, upon surrender and cancellation of this Warrant, the Company shall execute
            and deliver to the Holder a new Warrant (in accordance with Section 7(d)) representing
            the right to purchase the Warrant Shares then underlying this Warrant.

            

            
                    
                      (c) Exchangeable for
            Multiple Warrants. This Warrant is exchangeable, upon the surrender hereof by the
            Holder at the principal office of the Company, for a new Warrant or Warrants (in
            accordance with Section 7(d)) representing in the aggregate the right to purchase the
            number of Warrant Shares then underlying this Warrant, and each such new Warrant will
            represent the right to purchase such portion of such Warrant Shares as is designated by
            the Holder at the time of such surrender; provided, however, that no Warrants for
            fractional shares of Common Stock shall be given.

            

            
                    
                      (d) Issuance of New
            Warrants. Whenever the Company is required to issue a new Warrant pursuant to the
            terms of this Warrant, such new Warrant (i) shall be of like tenor with this Warrant,
            (ii) shall represent, as indicated on the face of such new Warrant, the right to
            purchase the Warrant Shares then underlying this Warrant (or in the case of a new
            Warrant being issued pursuant to Section 7(a) or Section 7(c), the Warrant Shares
            designated by the Holder which, when added to the number of shares of Common Stock
            underlying the other new Warrants issued in connection with such issuance, does not
            exceed the number of Warrant Shares then underlying this Warrant), (iii) shall have an
            issuance date, as indicated on the face of such new Warrant which is the same as the
            Issuance Date, and (iv) shall have the same rights and conditions as this
            Warrant.

            

            
                    8.  
            NOTICES. Whenever notice is required to be given under this Warrant, unless
            otherwise provided herein, such notice shall be given in accordance with Section 9(f)
            of the Securities Purchase Agreement. The Company shall provide the Holder with prompt
            written notice of all actions taken pursuant to this Warrant, including in reasonable
            detail a description of such action and the reason therefore. Without limiting the
            generality of the foregoing, the Company will give written notice to the Holder (i)
            immediately upon any adjustment of the Exercise Price, setting forth in reasonable
            detail, and certifying, the calculation of such adjustment and (ii) at least fifteen
            days prior to the date on which the Company closes its books or takes a record (A) with
            respect to any dividend or distribution upon the shares of Common Stock, (B) with
            respect to any grants, issuances or sales of any Options, Convertible Securities or
            rights to purchase stock, warrants, securities or other property to holders of shares
            of Common Stock or (C) for determining rights to vote with respect to any Fundamental
            Transaction, dissolution or liquidation, provided in each case that such information
            shall be made known to the public prior to or in conjunction with such notice being
            provided to the Holder.

            

            
                    9.  
            AMENDMENT AND WAIVER. Except as otherwise provided herein, the provisions of
            this Warrant may be amended and the Company may take any action herein prohibited, or
            omit to perform any act herein required to be performed by it, only if the Company has
            obtained the written consent of the Required Holders; provided that no such action may
            increase the exercise price of any SPA Warrant or decrease the number of shares or
            class of stock obtainable upon exercise of any SPA Warrant without the written consent
            of the Holder. No such amendment shall be effective to the extent that it applies to
            less than all of the holders of the SPA Warrants then outstanding.

            

            -14-

            
            
            

            
            

            

            
                    10.  
            GOVERNING LAW. This Warrant shall be governed by and construed and enforced in
            accordance with, and all questions concerning the construction, validity,
            interpretation and performance of this Warrant shall be governed by, the internal laws
            of the State of New York, without giving effect to any choice of law or conflict of law
            provision or rule (whether of the State of New York or any other jurisdictions) that
            would cause the application of the laws of any jurisdictions other than the State of
            New York.

            

            
                    11.  
            CONSTRUCTION; HEADINGS. This Warrant shall be deemed to be jointly drafted by
            the Company and all the Buyers and shall not be construed against any person as the
            drafter hereof. The headings of this Warrant are for convenience of reference and shall
            not form part of, or affect the interpretation of, this Warrant.

            

            
                    12.  
            DISPUTE RESOLUTION. In the case of a dispute as to the determination of the
            Exercise Price or the arithmetic calculation of the Warrant Shares, the Company shall
            submit the disputed determinations or arithmetic calculations via facsimile within two
            Business Days of receipt of the Exercise Notice giving rise to such dispute, as the
            case may be, to the Holder. If the Holder and the Company are unable to agree upon such
            determination or calculation of the Exercise Price or the Warrant Shares within three
            Business Days of such disputed determination or arithmetic calculation being submitted
            to the Holder, then the Company shall, within two Business Days submit via facsimile
            (a) the disputed determination of the Exercise Price to an independent, reputable
            investment bank selected by the Company and approved by the Holder or (b) the disputed
            arithmetic calculation of the Warrant Shares to the Company’s independent,
            outside accountant. The Company shall cause at its expense the investment bank or the
            accountant, as the case may be, to perform the determinations or calculations and
            notify the Company and the Holder of the results no later than ten Business Days from
            the time it receives the disputed determinations or calculations. Such investment
            bank’s or accountant’s determination or calculation, as the case may be,
            shall be binding upon all parties absent demonstrable error.

            

            
                    13.  
            REMEDIES, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF. The remedies
            provided in this Warrant shall be cumulative and in addition to all other remedies
            available under this Warrant and the other Transaction Documents, at law or in equity
            (including a decree of specific performance and/or other injunctive relief), and
            nothing herein shall limit the right of the Holder right to pursue actual damages for
            any failure by the Company to comply with the terms of this Warrant. The Company
            acknowledges that a breach by it of its obligations hereunder will cause irreparable
            harm to the Holder and that the remedy at law for any such breach may be inadequate.
            The Company therefore agrees that, in the event of any such breach or threatened
            breach, the holder of this Warrant shall be entitled, in addition to all other
            available remedies, to an injunction restraining any breach, without the necessity of
            showing economic loss and without any bond or other security being required.

            

            
                    14.  
            TRANSFER. This Warrant may be offered for sale, sold, transferred or assigned
            without the consent of the Company, except as may otherwise be required by Section 2(g)
            of the Securities Purchase Agreement.

            

            -15-

            
            
            

            
            

            

            
                    15.  
            CERTAIN DEFINITIONS. For purposes of this Warrant, the following terms shall
            have the following meanings:

            

            
                    
                      (a) “Approved
            Stock Plan” means any employee benefit plan which has been approved by the
            Board of Directors of the Company, pursuant to which the Company’s securities may
            be issued to any employee, consultant, officer or director for services provided to the
            Company.

            

            
                    
                      (b) “Black Scholes
            Value” means the value of this Warrant based on the Black and Scholes Option
            Pricing Model obtained from the “OV” function on Bloomberg determined as of
            the day of closing of the applicable Fundamental Transaction for pricing purposes and
            reflecting (i) a risk-free interest rate corresponding to the U.S. Treasury rate for a
            period equal to the remaining term of this Warrant as of such date of request, (ii) an
            expected volatility equal to the greater of 100% and the 100 day volatility obtained
            from the HVT function on Bloomberg as of the day immediately following the public
            announcement of the applicable Fundamental Transaction and (iii) the underlying price
            per share used in such calculation shall be the sum of the price per share being
            offered in cash, if any, plus the value of any non cash consideration, if any, being
            offered in the Fundamental Transaction.

            

            
                    
                      (c)
            “Bloomberg” means Bloomberg Financial Markets.

            

            
                    
                      (d) “Business
            Day” means any day other than Saturday, Sunday or other day on which
            commercial banks in The City of New York are authorized or required by law to remain
            closed.

            

            
                    
                      (e) “Closing Bid
            Price” and “Closing Sale Price” means, for any security as
            of any date, the last closing bid price and last closing trade price, respectively, for
            such security on the Principal Market, as reported by Bloomberg, or, if the Principal
            Market begins to operate on an extended hours basis and does not designate the closing
            bid price or the closing trade price, as the case may be, then the last bid price or
            last trade price, respectively, of such security prior to 4:00:00 p.m., New York Time,
            as reported by Bloomberg, or, if the Principal Market is not the principal securities
            exchange or trading market for such security, the last closing bid price or last trade
            price, respectively, of such security on the principal securities exchange or trading
            market where such security is listed or traded as reported by Bloomberg, or if the
            foregoing do not apply, the last closing bid price or last trade price, respectively,
            of such security in the over-the-counter market on the electronic bulletin board for
            such security as reported by Bloomberg, or, if no closing bid price or last trade
            price, respectively, is reported for such security by Bloomberg, the average of the bid
            prices, or the ask prices, respectively, of any market makers for such security as
            reported in the “pink sheets” by Pink Sheets LLC (formerly the National
            Quotation Bureau, Inc.). If the Closing Bid Price or the Closing Sale Price cannot be
            calculated for a security on a particular date on any of the foregoing bases, the
            Closing Bid Price or the Closing Sale Price, as the case may be, of such security on
            such date shall be the fair market value as mutually determined by the Company and the
            Holder. If the Company and the Holder are unable to agree upon the fair market value of
            such security, then such dispute shall be resolved pursuant to Section 12. All such
            determinations to be appropriately adjusted for any stock dividend, stock split, stock
            combination or other similar transaction during the applicable calculation
            period.

            

            -16-

            
            
            

            
            

            

            
                    
                      (f) “Common
            Stock” means (i) the Company’s shares of Common Stock, par value
            $0.001 per share, and (ii) any share capital into which such Common Stock shall
            have been changed or any share capital resulting from a reclassification of such Common
            Stock.

            

            
                    
                      (g) “Convertible
            Securities” means any stock or securities (other than Options) directly or
            indirectly convertible into or exercisable or exchangeable for shares of Common
            Stock.

            

            
                    
                      (h) “Eligible
            Market” means the Principal Market, the American Stock Exchange, The New York
            Stock Exchange, Inc., The NASDAQ Global Market The NASDAQ Capital Market or The NASDAQ
            Global Select Market.

            

            
                    
                      (i) “Excluded
            Securities” means any Common Stock issued or issuable: (i) in connection with
            any Approved Stock Plan; (ii) upon conversion of the SPA Securities or the exercise of
            the SPA Warrants; (iii) in connection with the payment of any Interest Shares on the
            SPA Securities; and (iv) upon exercise of any Options or Convertible Securities which
            are outstanding on the day immediately preceding the Subscription Date, provided that
            the terms of such Options or Convertible Securities are not amended, modified or
            changed on or after the Subscription Date.

            

            
                    
                      (j) “Expiration
            Date” means the date sixty (60) months after the Issuance Date or, if such
            date falls on a day other than a Business Day or on which trading does not take place
            on the Principal market (a “Holiday”), the next day that is not a
            Holiday.

            

            
                    
                      (k) “Fundamental
            Transaction” means that the Company shall directly or indirectly, in one or
            more related transactions, (i) consolidate or merge with or into (whether or not the
            Company is the surviving corporation) another Person, or (ii) sell, assign, transfer,
            convey or otherwise dispose of all or substantially all of the properties or assets of
            the Company to another Person, or (iii) allow another Person to make a purchase, tender
            or exchange offer that is accepted by the holders of more than the 50% of either the
            outstanding shares of Common Stock (not including any shares of Common Stock held by
            the Person or Persons making or party to, or associated or affiliated with the Persons
            making or party to, such purchase, tender or exchange offer), or (iv) consummate a
            stock purchase agreement or other business combination (including, without limitation,
            a reorganization, recapitalization, spin-off or scheme of arrangement) with another
            Person whereby such other Person acquires more than the 50% of the outstanding shares
            of Common Stock (not including any shares of Common Stock held by the other Person or
            other Persons making or party to, or associated or affiliated with the other Persons
            making or party to, such stock purchase agreement or other business combination), or
            (v) reorganize, recapitalize or reclassify its Common Stock, or (vi) any
            “person” or “group” (as these terms are used for purposes of
            Sections 13(d) and 14(d) of the Exchange Act), become the “beneficial
            owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly,
            of 50% of the aggregate ordinary voting power represented by issued and outstanding
            Common Stock.

            

            -17-

            
            
            

            
            

            

            
                    
                      (l)
            “Options” means any rights, warrants or options to subscribe for or
            purchase shares of Common Stock or Convertible Securities.

            

            
                    
                      (m) “Parent
            Entity” of a Person means an entity that, directly or indirectly, controls
            the applicable Person and whose common stock or equivalent equity security is quoted or
            listed on an Eligible Market, or, if there is more than one such Person or Parent
            Entity, the Person or Parent Entity with the largest public market capitalization as of
            the date of consummation of the Fundamental Transaction.

            

            
                    
                      (n)
            “Person” means an individual, a limited liability company, a
            partnership, a joint venture, a corporation, a trust, an unincorporated organization,
            any other entity and a government or any department or agency thereof.

            

            
                    
                      (o) “Principal
            Market” means the OTC Bulletin Board.

            

            
                    
                      (p) “Registration
            Rights Agreement” means that certain Registration Rights Agreement dated as
            of the Issuance Date by and among the Company and the Buyers.

            

            
                    
                      (q) “Required
            Holders” means the holders of the SPA Warrants representing at least a
            majority of shares of Common Stock underlying the SPA Warrants then
            outstanding.

            

            
                    
                      (r) “SPA
            Securities” means the Notes issued pursuant to the Securities Purchase
            Agreement.

            

            
                    
                      (s) “Successor
            Entity” means the Person (or, if so elected by the Required Holders, the
            Parent Entity) formed by, resulting from or surviving any Fundamental Transaction or
            the Person (or, if so elected by the Required Holders, the Parent Entity) with which
            such Fundamental Transaction shall have been entered into.

            

            
                    
                      (t) “Trading
            Day” means any day on which the Common Stock is traded on the Principal
            Market, or, if the Principal Market is not the principal trading market for the Common
            Stock, then on the principal securities exchange or securities market on which the
            Common Stock is then traded; provided that “Trading Day” shall not include
            any day on which the Common Stock is scheduled to trade on such exchange or market for
            less than 4.5 hours or any day that the Common Stock is suspended from trading during
            the final hour of trading on such exchange or market (or if such exchange or market
            does not designate in advance the closing time of trading on such exchange or market,
            then during the hour ending at 4:00:00 p.m., New York Time).

            

            -18-

            
            
            

            
            

            

            
                    
                      (u) “Weighted
            Average Price” means, for any security as of any date, the dollar
            volume-weighted average price for such security on the Principal Market during the
            period beginning at 9:30:01 a.m., New York Time (or such other time as the Principal
            Market publicly announces is the official open of trading), and ending at 4:00:00 p.m.,
            New York Time (or such other time as the Principal Market publicly announces is the
            official close of trading) as reported by Bloomberg through its “Volume at
            Price” functions, or, if the foregoing does not apply, the dollar volume-weighted
            average price of such security in the over-the-counter market on the electronic
            bulletin board for such security during the period beginning at 9:30:01 a.m., New York
            Time (or such other time as such market publicly announces is the official open of
            trading), and ending at 4:00:00 p.m., New York Time (or such other time as such market
            publicly announces is the official close of trading) as reported by Bloomberg, or, if
            no dollar volume-weighted average price is reported for such security by Bloomberg for
            such hours, the average of the highest closing bid price and the lowest closing ask
            price of any of the market makers for such security as reported in the “pink
            sheets” by Pink Sheets LLC (formerly the National Quotation Bureau, Inc.). If the
            Weighted Average Price cannot be calculated for a security on a particular date on any
            of the foregoing bases, the Weighted Average Price of such security on such date shall
            be the fair market value as mutually determined by the Company and the Holder. If the
            Company and the Holder are unable to agree upon the fair market value of such security,
            then such dispute shall be resolved pursuant to Section 12. All such determinations are
            to be appropriately adjusted for any stock dividend, stock split, stock combination or
            other similar transaction during the applicable calculation period.

            

            [Signature Page
            Follows]

            

            

            

            

            

            

            -19-

            
            

            
            

            

            
                    
            IN WITNESS WHEREOF, the Company has caused this Warrant to Purchase Common Stock to
            be duly executed as of the Issuance Date set out above.

            	
                    	
                    
	
                    	AMISH
                    NATURALS, INC.

                    

                    By:___________________________

                    Name:

                    Title: 

            

            

            

            

            
            

            
            

            

            EXHIBIT
            A

            

            EXERCISE NOTICE
            TO BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS

            WARRANT TO PURCHASE COMMON STOCK

            

            AMISH NATURALS,
            INC.

            

            
                    The
            undersigned holder hereby exercises the right to purchase _________________ of the
            shares of Common Stock (“Warrant Shares”) of Amish Naturals, Inc., a
            Nevada corporation (the “Company”), evidenced by the attached
            Warrant to Purchase Common Stock (the “Warrant”). Capitalized terms
            used herein and not otherwise defined shall have the respective meanings set forth in
            the Warrant.

            

            
                1.       
            Form of Exercise Price. The Holder intends that payment of the Exercise Price shall be
            made as:

            

            	 	
                    ____________ a "Cash
                    Exercise" with respect to _________________ Warrant Shares; and/or 

            

            

            	 	
                    ____________ a "Cashless
                    Exercise" with respect to _______________ Warrant Shares. 

            

            

            
                2.       
            Payment of Exercise Price. In the event that the holder has elected a Cash Exercise
            with respect to some or all of the Warrant Shares to be issued pursuant hereto, the
            holder shall pay the Aggregate Exercise Price in the sum of $___________________ to the
            Company in accordance with the terms of the Warrant.

            

            
                3.       
            Delivery of Warrant Shares. The Company shall deliver to the holder __________ Warrant
            Shares in accordance with the terms of the Warrant.

            

            Date:
            _______________ __, ______

            

            
            ____________________________

                 Name of Registered Holder

            

            By:______________________

                   Name:

                   Title:

            
            
            

            
            

            

            
            ACKNOWLEDGMENT

            

            
                    The
            Company hereby acknowledges this Exercise Notice and hereby directs Signature Stock
            Transfer, Inc. to issue the above indicated number of shares of Common Stock in
            accordance with the Transfer Agent Instructions dated September __, 2007 from the
            Company and acknowledged and agreed to by Signature Stock Transfer,
            Inc.

            	
                    	
                    
	
                    	AMISH
                    NATURALS, INC.

                    

                    By: _______________________________________________

                             Name:

                             Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00129-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00129-of-00352.parquet"}]]